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The molecular structures of [!3-S2H-TmBu
t]Na(THF)3 and [!3-S2H-TmAd]Na(THF)3 
have been obtained, which is significant as these are the first two examples of 
monomeric !3-S2H coordinate sodium compounds to be reported.  Based on an 
extensive structural analysis of all of the [TmR]M compounds listed in the Cambridge 
Structural Database, a set of criteria has been generated that can be used to classify 
[TmR] ligands according to their coordination modes.  Compounds exhibiting !3-S3 
coordination are found to be the most prevalent, as are compounds exhibiting 0:3 
conformation modes. 
A series of [TmBut]CdO2CR complexes (R = C6H4-4-Me; C6H4-4-F; C6H3-3,5-F2; 
C6H3-2,6-F2; C3H6Ph; 9-An; and tridecyl) has been prepared via the reaction of 
[TmBut]CdMe with the corresponding carboxylic acids.  [TmBut]ZnO2CR (R = C6H4-4-
Me; C6H4-4-F; C6H3-3,5-F2; C6H3-2,6-F2; 9-An) have been prepared by an analogous 
method.  In addition, two thiobenzoate complexes, [TmBut]MSC(O)Ph (M = Zn, Cd), 
 
have been obtained via the treatment of [TmBut]MR (R = Me) with thiobenzoic acid.  An 
extensive structural analysis of the [TmBut]MO2CR and [TmBu
t]MSC(O)Ph complexes has 
been provided, based on single crystal X-ray diffraction and NMR spectroscopy.  In 
addition, degenerate benzoate exchange between [TmBut]MO2C(4-C6H4-F) and 4-
fluorobenzoic acid has been investigated by 19F-NMR lineshape analysis over a large 
temperature range (195-262 K).  The acid concentration dependence of the rate for the 
exchange process supports an associative exchange mechanism.  [TmBut]MO2C(4-C6H4-
F) benzoate exchange is extremely rapid on the 19F NMR timescale at 25˚, and has been 
observed to be faster for [TmBut]CdO2C(4-C6H4-F) than for [TmBu
t]ZnO2C(4-C6H4-F). 
The reactivity of [TmBut]CdS(C6H4-4-F) towards different thiols, ArSH (Ar = C6H4-
4-F, C6H4-4-But, C6H4-4-OMe, C6H4-3-OMe), has been investigated using various NMR 
techniques.  In contrast to the results of our degenerate benzoate exchange studies, 
thiolate exchange between [TmBut]CdS(C6H4-4-F) and ArSH is slow on the 1H NMR 
timescale.  Even at elevated temperatures, the NMR signals for the reaction species 
remain resolved with minimal linebroadening.  The equilibrium constants for the 
reactions of [TmBut]CdS(C6H4-4-F) with ArSH (Ar = C6H4-4-But, C6H4-4-OMe, C6H4-3-
OMe) have been calculated and determined to be indistinguishable, with equilibrium 
favoring the [TmBut]CdS(C6H4-4-F) and ArSH species.  Additionally, the reactivity of 
[TmBut]CdS(C6H4-4-F) toward phenols, ArOH (Ar = Ph, 2,6-diphenylphenol), has been 
investigated.  While [TmBut]CdS(C6H4-4-F) has been found to be unreactive toward 
ArOH, [TmBut]CdSOAr (Ar = 2,6-diphenylphenol) reacts immediately (C6H4-4-F)SH, 
resulting in complete conversion to [TmBut]CdS(C6H4-4-F).  Two monomeric 
 
[TmBut]CdE(2-C5H4N) complexes (E = S, Se) have also been prepared, and structurally 
characterized.   
A monomeric, terminal zinc hydride complex, [TmBut]ZnH, has been prepared via 
the reaction of [TmBut]ZnOPh with phenylsilane.  The molecular structure of 
[TmBut]ZnH has been obtained by single crystal X-ray diffraction techniques, and the 
reactivity of [TmBut]ZnH towards various reagents has been investigated.  [TmBut]ZnH 
reacts rapidly with ArEH (EAr = OPh, S(C6H4-4-F), SePh) to form [TmBu
t]ZnEA via H2 
elimination.  [TmBut]ZnH reacts with CO2 to form [TmBu
t]ZnO2CH via CO2 insertion into 
the Zn-H bond.  [TmBut]ZnO2CH can also be prepared by the reaction of [TmBu
t]ZnH 
with formic acid.  [TmBut]ZnH reacts rapidly with ZnEt2 to form [TmBu
t]ZnEt.  The 
reaction of [TmBut]ZnH with CpMo(CO)3H resulted in the formation of a metal-metal 
bonded complex, namely [TmBut]Zn-MoCp(CO)3.   
A series of [TmBut]M-M’Cp(CO) heterobimetallic complexes (M = Zn, Cd; M’ = 
Cr, Mo, W) has been prepared via the reaction of [TmBut]MR (R = Me) with 
CpM’(CO)3H.  An extensive structural analysis of these complexes is provided, based 
on X-ray diffraction and NMR spectroscopy.  Each of these complexes features a direct 
M-M’ bond, which is supported by two partially bridging carbonyl ligands.  Only a 
few complexes featuring an M-M’ bond have been structurally characterized, and the 
molecular structures of [TmBut]Zn-CrCp(CO)3 and [TmBu
t]Cd-WCp(CO)3 represent the 
first two structures reported for compounds featuring either a Zn-Cr or Cd-W bond. 
The coordination chemistry of [tpyAr2] (Ar = p-tolyl, mesityl) and [bppBut] with 
various main group and transition metals has been investigated.  [tpyAr2]MX2 
complexes (M = Co, Zn; X = Cl, I) are prepared by the reaction of [tpyAr2] with the 
 
dihalide MX2 complex.  [bppBu
t]MX2 (M = Fe, Co, Zn, Cd; X = Cl, I) complexes are 
prepared by an analogous method.  Each of these [tpyAr2]MX2 and [bppBu
t]MX2 
complexes have been characterized by single crystal X-ray diffraction.  The [bppBut]LiI 
compound was unexpectedly obtained from the reaction of [bppBut]FeCl2 with MeLi, 
which is significant as it is the first example of an alkali metal complex featuring a 
[bppBut] ligand that has been structurally characterized.  
 
 i 
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1.1 Introduction 
The tris(pyrazolyl)hydroborato ligand, an L2X1 [N3] donor ligand abbreviated 
[TpR,R’] (Figure 1), was first introduced by Trofimenko during the 1960s.2,3  Due to the 
structural and electronic tunability of polypyrazolylborate ligands, they are an 
extremely versatile family of ligands, with 4288 molecular structures of metal 
complexes featuring [TpR,R’] ligands having been reported.4  [TpR,R’] ligands have found 
important applications as structural and functional models for the active sites of 
histidine-rich enzymes, which in turn motivated the development of an [S3] analogue 
for use in modeling the active site of cysteine-rich enzymes.5b  The 
tris(mercaptoimidazolyl)hydroborato ligands, [TmR] (Figure 1),5,6 a family of L2X [S3] 
donor ligands first reported by Reglinski and Spicer in 1996,7 have provided the 
desired complement for the [TpR,R’] ligands.  The success of [TmR] ligands has in turn 
resulted in the development of the oxygen and selenium analogues, [ToR]8 and [TseR]9,10, 
as well as their bis(mercaptoimidazolyl)hydroborato derivatives, [BmR].11,12,13,14  
 




The tert-butyl substituted ligand, [TmBut], is a particularly popular analogue as the 
bulky substituents i) enhance solubility, ii) act as a useful 1H NMR handle, and iii) 
generate a sterically demanding pocket about the metal center.5b,c  Although the 
molecular structures of [TmBut]M complexes have been obtained for various main group 
and transition metals, the structure of an alkali metal [TmR]M complex had previously 
not been reported.16  Our recent report of the molecular structures of [!3-S2H-
TmBut]Na(THF)3 (Figure 2) and [!3-S2H-TmAd]Na(THF)3 (Figure 3) is therefore 
significant.17  Within that report we also provided an in depth analysis of the 
coordination and conformation modes assumed by the [TmR] ligands, and our findings 
will be described herein.  
 
1.2 Results & Discussion  
1.2.1 Preparation of [!3-S2H-TmBu
t]Na(THF)3 and [!3-S2H-TmAd]Na(THF)3 
Traditionally the [TmBut] ligand is prepared as the alkali metal derivative, 
[TmBut]M (M = Na,5c K5b), by treating 1-t-butyl-1,3-dihydro-2H-imidazole-2-thione with 
NaBH4 or KBH4 in toluene.  These alkali derivatives are useful precursors for the 
synthesis of various {[TmBut]M} complexes, and although many of these {[TmBut]M} 
complexes have been structurally characterized by X-ray diffraction, 5a,b,c,18 the sodium 
and potassium derivatives have not.  It is therefore significant that we were able to 
isolate large crystals of the THF adduct [!3-S2H-TmBu
t]Na(THF)3 by treating 1-t-butyl -
1,3-dihydro-2H-imidazole-2-thione with NaBH4 in THF (Scheme 1.).  We were also 
able to isolate crystals suitable for X-ray diffraction of the [!3-S2H-TmAd]Na(THF)3 





Scheme 1.  Preparation of the [!3-S2H-TmR]Na(THF)3 complexes.20 
 
1.2.2 Structural Analysis of [!3-S2H-TmR]Na(THF)3  
Analysis of the molecular structures of [!3-S2H-TmBu
t]Na(THF)3 and [!3-S2H-
TmAd]Na(THF)3 (Figure 2 and Figure 3 respectively) indicate that they are structurally 
similar, monomeric compounds.  The [!3-S2H-TmBu
t]Na(THF)3 compound contains two 
coordinating sulfur atoms with Na-S bond lengths of 2.877(1) Å and 3.074(2) Å, while 
the third sulfur is positioned significantly further away from the Na center [Na•••S = 
4.627(2) Å], indicating that there is no bonding interaction.  The [!3-S2H-
TmAd]Na(THF)3 exhibits similar Na•••S interactions (Table 1), with only two of the 
three sulfur atoms coordinating to the Na center.  Both [!3-S2H-TmBu
t]Na(THF)3 and 
[!3-S2H-TmAd]Na(THF)3 feature significant Na•••B-H bonding interactions, with 
Na•••H distances of 2.30(3) Å and 2.15(2) Å respectively, such that the bonding in 




















Table 1.  Select bond length data (Å) for [TmR]Na moieties.21 
 d(Na•••S1) d(Na•••S2) d(Na•••S3) Ref 
[!3-S2H-TmBu
t]Na(THF)3 2.877(1) 3.074(2) 4.627(2) 17 
[!3-S2H-TmAd]Na(THF)3 2.990(2) 3.060(2) 4.389(2) 17 
{[!3-S2H-TmMe]Na}2(µ-DMF)2 2.7370(7) 2.8075(7) 4.908 16e 
{[!3-S3-TmMeBenz]Na}2(µ-THF)3 2.802(1) 2.816(1) 2.873(1) 11c 
[!3-S2H-TmBu
tBenz]Na(THF)}2(µ-THF)2 2.945(3) 3.078(3) 3.552(3) 23 
[TmMe]Na•3.25H2O•0.5DMFa 3.128(1)  5.259 5.426 16e 





Table 1 (continued).  Select bond length data (Å) for [TmR]Na moieties. 
 d(Na•••B) d(Na•••H) Ref 
[!3-S2H-TmBu
t]Na(THF)3 3.241(3) 2.30(3) 17 
[!3-S2H-TmAd]Na(THF)3 3.141(4) 2.15(2) 17 
{[!3-S2H-TmMe]Na}2(µ-DMF)2 3.210 2.36 16e 
{[!3-S3-TmMeBenz]Na}2(µ-THF)3 4.193 – 11c 
[!3-S2H-TmBu
tBenz]Na(THF)}2(µ-THF)2 3.246 2.12(5) 23 
[TmMe]Na•3.25H2O•0.5DMFa 4.787 – 16e 






As is evident by the data displayed in Table 1, [TmR]Na compounds can assume a 
variety of coordination modes depending on the type of substituent and crystallization 
medium used.  For example, the [TmMe] moiety of the [TmMe]Na•4.5H2O compound is 
present as discrete [TmMe]– anions, such that it assumes a !0 coordination and does not 
directly bond to the sodium cation.7b,22  The [TmMe]Na•3.25H2O•0.5DMF compound 
incorporates two solvent molecules into its structure, such that the [TmMe] moieties 
assume two different coordination modes, namely !0 and !1-S.16e  [TmR]Na compounds 
can also assume !3-S3 coordination, as exhibited by the {[TmMeBenz]Na}2(µ-THF)3 
compound, in which all three of the sulfur atoms coordinate to the Na center.8, 11c  The 
k3-S2H coordination mode exhibited by the [!3-S2H-TmR]Na(THF)3 (R = But, 1-Ad) 
compounds is featured in two similar dinuclear [TmR]Na compounds, namely {[!3-S2H-
TmButBenz]Na(THF)}2(µ-THF)223 and {[!3-S2H-TmMe]Na}2(µ-DMF)2,16e however, this type of 
coordination is unprecedented for mononuclear alkali metal compounds.24  
 
1.3 Analysis of the coordination and conformational modes assumed by [TmR] 
Ligands 
1.3.1 Coordination modes 
The [TmR] ligand can coordinate to a metal center through any number of its 
sulfur atoms (i.e. !-S, !2-S2 and !3-S3 coordination modes) as well as through the 
hydrogen atom in the B–H moiety (i.e  !2-SH, !3-S2H and !4-S3H), such that there are a 





Figure 4.  Possible coordination modes assumed by [TmR] ligands. 
 
 
The ability of the [TmR] ligand to adopt a wide range of coordination modes 
allows it to stabilize a variety of transition and main group metal centers.  In an 
attempt to evaluate the coordination preferences of the [TmR] ligand, we performed a 
detailed analysis of all of the structurally characterized [TmR]M compounds listed in the 
Cambridge Structural Database.25,26  The coordination mode exhibited by each 
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compound was identified by normalizing the M–Smed, M–Slong, M–B and M–H distances 
relative to the shortest M–S bond length (M–Sshort) in the complex, i.e. "(M–X) = d(M–X) 




Table 2.  Criteria for classifying [TmR] ligand coordination modes. 
 Coordination mode 
 !1-S1 !2-S2 !3-S2H !3-S3 !4-S3He 
"(M–Smed)/Åa > 0.7 ≤ 0.7 ≤ 0.3 ≤ 0.3 ≤ 0.2 
"(M–Slong)/Åb ≥ 2.1 ≥ 2.2 ≥ 1.2 ≤ 0.4 ≤ 0.2 
"(M–B)/Åc ≥ 0.9 ≥ 0.9 < 0.9 1.0 to 2.0 0.1 to 0.3 
"(M–H)/Åd >0.0 > 0.0 ≤ 0.0 2.0 to 3.2 –0.7 to –1.0 
(a)  "(M–Smed) = d(M–Smed) – d(M–Sshort) 
(b)  "(M–Slong) = d(M–Slong) – d(M–Sshort) 
(c)  "(M–B) = d(M–B) – d(M–Sshort) 
(d)  "(M–H) = d(M–H) – d(M–Sshort) 








A plot (Figure 5)27 of the normalized M–S distances for the medium and long M–
S interactions, i.e. "(M–Smed) versus "(M–Slong), was generated in an attempt to develop 
criteria to differentiate between S1, S2 and S3 coordination modes.  These coordination 
modes were found to occupy three distinct regions in the plot: (i) for compounds 
featuring S1 coordination "(M–Smed) > 0.7 Å and "(M–Slong) ≥ 2.1Å, (ii) for compounds 
featuring S2 coordination "(M–Smed) ≤ 0.7 Å and "(M–Slong) ≥ 2.1 Å, (iii) for compounds 
that feature S3 "(M–Smed) ≤ 0.3 Å and "(M–Slong) ≤ 0.4 Å.  The criteria developed for 
distinguishing between S1, S2 and S3 coordination modes is listed in Table 2.  It is 
important to note that while this set of criteria can be used as a set of guidelines to 
describe the coordination modes assumed by [TmR] ligand, compounds with values 
falling on the borderlines must be given special consideration as the assignment of the 
coordination mode becomes subjective in these cases.  This is especially important to 
keep in mind when attempting to draw conclusions about molecular properties based 
on the assigned coordination mode.  For example, most reported compounds that are 
described as exhibiting !2-S2 coordination are characterized by values of "(M–Smed) ≤ 0.3 
Å; however the [TmMe]2SbX (X = Br, I) compound has also been described as a !2-S2 
coordination compound despite the fact that it possess significantly larger "(M–Smed) 





Figure 5.  Use of the normalized "(M–Smed) and "(M–Slong) values as 
criteria for distinguishing between !x-Sx coordination modes. 
 
Although the plot in Figure 5 can be used to identify [TmR] ligands based on the 
number of sulfur atoms coordinated to the metal center, it cannot be used to distinguish 
between !x-Sx and !x+1-SxH coordination modes.  In order to make this sort of 
distinction, the M•••H distance as well as the orientation of the B-H group with respect 
to the metal center must be considered.  A plot of the normalized "(M–H) values versus 
"(M–Smed) (Figure 6) shows that the !x+1-SxH coordination modes occupy the region in 
which "(M–H) ≤ 0.0 Å.27  In [TmR]M compounds, the M-H bond is expected to be 
approximately 0.8 Å shorter than a M-S bond, due to the fact that i) the covalent radii of 
H and S are 0.31 Å and 1.05 Å respectively,29 and ii) the length of a M-S bond in [TmR] 
compounds is approximately 0.1 Å longer than in M-SR compounds, as the [TmR] 
 
 13 
ligand is an L2X donor.18j,30  The fact, however, that the M•••H distance for a 3-center-2-
electron M•••H-B interaction can be up to 0.7 Å longer than a typical 2-center-2-electron 
M-H bond,31 provides a rationalization for this upper limit of "(M–H) = 0 in !x+1-SxH 
coordinate [TmR] ligands ("(M–H) = –0.8 + 0.7 = –0.1 Å, i.e. ≈ 0).  The criteria 
developed for distinguishing between !x-Sx and !x+1-SxH coordination modes is listed in 
Table 2. 
The Na•••H-B distance in the [TmBut]Na(THF)3 (–0.58 Å) and [TmAd]Na(THF)3 (–
0.84 Å) compounds suggest a strong Na•••B-H bonding interaction, based on the 
criteria presented in Table 2.  These values are in the range of those reported for most 
[TmR]M compounds described as possessing !3-S2H coordination,6c,13h,18e,h,32 such as 
[TmMe]Ru(PPh3)(CO)H (–0.56 to –0.70 Å),33 [TmMe]Ru(PPh3)2H (–0.50 Å),34 
[TmMe]Ru(DMSO)2Cl (–0.51 Å),13v [TmBut]Fe(py)Cl (–0.21 Å),18e and [TmMe]2Ba(OH2)2 (–
0.55 Å).22a  It should be noted, however, that there are a few examples of compounds in 
the literature with significantly larger values of "(M–H) (ca. 0.5 Å35) that have been 





Figure 6.  Use of the normalized "(M–H) values as criteria for distinguishing 
between !x-Sx and !x+1-SxH coordination modes. 
 
 Figure 7 displays a plot of "(M–H) versus "(M–B), which can be used to analyze 
the distribution of [TmR] ligands according to the orientation of their B-H groups with 
respect to the metal center;36 a feature that helps to further distinguish between !x-Sx 
and !x+1-SxH coordination.  Analysis of the plot reveals that the [TmR] ligands fall in 
two distinct regions.  Region 1 ["(M–H) > "(M–B)] is occupied by compounds in which 
the hydrogen of the B–H bond points away from the metal, the majority of which 
possess !3-S3 coordination.  Only one compound in Region 1 possesses a different 
coordination mode, namely [TmMe]2Te,37,38 which exhibits !2-S2 coordination (Figure 19) 
with an unusual geometry that will be further described in Section 2.3.2.   
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If the M•••B-H moieties in the [!3-S3-TmR]M compounds are close to linear, then 
it would be expected that a linear plot (slope = 1) of their "(M–H) versus "(M–B) values 
would yield a y-intercept that is equal to the mean B-H bond length (1.07 Å) in all [TmR] 
complexes listed in the Cambridge Structural Database.39  This linear plot yields an 
intercept of 1.07 Å (Figure 7), which verifies that indeed [!3-S3-TmR]M compounds 
feature linear M•••B-H moieties.   
Region 2 ["(M–H) < "(M–B)] of the graph in Figure 7 is occupied by compounds 
in which the hydrogen of the B–H moiety points towards the metal.  Interestingly there 
is one compound, namely {[!2-S2-TmMe][B(mimMe)3]2Rh2}+,40 that falls on the line "(M–
H) = "(M–B) that separates Region 1 from Region 2.  The location of this compound on 
the graph suggests that its B-H bond is positioned orthogonal to the metal.  This 
uncommon geometry is due to an unusual conformation of the 8-membered chelate 





Figure 7.  Distribution of [TmR] ligands according to the values of "(M–H) and "(M–
B).  The straight line drawn through the origin corresponds to the equation "(M–H) = 
"(M–B).  As such, any point above this line corresponds to Region 1, with "(M–H) > 
"(M–B) and the hydrogen directed away from the metal, while points below the line 
correspond to Region 2, with "(M–H) < "(M–B) and the hydrogen directed towards the 
metal.  The dotted line "(M–H) = "(M–B) + 1.07 verifies an approximately linear 








It is also important to note that there are several reported examples of 
compounds exhibiting !0 coordination,7b,16e,221,28,41 in which the [TmR] ligand acts as a 
discrete anion, as well as examples of compounds possessing bridging [TmR] 
ligands.6b,c,9,12a,16f,18a,b,c,d,l,m,p,22a,42  Possible bridging coordination modes include (i) a 
!1,!1,!1 mode in which the [TmR] ligand bridges three metal centers,18b,d,22a or (ii) a !1,!1 
mode,18c (ii) a !1,!2 mode,9,18a,l,6b or (iii) a µ-!2, !2 mode6c,12a,18c,m,p,42 in which the [TmR] 
ligand bridges two metal centers.  Such bridging modes are illustrated in Figure 8. 
 
 
Figure 8.  Coordination modes associated with [TmR] ligands that bridge more than 
one metal. 
 
Figure 9 provides a graphical representation of the distribution of [TmR] ligands 
according to their coordination modes, and Table 3 provides the prevalence of each 
coordination mode as a percentage of all [TmR] ligands listed in the Cambridge 
Structural Database.  The !3-S3 coordination is the most predominate (71.9%) mode of 
coordination in [TmR] ligands, while !4-S3H coordination is the least (0.8%).  
Interestingly, there are no reported compounds featuring !2-SH coordination listed in 


















Table 3.  Prevalence of [TmR] coordination modes relative to all [TmR] ligands listed in 
the Cambridge Structural Database. 
Coordination mode Number of Examplesa % 
!0 6 1.6 
!1-S1 8 2.2 
!2-SH 0 0.0 
!2-S2 20 5.4 
!3-S2H 33b 8.9 
!3-S3 266 71.9 
!4-S3H 3c 0.8 
µ–[TmR] 34 9.2 
(a)  number of times the coordination mode is observed in structurally 
characterized compounds listed in the CSD.   
(b)  includes [!3-S2H-TmBu
t]Na(THF)3 and [!3-S2H-TmAd]Na(THF)3. 
(c)  includes one compound, namely [TmMeBenz]K(OCMe2)3, which is not listed in 
the CSD (reference 23). 
 
1.3.2 Conformation modes 
The imidazolethione moieties in the [TmR] ligands are free to rotate about the B-
N bond, allowing the ligand to assume various conformations based on the direction of 
the thione donors with respect to the B-H bond (Figure 10).  Thione donors that point 
towards the B-H moiety are described as syn, with a H-B-N-C(S) torsion angle < 90˚, 
while thione donors that point away are described as anti, possessing H-B-N-C(S) 
torsion angles > 90˚ (Figure 11).  In 2013 Reglinski and Spicer introduced a systematic 
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method for describing the conformation of [TmR] ligands using the form (x:y), in which 
“x” refers to the number of thione donors syn and “y” refers to the number of thione 
donors anti to the B-H moiety (Figure 10).43  
 
 
Figure 10.  Idealized conformations of [TmR] ligands, expressed using the form (x:y).  
The first number of the x:y designation refers to the number of thiones that are syn to 
the B–H group, while the second number refers to the number that are anti. 
 
 
Figure 11.  H–B–N–C(S) torsion angles.  Imidazolethione moieties with torsion angles 
< 90˚ are classified as syn to the B–H group, while those with values > 90˚ are classified 




The histogram displayed in Figure 12 graphically presents the distribution of H-
B-N-C(S) torsion angles for the imidazolethione moieties present in each of the reported 
[TmR] ligands.27  Analysis of the histogram reveals that the torsion angles occupy three 
regions with average weighted values of 12.6˚, 48.9˚, and 147.0˚.  The cluster at 147.0˚ 
represents the torsion angles for 76 % of the total number of imidazolethione moieties in 
all reported [TmR] ligands, thereby indicating that an anti conformation of the 
imidazolethione moiety is the predominant geometry (Table 4).27  
 
 
Figure 12.  Distribution of H–B–N–C(S) torsion angles for all reported [TmR]M 
compounds listed in the CSD.  The categories (x-y) refer to torsion angle values (#) that 




Table 4.  Distribution of H–B–N–C(S) torsion angles for all reported [TmR]M 
compounds listed in the CSD.a 
Torsion angle range/˚ Average torsion angle/˚ Number of entries 
0 – 30 12.6 90 
30 – 75 48.9 157 
75 – 110 89.8 1 
110 – 180 147.0 805 
(a)  includes [!3-S2H-TmBu
t]Na(THF)3 and [!3-S2H-TmAd]Na(THF)3, and one compound, 
namely [TmMeBenz]K(OCMe2)3, which is not listed in the CSD (reference 23). 
 
The distribution of all [TmR] ligands reported in the Crystal Structural Database 
according to their idealized conformations is presented in the form of a histogram in 
Figure 13.  Analysis of the histogram reveals that the 0:3 conformation is most 
prevalent, which is to be expected as this conformation is required for !3-S3 
coordination, which is the most common coordination mode assumed by [TmR] ligands.  
The histogram in Figure 13 also indicates that the 1:2 conformation mode is the least 
prevalent, with only one reported compound exhibiting this geometry, namely 
{[TmMe]CH2}+ (Figure 14).13g  The uncommon conformational mode assumed by 
{[TmMe]CH2}+ is rationalized by the fact that this is the only [TmR] compound that does 
not contain a metal center, but rather two of the thione donors coordinate to a 









Figure 14.  The only example of a [TmR] compound listed in the Cambridge Structural 
Database that features a 1:2 conformation, namely {[TmMe]CH2}+.  Coordinates taken 
from reference 13g. 
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Most coordination modes of [TmR] ligands can be associated with more than one 
conformation mode (Table 5); however, due to geometrical constraints, [TmR] ligands 
featuring !3-S3 and !4-S3H coordination modes can only assume 0:3 and 3:0 
conformations respectively.  Table 5 summarizes the prevalence of conformational 




Table 5.  Distribution of [TmR] ligand conformational modes as a function of 
coordination mode.a 
Coordination mode 3:0 2:1 2:– 1:2 0:3 
!3-S3 – – – – 266 
!4-S3H 3 – – – – 
!2-S2 7 12 – 1 – 
!3-S2H 18 14 1 – – 
!1-S 5 3 – – – 
!2-SH – – – – – 
µ–[TmR] 32 2 – – – 
!0- 5 1 – – – 
Total 70 32 1 1 266 
(a)  data taken from the CSD, but exclude duplicate compounds; data also include 
[!3-S2H-TmBu
t]Na(THF)3 and [!3-S2H-TmAd]Na(THF)3, and one compound, namely 




 As is evident from Table 5, compounds exhibiting !1-S1 coordination are rare; 
however, they are known to adopt either 3:016e,18i or 2:144 conformational modes, 
examples of which are [TmBut]HgMe (Figure 15)18i and [TmMe]SnPh3 (Figure 16),44a 
respectively. 
 
Figure 15.  An example of a !1-S [TmR] compound, namely [TmBut]HgMe, that adopts a 
3:0 conformation.  Coordinates taken from reference 18i. 
 
Figure 16.  An example of a !1-S [TmR] compound, namely [TmMe]SnPh3, that adopts a 
2:1 conformation.  Coordinates taken from reference 48a. 
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Analysis of Table 5 shows that [TmR] ligands exhibiting !2-S2 coordination modes 
can assume either a 3:018a,c,28,35,37 or 2:16b,18a,p,28,35,37,40 conformation.  For example, the 
compound [!2-S2-TmBu
t]AuPPh3 exhibits a 3:0 conformation (Figure 17), while the 
compound [!2-S2-TmBu
t]2Zn assumes a 2:1 conformation (Figure 18).  It is logical to 
assume that a 1:2 conformation could also be associated with a !2-S2 coordinate 
compound, however, this type of conformational mode has not been observed for any 
of the reported metal [!2-S2-TmR]M complexes.  Likewise, in theory, [!2-S2-TmR]M 
complexes could assume a 0:3 conformation, however the close proximity of the three 
thione donors to the metal center promotes !3-S3 coordination. 
 
 
Figure 17.  An example of a complex featuring !2-S2 coordination and a 3:0 




Figure 18.  An example of a complex exhibiting !2-S2 coordination and a 2:1 
conformation, namely [TmBut]2Zn.  Coordinates taken from reference 6b. 
 
For [!2-S2-TmR]M compounds that exhibit a 2:1 conformation, the [TmR] ligand 
usually coordinates to the metal center through two syn thione donors; however, 
[TmMe]2Te (Figure 19)37 and {[TmMe][B(mimMe)3]2Rh2}+ (Figure 20)40 are two examples of 
compounds in which coordination occurs through one syn and one anti thione donor.  
The geometry assumed by this syn/anti coordination directs the B-H moiety away from 
the metal center, thereby inhibiting any M•••H-B interaction.  For example, the 
M•••H distance in {[TmMe][B(mimMe)3]2Rh2}+ is 4.36 Å, therefore it is appropriately 





Figure 19.  Molecular structure of [TmMe]2Te, illustrating two types of uncommon !2-S2 
coordination modes, i.e. the tellurium coordinates to one [TmR] ligand via one sulfur 
that is syn and one that is anti to the B–H group (right hand side) and to one [TmR] 
ligand that exhibits a chair-like conformation (left hand side).  Coordinates taken from 
reference 37. 
 
Figure 20.  Molecular structure of {[TmMe][B(mimMe)3]2Rh2}+ illustrating the 
coordination of the rhodium to one sulfur that is syn and one that is anti to the B–H 
group (coordinates taken from reference 40). 
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As is evident from Table 5, there is only one !3-S2H compound that exhibits what 
we describe as a 2:- conformation, namely [TmMe]Ru(DMSO)2Cl (Figure 21).13v  The H-
B-N-C(S) torsion angle of the uncoordinated thione is 89.8˚, which is sufficiently close to 
90˚; therefore, the conformation of this compound can not be accurately described as 
either 3:0 or 2:1.  The (x:y) form of classification introduced by Reglinski and Spicer did 
not account for this type of conformation,43 therefore we describe the conformation of 
this compound as 2:-, where the dash is used to indicate that the uncoordinated thione 
is not pointing significantly in either direction. 
 
 
Figure 21.  A single example of a {[TmR]M} compound that features a 2:– conformation 
in which the uncoordinated imidazolethione has a torsion angle of 90˚, namely 





1.3.3 Boat-like vs. chair-like geometrical conformations of the [TmR] ligand 
The 8-membered chelate ring formed by !2-S2 coordination of the [TmR] ligand 
can assume two different geometrical conformations, which can be loosely described as 
either “boat-like” or “chair-like”, as illustrated in Figure 22.45,46  In a “boat-like” 
structure, the metal center is located in an endo position relative to the B-H moiety 
(Figure 22), as illustrated by the [TmMe]Rh(CO)[P(NMe2)3] complex (Figure 23).34  All 
reported [!3-S2H-TmR]M compounds assume a “boat-like” geometrical conformation, as 




Figure 22.  “Boat-like” (left) and “chair-like” (right) geometrical conformations of the 
8-membered rings in !2-S2 {[TmR]M} complexes.  For the boat-like conformation, M 
adopts an endo position with respect to the B–H moiety, whereas it adopts an exo 






Figure 23.  An example of a !2-S2 {[TmR]M} compound, [TmMe]Rh(CO)[P(NMe2)3], that 
features a “boat-like” conformation.  Coordinates taken from reference 34. 
 
 
In a “chair-like” structure, the metal is in an exo position (Figure 24).  There are 
only two reported [TmR]M compounds in the Cambridge Structural Database that 
exhibit a “chair-like” conformation, namely [TmMe]2Te (Figure 19)37 and {[TmMe]2Sb}+ 
(Figure 24).28  The [TmMe]2Te compound is an example of how the [TmR] ligands in bis-
[TmR]2M compounds can assume different conformations.  As previously stated, one of 
the [TmMe] ligands in the [TmMe]2Te compound exhibits a twisted syn/anti conformation, 





Figure 24.  An example of a [!2-S2-TmR]M compound, [TmMe]3Sb, that exhibits a “chair-
like” conformation of the 8-membered chelate ring.  In addition to the !2-S2 
coordination mode, there is also a !3-S3-[TmMe] coordinated ligand and a [TmMe]– 
counterion (not shown).  Coordinates taken from reference 37. 
 
 
1.3.4 Conformational preferences of [TmR]– anions 
Whereas the conformations assumed by !x-Sx and !x+1-SxH compounds, where x > 
0, are affected by geometrical restrictions associated with coordination to the metal 
center, the imidazole thione donors in a !0 [TmR] – anion are free to rotate about the B-N 
bond without restrictions.  Therefore, it is interesting that the only conformations 
observed for reported examples of !0 [TmR] – anions are 3:07b,16e,22a,28,41 and 2:141b (Table 5).  
In order to investigate the conformational preferences for !0 [TmR] – anions, a series of 
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density functional theory (DFT) calculations were performed, where R = But, 1-Ad 
(Figure 25).  
For both the [TmBut] – and [TmAd] – anions, the lowest energy conformation was 
determined to be 2:1 (Figure 25), which support the reported results from similar 
calculations performed on the [TmMe] – and [TmMeBenz] – anions (Table 6).11c,43a  In each 
case the 3:0 conformation, which is only approximately 3 kcal mol-1 higher than the 2:1 
conformation, was determined to have the next lowest energy.  The results of these 
calculations help explain why these two conformations are the only modes exhibited by 
reported examples of !0 [TmR] – anions in the solid state (Table 5).7b,16e,22a,28,41b  
These calculations also support the experimental observation that [TmR] 
compounds exhibiting a 1:2 conformation are exceedingly rare (Table 5), in that a stable 
1:2 conformation could not be obtained for the [TmBut] – anion; the structure with this 
initial geometry rearranged to the more stable 2:1 conformation during the optimization 
process.  Interestingly, it was possible to geometry optimize a stable 1:2 conformation 
for the [TmAd] – anion, the energy of which was calculated to be 6.8 kcal mol-1 higher 
than the 2:1 conformation (Table 6).  
The 0:3 conformation proved to be the highest in energy for both the [TmBut] – 
(16.3 kcal mol-1) and [TmAd] – (15.3 kcal mol-1) anions, suggesting that it is indeed the 
least stable conformation (Table 6).  This result seems counterintuitive, as it is the 0:3 
conformation that is most commonly observed in [TmR]M compounds, due to the fact 
that it is the geometry required by compounds exhibiting !3-S3 coordination (Table 5).  
This result is a reflection of the M-S bonds in these metal compounds being sufficiently 
strong to compensate for the energetic penalty associated with the [TmR] ligand 
assuming the 0:3 conformation, which is not favored for the gas phase [TmR] anion.  
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The 0:3 conformation of the [TmMe] – was previously reported as having an energy of 
14.4 - 14.7 kcal mol-,11c,43a which is in accord with our result for the [TmBut] – and [TmAd] – 
anions.  Calculations performed on the [TmMeBenz] – anion, however, revealed that the 
0:3 conformation had an energy of 4.9 kcal mol-1,11c which is significantly lower than that 
of the 0:3 conformation of the non-benzannulated [TmR] – anions studied, thereby 
supporting the experimental observation that benzannulation facilitates !3-S3 





Figure 25.  Geometry optimized (B3LYP functional and 6-31G** basis set) 
conformations of [TmR]– anions (R = 1-Ad, But).  A stable 1:2 conformation (*) was not 
observed for [TmBut]–; a structure with this conformation as the initial geometry 
rearranged to the more stable 2:1 structure during the optimization process. 
 
 36 
Table 6.  Relative energies of [TmR]– conformers. 
 Relative Energy/kcal mol–1 Reference 
 3:0 2:1 1:2 0:3  
[TmMe]– 3.2 0.0 –a 14.7 11c 
[TmMe]– 2.9 0.0 –a 14.4 43a 
[TmBut]– 3.1 0.0 –a 16.3 17 
[TmAd]– 2.9 0.0 6.8 15.3 17 
[TmMeBenz]– 2.8 0.0 –a 4.9 11c 




1.4 Summary and Conclusions 
Despite the popularity of the [TmR]Na (R = But, 1-Ad) compounds, their crystal 
structures have not been reported.  We recently reported the first crystal structures of 
their THF adducts, [!3-S2H-TmBu
t]Na(THF)3 and [!3-S2H-TmAd]Na(THF)3 THF,17 a 
discussion of which is provided herein.  Analysis of their molecular structures 
revealed that both compounds are monomeric, with the [TmR] ligands coordinating to 
the sodium center via two thione donors, with these bonds further supported by a 
strong M•••H-B interaction.  Therefore the compounds are appropriately described as 
exhibiting !3-S2H coordination.  These compounds represent a new structural type for 
alkali [TmR]M compounds, as these two compounds are the first monomeric !3-S2H 
coordinate sodium compounds reported.  
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A detailed analysis of the [TmR]M compounds listed in the Cambridge Structural 
Database was performed in an attempt to determine the distribution of [TmR] ligands 
based on their coordination and conformation modes.  Compounds exhibiting !3-S3 
coordination were found to be the most prevalent, while compounds exhibiting !4-S3H 
are least common with only 3 known examples.  Based on our detailed analysis of 
these compounds, we were able to generate a set of criteria that can be used to classify 
[TmR] ligands according to their coordination modes.  
 DFT calculations performed on the [TmBut] – and [TmAd] – anions indicate that the 
most stable conformational mode is 2:1, while the least stable is 0:3.  The fact that the 
0:3 conformation corresponds to the most commonly observed coordination mode, 
namely !3-S3, suggests that the M-S bond must be strong enough in the solid state to 
overcome the energetic penalty associated with assuming this conformation in the gas 
phase. 
 In comparison to [TpRR’] ligands, the [TmR] ligands are much more flexible, as is 
evident from the diverse structural geometries they assume.  This flexibility in 
geometry is the result of the fact that the [TmR] ligands possess a 3-atom linker between 
the boron and sulfur donor atom, whereas the [TpRR’] ligands only possess a 2-atom 
linker between the boron and its nitrogen donor atom.  For example, whereas !4-S3H 
coordination is possible in [TmR] ligands, this type of “inverted” !4–coordination is not 
possible for [TpRR’] ligands.  The increased flexibility of the [TmR] ligand is particularly 
advantageous as it allows for the ligand to coordinate a variety of metal centers and it 




1.5 Experimental Section 
1.5.1 General Considerations 
 All manipulations were performed using a combination of glovebox, high 
vacuum, and Schlenk techniques under a nitrogen or argon atmosphere.47  Solvents 
were purified and degassed by standard procedures.  1H NMR spectra were measured 
on Bruker 300 DRX, Bruker 400 DRX, Bruker 400 Cyber-enabled Avance III and Bruker 
Avance 500 DMX spectrometers.  1H NMR spectra are reported in ppm relative to 
SiMe4 ($ = 0) and were referenced internally with respect to the protio solvent impurity 
($ 7.26 for CDCl3 and 2.50 for d6-DMSO).48  13C NMR spectra are reported in ppm 
relative to SiMe4 ($ = 0) and were referenced internally with respect to the solvent ($ 
77.16 for CDCl3 and 39.52 for d6-DMSO).48  Coupling constants are given in hertz.  
Infrared spectra were recorded on a PerkinElmer Spectrum Two spectrometer and are 
reported in reciprocal centimeters (cm–1).  Mass spectra were obtained on a JEOL JMS-
HX110HF tandem mass spectrometer using fast atom bombardment (FAB).  1-t-butyl-
1,3-dihydro-2H-imidazole-2-thione49 and 1-adamantyl-1,3-dihydro-2H-imidazole-2-
thione6a were prepared by the literature methods and NaBH4 (VWR) was obtained 
commercially and used as received.  
 
1.5.2 X-ray Structure Determinations 
 Single crystal X-ray diffraction data were collected on a Bruker Apex II 
diffractometer and crystal data, data collection and refinement parameters are 
summarized in Table 7. The structures were solved using direct methods and standard 
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difference map techniques, and were refined by full-matrix least-squares procedures on 
F2 with SHELXTL (Version 2008/4).50 
 
1.5.3 Computational Details 
Calculations were carried out using DFT as implemented in the Jaguar 7.7 (release 107) 
suite of ab initio quantum chemistry programs.51  Geometry optimizations and 
frequency calculations were performed with the B3LYP density functional52 using the 
6-31G** (H, B, C, N, S, Na) basis set.53  
 
1.5.4 Synthesis of [!3-S2H-TmBu
t
]Na(THF)3•THF 
[TmBut]Na was prepared by modification of a literature method.3c A mixture of 1-t-butyl-
1,3-dihydro-2H-imidazole-2-thione (811 mg, 5.19 mmol) and NaBH4 (65 mg, 1.72 mmol) 
was placed in a pressure vessel and treated with dry THF (ca. 5 mL).  The mixture was 
heated at 138˚ C under a N2 atmosphere for 3 days, at which point the solution was a 
light brown color.  The stirring was stopped and the reaction mixture was allowed to 
cool to room temperature, at which point large crystals of [TmBut]Na(THF)3•THF, 
suitable for X-ray diffraction, began to grow.  The reaction solution was allowed to sit 
at room temperature for 3 days to allow for crystallization.  The reaction vessel was 
then placed in an ice bath for 3 hours to induce further crystallization and the crystals 
were isolated by filtration.  The coordinated THF may be removed by washing with 
pentane (ca. 3 mL) and drying in vacuo to yield [TmBut]Na as an off-white solid (522 mg, 
61%).  Analysis calcd. for [TmBut]Na: C, 50.4%; H, 6.9%; N, 16.8%.  Found: C, 50.2%; H, 
6.9%; N, 16.5%.  1H NMR for [TmBut]Na(THF)3•THF (CDCl3): 1.77 [s, 27H of 
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HB{C2N2H2[C(CH3)3]CS}3], 1.85 [m, 16H of 4 CH2 of 4 THF], 3.74 [m, 16H of 4 CH2 of 4 
THF], 6.06 [d, 3JH-H = 2, 3H of HB{C2N2H2[C(CH3)3]CS}3], 6.81 [d, 3JH-H = 2, 3H of 
HB{C2N2H2[C(CH3)3]CS}3].  13C{1H} NMR for [TmBu
t]Na(THF)3•THF (CDCl3): 25.8 [8C of 
4 CH2 of 4 THF], 28.7 [9C,, HB{C2N2H2[C(CH3)3]CS}3], 58.5 [3C,, 
HB{C2N2H2[C(CH3)3]CS}3], 68.1 [8C of 4 CH2 of 4 THF], 115.6 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 118.1 [3C,, HB{C2N2H2[C(CH3)3]CS}3],  161.7 [3C, 
HB{C2N2H2[C(CH3)3]CS}3]. IR Data (ATR, cm-1): 3315 (w), 3150 (w), 2972 (w), 2872 (w), 
2529 (w), 1636 (w), 1482 (w), 1455 (w), 1407 (w), 1355 (s), 1268 (m), 1222 (w), 1199 (m), 
1162 (m), 1091 (m), 1053 (m), 976 (w), 897 (w), 822 (w), 781 (w), 736 (m), 713 (m), 677 
(m), 599 (w), 564 (w), 550 (w), 497 (w), 483 (w), 461 (w), 406 (w).  FAB-MS: m/z = 500.2 
[M]+, M = [TmBut]Na. 
 
1.5.5 Synthesis of [k3-S2H-TmAd]Na(THF)3•0.5THF 
A mixture of 3-adamantyl-1H-imidazole-2-thione (495 mg, 2.11 mmol) and NaBH4 (26.6 
mg, 0.70 mmol) was placed in a pressure vessel and treated with dry THF (ca. 6 mL).  
The mixture was heated at 138˚ C under a N2 atmosphere for 4 days, at which point the 
mixture was a white suspension.  The stirring was stopped and the reaction mixture 
was allowed to cool to room temperature.  The mixture was filtered and the precipitate 
was washed with pentane (ca. 2 mL) and dried in vacuo, yielding [TmAd]Na as a white 
solid (362.5 mg, 70%).  Crystals of [TmAd]Na(THF)3 suitable for X-ray diffraction were 
grown from a solution in THF.  Analysis calcd. for [TmAd]Na: C, 63.7%; H, 7.1%; N, 
11.4%.  Found: C, 63.5%; H, 6.9%; N, 11.2%.  1H NMR for [TmAd]Na (DMSO-d6): 1.65 
[broad m, 18H, HB{C2N2H2[C10H15 ]CS}3]], 2.11 [broad, 9H HB{C2N2H2[C10H15 ]CS}3]], 2.58 
[broad, 18H, HB{C2N2H2[C10H15 ]CS}3]], 4.44 [broad,1H, HB{C2N2H2[C10H15 ]CS}3]],  5.85 
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[d, 3JH-H = 2, 3H, HB{C2N2H2[C10H15 ]CS}3]], 6.79 [d, 3JH-H = 2, 3H, HB{C2N2H2[C10H15 
]CS}3]].  13C{1H} NMR for [TmAd]Na (DMSO-d6): 29.3 [9C, HB{C2N2H2[C10H15 ]CS}3], 
35.72 [9C,, HB{C2N2H2[C10H15 ]CS}3], 57.41 [3C,, HB{C2N2H2[C10H15 ]CS}3]], 112.81 [3C, 4 
HB{C2N2H2[C10H15 ]CS}3], 119.12 [3C, HB{C2N2H2[C10H15 ]CS}3]], 161.79 [3C,, 
HB{C2N2H2[C10H15 ]CS}3]] (signals for the remaining 9 carbons are obscured by the 
solvent.  IR Data for [TmAd]Na(THF)3 (ATR, cm-1): 3389 (w), 2904 (s), 2850 (m), 2658 
(w), 2498 (w), 2050 (w), 1643 (w), 1482 (w), 1456 (w), 1409 (m), 1378 (s), 1357 (s), 1340 (s), 
1308 (m), 1279 (s), 1244 (m), 1189 (s), 1178 (s), 1159 (s), 1095 (s), 1078 (s), 1059 (s), 1024 
(m), 984 (w), 965 (w), 912 (w), 831 (m), 817 (m), 772 (w), 745 (m), 711 (s), 666(s), 550 (s), 


















1.6 Crystallographic Data 





lattice Orthorhombic Triclinic 
formula C37H66BN6NaO4S3 C53H80BN6NaO3.5S3 
formula weight 788.94 987.21 
space group P212121 P-1 
a/Å 10.2154(10) 13.4039(13) 
b/Å 11.6483(12) 13.5804(13) 
c/Å 36.498(4) 16.5744(16) 
%/˚ 90 89.086(2) 
&/˚ 90 77.146(2) 
'/˚ 90 62.0650(10) 
V/Å3 4342.9(8) 2585.0(4) 
Z 4 2 
temperature (K) 150(2) 150(2) 
radiation ((, Å) 0.71073 0.71073 
) (calcd.), g cm-3 1.207 1.268 
µ (Mo K%), mm-1 0.224 0.202 
* max, deg. 28.28 28.28 
no. of data 
collected 
60218 35165 
no. of data used 10802 12774 
no. of parameters 483 590 
R1 [I > 2+(I)] 0.0573 0.0681 
wR2 [I > 2+(I)] 0.1278 0.0881 
R1 [all data] 0.0763 0.1606 
wR2 [all data] 0.1379 0.1026 
GOF 1.016 1.027 
Rint 0.0711 0.1044 
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(34)  Jiménez-Tenorio, M.; Puerta, M. C.; Valerga, P. Organometallics 2009, 28, 2787–
2798.   
 
(35)  López-Gómez, M. J.; Connelly, N. G.; Haddow, M. F.; Hamilton, A.; Orpen, A. G.  
Dalton Trans. 2010, 39, 5221–5230. 
 
(36)  (a)  In addition to compounds listed in the Cambridge Structural Database, the 
figure also includes data for [!3-S2H-TmBu
t]Na(THF)3 and [!3-S2H-TmAd]Na(THF)3, 
and one compound, namely [TmMeBenz]K(OCMe2)3, which is not listed in the CSD 
(reference 23).  Compounds with bridging [TmR] ligands are not included. 
(b)  Data for compounds that possess very unreasonable B–H bond lengths (i.e. 
outside the range 0.9 – 1.3 Å) were not included. 
 
(37)  Dodds, C. A.; Kennedy, A. R.; Reglinski, J.; Spicer, M. D. Inorg. Chem. 2004, 43, 
394–395.   
 
(38)  It should be noted that [TmMe]2Te contains two [TmMe] ligands, only one of which 
has a value of "(M–H) > "(M–B). 
 
(39)  Furthermore, the average bond length for terminal B–H groups listed in the 
Cambridge Structural Database is 1.10 Å. 
 
(40)  Crossley, I. R.; Hill, A. F.; Humphrey, E. R.; Willis, A. C. Organometallics 2005, 24, 
4083–4086.   
 
(41)  (a)  Dodds, C. A.; Jagoda, M.; Reglinski, J.; Spicer, M. D. Polyhedron 2004, 23, 445-
450.  
(b)  Baba, H.; Nakano, M. Polyhedron 2011, 30, 3182-3185.  
 
(42)  Effendy; Gioia Lobbia, G.; Pettinari, C.; Santini, C.; Skelton, B. W.; White, A. H.  
Inorg. Chim. Acta 2000, 308, 65–72.  
  
(43)  The 3:0, 2:1, 1:2 and 0:3 descriptions of the conformations were introduced in:  
Rajasekharan-Nair, R.; Moore, D.; Chalmers, K.; Wallace, D.; Diamond, L. M.; 
Darby, L.; Armstrong, D. R.; Reglinski, J.; Spicer, M. D. Chem. Eur. J. 2013, 19, 
2487-2495. 
 
(44)  (a)  Hill, A. F.; Smith, M. K. Chem. Commun. 2005, 1920–1922.   
(b)  Santini, C.; Pellei, M.; Gioia Lobbia, G.; Pettinari, C.; Drozdov, A.; Troyanov, 
S.  Inorg. Chim. Acta 2001, 325, 20–28.   
(c)  Hill, A. F.; Tshabang, N.; Willis, A. C. Eur. J. Inorg. Chem. 2007, 3781–3785.  
  
(45)  A variety of descriptions have been given for the conformations of 8-membered 
ring systems but these classifications are less easy to apply when the ring 
contains several different types of atoms.  Therefore, we only use simplified 





(46)  Boat-like and chair-like conformations similar to those observed for [TmR] 
ligands are also observed for bis(mercaptoimidazolyl)hydroborato ligands, 
[BmR], and their oxygen and selenium counterparts.  See, for example, 
references 11c, 12b, 14, and Al-Harbi, A.; Rong, Y.; Parkin, G. Inorg. Chem. 2013, 
52, 10226-10228. 
 
(47) (a)  McNally, J. P.; Leong, V. S.; Cooper, N. J. in Experimental Organometallic 
Chemistry, Wayda, A. L.; Darensbourg, M. Y., Eds.; American Chemical Society: 
Washington, DC, 1987; Chapter 2, pp 6-23. 
(b)  Burger, B.J.; Bercaw, J. E. in Experimental Organometallic Chemistry; Wayda, 
A. L.; Darensbourg, M. Y., Eds.; American Chemical Society: Washington, DC, 
1987; Chapter 4, pp 79-98. 
(c)  Shriver, D. F.; Drezdzon, M. A. The Manipulation of Air-Sensitive Compounds, 
2nd Edition; Wiley-Interscience: New York, 1986.   
 
(48) (a)  Gottlieb, H. E.; Kotlyar, V.; Nudelman, A. J. Org. Chem. 1997, 62, 7512-7515. 
(b)  Fulmer, G. R.; Miller, A. J. M.; Sherden, N. H.; Gottlieb, H. E.; Nudelman, A.; 
Stoltz, B. M.; Bercaw, J. E.; Goldberg, K. I. Organometallics 2010, 29, 2176-2179. 
 
(49) (a)  Cassidy, C. S.; Reinhardt, L. A.; Cleland, W. W.; Frey, P. A. J. Chem. Soc., 
Perkin Trans. 1999, 2, 635-641. 
(b)  Bedford, C. D.; Harris, R. N.; Howd, R. A.; Goff, D. A.; Koolpe, G. A.; 
Petesch, M.; Miller, A.; Nolen, H. W.; Musallam, H. A.; Pick, R. O.; Jones, D. E.; 
Koplovitz, I.; Sultan, W. E. J. Med. Chem. 1989, 32, 493-503. 
 
(50) (a)  Sheldrick, G. M. SHELXTL, An Integrated System for Solving, Refining and 
Displaying Crystal Structures from Diffraction Data; University of Göttingen, 
Göttingen, Federal Republic of Germany, 1981. 
(b)  Sheldrick, G. M. Acta Cryst. 2008, A64, 112-122. 
 
(51)  Jaguar 7.7, Schrödinger, LLC, New York, NY 2010. 
 
(52) (a)  Becke, A. D. J. Chem. Phys. 1993, 98, 5648-5652. 
(b)  Becke, A. D. Phys. Rev. A 1988, 38, 3098-3100. 
(c)  Lee, C. T.; Yang, W. T.; Parr, R. G. Phys. Rev. B 1988, 37, 785-789. 
(d)  Vosko, S. H.; Wilk, L.; Nusair, M. Can. J. Phys. 1980, 58, 1200-1211. 
(e)  Slater, J. C. Quantum Theory of Molecules and Solids, Vol. 4: The Self-Consistent 
Field for Molecules and Solids; McGraw-Hill: New York, 1974. 
 
(53)  (a)  Hay, P. J.; Wadt, W. R. J. Chem. Phys. 1985, 82, 270-283. 
(b)  Wadt, W. R.; Hay, P. J. J. Chem. Phys. 1985, 82, 284-298. 




Synthesis, structure, and degenerate carboxylate exchange kinetics of tris(2-mercapto-
1-t-butylimidazolyl)hydroborato zinc and cadmium complexes  
 
Table of Contents 
2.1! Introduction........................................................................................................................52!
2.2! Results and Discussion .....................................................................................................53!
2.2.1! Synthesis and structural characterization of [TmBut]CdO2CR complexes.......53!
2.2.2! Synthesis and structural characterization of [TmBut]ZnO2CR complexes.......71!
2.2.3! Reactivity of [TmBut]MR (M = Zn, Cd; R = Me) towards thiobenzoic acid.....85!
2.2.4! Degenerate benzoate exchange between [TmBut]MO2CR and HO2CR............89!
2.3! Summary and Conclusions ............................................................................................104!
2.4! Experimental Section.......................................................................................................105!
2.4.1! General Considerations........................................................................................105!
2.4.2! X-ray Structure Determinations..........................................................................106!
2.4.3! Computational Details .........................................................................................106!
2.4.4! Kinetics of Benzoate Ligand Exchange..............................................................107!
2.4.5! Variable temperature 19F NMR experiments ....................................................108!
2.4.6! Synthesis of [TmBut]CdMe....................................................................................108!
2.4.7! Synthesis of [TmBut]CdO2C(C6H4-4-Me).............................................................109!
2.4.8! Synthesis of [TmBut]CdO2C(C6H4-4-F) ................................................................111!
2.4.9! Synthesis of [TmBut]CdO2C(C6H3-3,5-F2) ............................................................113!
2.4.10! Synthesis of [TmBut]CdO2C(C6H3-2,6-F2) ..........................................................114!
 
 51 
2.4.11! Synthesis of [TmBut]CdO2C(C3H6Ph) ................................................................115!
2.4.12! Synthesis of [TmBut]CdO2C(9-An) .....................................................................116!
2.4.13! Synthesis of [TmBut]CdO2C(tridecyl) ................................................................117!
2.4.14! Synthesis of [TmBut]CdSC(O)Ph ........................................................................118!
2.4.15! Synthesis of [TmBut]ZnMe ..................................................................................119!
2.4.16! Synthesis of [TmBut]ZnO2C(C6H4-4-Me) ...........................................................119!
2.4.17! Synthesis of [TmBut]ZnO2C(C6H4-4-F)...............................................................120!
2.4.18! Synthesis of [TmBut]ZnO2C(C6H3-3,5-F2) ..........................................................122!
2.4.19! Synthesis of [TmBut]ZnO2C(C6H3-2,6-F2) ..........................................................123!
2.4.20! Synthesis of [TmBut]ZnO2C(9-An) .....................................................................124!
2.4.21! Synthesis of [TmBut]ZnO2C(9-An)•HO2C(9-An).............................................125!
2.4.22! Synthesis of [TmBut]ZnSC(O)Ph ........................................................................125!
2.5! Crystallographic Data .....................................................................................................127!




The surface functionalization of metal chalcogenide nanocrystals, via ligand 
exchange reactions, has led to their widespread application in electrical devices and 
biological imaging.1,2  The binding and exchange of ligands to nanocrystal surfaces 
influences their electronic properties, including their photoluminescence quantum 
yield,3 the thermal relaxation of excited carriers4, and the trapping of electrical carriers.5  
For this reason, several studies have been conducted to investigate the exchange 
kinetics of surface capping ligands such as carboxylic acids,6 amines,7 thiols,8 and 
phosphines1a on the surface of nanocrystals.9  For example, a recent study on CdSe 
quantum dots that feature oleate ligands as surfactants has shown that (i) the capping 
ligands are oleate, rather than oleic acid, bound to the surface cadmium sites, and (ii) 
the oleate ligands undergo dynamic self-exchange with excess oleic acid via a two-step 
process involving proton transfer.6  The first step, in which excess oleic acid exchanges 
with ligands in a physisorbed state, was found to be rapid on the 1H NMR timescale, 
while the second step involves slow exchange of the physisorbed ligand with bound 
oleate.6  Despite these recent efforts, however, the complexity of the nanocrystal 
surface has limited direct quantitative studies of ligand exchange.7,9,10 
In an attempt to provide data of relevance to carboxylate exchange on nanocrystal 
surfaces, we proposed the use of small molecules as model systems.  For this purpose 
we employed the tris(2-mercapto-1-t-butylimidazolyl)hydroborato, [TmBut], ligand to 
imitate the chalogen-rich environment of group 12 metal chalcogenide nanocrystals.  
The tripodal sulfur environment makes [TmR]M (M = Zn, Cd) analogous to surface 
metal atoms on the [111] facet of a zinc blende crystal or the [001] facet of Wurtzite 
metal chalcogenide crystals.  A variety of complexes have been prepared by reaction of 
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[TmBut]MR (M = Zn, Cd; R = Me) with alcohols, thiols, selenols, and tellurols,11 however 
its reactivity toward carboxylic acids is unknown.  Herein we present the synthesis of a 
series of [TmBut]MO2CR (M = Zn, Cd) complexes via the reaction of [TmBu
t]MR (R = Me) 
with various carboxylic acids, and include an extensive structural analysis of these 
complexes based on single crystal X-ray diffraction and NMR spectroscopy.  In 
addition, a we investigate the dynamic process of benzoate ligand exchange that occurs 
when [TmBut]MO2CR (M = Zn, Cd; R = C6H4-4-F) and 4-fluorobenzoic acid are mixed in 
solution, using variable temperature 19F NMR spectroscopy. 
 
2.2 Results and Discussion 
2.2.1 Synthesis and structural characterization of [TmBut]CdO2CR complexes 
 [TmBut]CdO2CR complexes (R = C6H4-4-Me; C6H4-4-F; C6H3-3,5-F2; C6H3-2,6-F2; 
C3H6Ph; 9-An; and tridecyl) are readily synthesized from two different cadmium 
precursors: (i) [TmBut]CdMe (Scheme 1), and (ii) Cd(O2CR)2 (Scheme 2).12  Treatment of 
[TmBut]CdMe with carboxylic acid at room temperature in benzene proved to be the 
most efficient synthetic approach, with Cd-C bond cleavage resulting in the immediate 






















Traditionally [TmBut]CdMe is synthesized via the reaction of [TmBut]Tl with 
Me2Cd;11b however, our preparation of the [TmBu
t]CdMe precursor frequently gave rise 
to minor amounts of [TmBut]2Cd.  Although it is difficult to separate [TmBu
t]CdMe from 
[TmBut]2Cd, we found [TmBu
t]2Cd converts rapidly to [TmBu
t]CdMe upon mixing with 
Me2Cd (Scheme 3).  This reaction proved to be a convenient method of purifying 
[TmBut]CdMe, and led to the development of a new, more facile synthesis of 
[TmBut]CdMe, via a one-pot reaction (Scheme 4).  In our new synthetic method, heating 
a mixture of two equivalents [TmBut]Na and one equivalent of anhydrous cadmium 
chloride in dry C6H6 at 125˚ C results in the generation of [TmBu
t]2Cd and NaCl.  The 
addition of Me2Cd to this reaction mixture at 25˚ C results in the formation of 
[TmBut]CdMe, which is easily separated from the NaCl by filtration.  This synthetic 
method bypasses the use of [TmBut]Tl and reduces the number of synthetic steps in the 










Scheme 4.  Preparation of [TmBut]CdMe via a one-pot reaction. 
 
The [TmBut]CdO2CR complexes were characterized by 1H and 13C NMR 
spectroscopy, and the complexes featuring fluorinated benzoate ligands (R = C6H4-4-F; 
C6H3-3,5-F2; C6H3-2,6-F2) were additionally characterized by 19F NMR spectroscopy 
(Table 1).  The [TmBut]CdO2CR complexes, with the exception of the tetradecanoate 
analogue, were characterized by X-ray diffraction (Figures1-6) and select bond lengths 
and angles are presented in Tables 2-7.  
 
 
Table 1. 19F NMR data (ppm) for [TmBut]MO2CR 
R Zn Cd 
(C6H4-4-F) -114.02 -113.17 
(C6H4-2,6-F2) -114.36 -113.36 























Table 2.  Select bond lengths and angles for [TmBut]CdO2C(C6H4-4-Me) 
Bond Lengths (Å) Bond Angles (˚) 
C41-O(1) 1.287a S(1)-Cd-S(2) 104.14(3) 
C41-O(2) 1.282(11) S(1)-Cd-S(3) 103.57(3) 
Cd-O(1) 2.295a S(2)-Cd-S(3) 97.31(3) 
Cd-O(2) 2.423(2) S(1)-Cd-O(1) 112.3a 
Cd-S(1) 2.5525(10) S(1)-Cd-O(2) 97.16(6) 
Cd-S(2) 2.5595(10) S(2)-Cd-O(1) 139.7a 
Cd-S(3) 2.5603(10) S(2)-Cd-O(2) 104.33(6) 
  S(3)-Cd-O(1) 90.5a 
  S(3)-Cd-O(2) 144.42(7) 
  Cd-O(1)-C(41) 28.6 
  Cd-O(2)-Cd(41) 88.6(2) 
  O(1)-Cd-O(2) 55.0a 
  O(1)-C(41)-O(2) 120.3a 
(a) The O(1) atom was modeled for 2 part disorder, and the value presented above 










































Bond Lengths (Å) Bond Angles (˚) 
C41-O(1) 1.259(3) S(1)-Cd-S(2) 102.24(2) 
C41-O(2) 1.248(3) S(1)-Cd-S(3) 99.231(19) 
Cd-O(1) 2.2782(17) S(2)-Cd-S(3) 100.83(2) 
Cd-O(2) 2.4601(18) S(1)-Cd-O(1) 116.83(5) 
Cd-S(1) 2.5436(6) S(1)-Cd-O(2) 101.71(5) 
Cd-S(2) 2.5442(7) S(2)-Cd-O(1) 133.74(5) 
Cd-S(3) 2.5609(6) S(2)-Cd-O(2) 95.06(4) 
  S(3)-Cd-O(1) 96.54(4) 
  S(3)-Cd-O(2) 150.31(4) 
  Cd-O(1)-C(41) 95.35(14) 
  Cd-O(2)-Cd(41) 87.22(14) 
  O(1)-Cd-O(2) 55.07(6) 




















Table 4.  Select bond lengths and angles for [TmBut]CdO2C(C6H3-3,5-F2) 
Bond Lengths (Å) Bond Angles (˚) 
C41-O(1) 1.248(2) S(1)-Cd-S(2) 102.698(14) 
C41-O(2) 1.252(2) S(1)-Cd-S(3) 100.628(14) 
Cd-O(1) 2.2595(13) S(2)-Cd-S(3) 100.412(14) 
Cd-O(2) 2.5069(14) S(1)-Cd-O(1) 127.92(4) 
Cd-S(1) 2.5333(4) S(1)-Cd-O(2) 101.24(3) 
Cd-S(2) 2.5351)4_ S(2)-Cd-O(1) 122.70(4) 
Cd-S(3) 2.5728(5) S(2)-Cd-O(2) 94.63(3) 
  S(3)-Cd-O(1) 95.23(4) 
  S(3)-Cd-O(2) 149.93(3) 
  Cd-O(1)-C(41) 96.29(11) 
  Cd-O(2)-Cd(41) 84.78(11) 
  O(1)-Cd-O(2) 54.88(5) 

























Table 5.  Select bond lengths and angles for [TmBut]CdO2C(C6H3-2,6-F2) 
Bond Lengths (Å) Bond Angles (˚) 
C41-O(1) 1.221(4) S(1)-Cd-S(2) 101.15(3) 
C41-O(2) 1.232(4) S(1)-Cd-S(3) 104.45(3) 
Cd-O(1) 2.371(3) S(2)-Cd-S(3) 98.03(3) 
Cd-O(2) 2.351(3) S(1)-Cd-O(1) 107.12(10) 
Cd-S(1) 2.5451(9) S(1)-Cd-O(2) 110.34(9) 
Cd-S(2) 2.5321(10) S(2)-Cd-O(1) 144.79(9) 
Cd-S(3) 2.5521(10) S(2)-Cd-O(2) 96.36(7) 
  S(3)-Cd-O(1) 94.85(8) 
  S(3)-Cd-O(2) 138.75(8) 
  Cd-O(1)-C(41) 90.6(2) 
  Cd-O(2)-Cd(41) 91.3(2) 
  O(1)-Cd-O(2) 54.39(10) 
























Table 6.  Select bond lengths and angles for [TmBut]CdO2C(C3H6Ph) 
Bond Lengths (Å) Bond Angles (˚) 
C41-O(1) 1.204(6) S(1)-Cd-S(2) 106.43(4) 
C41-O(2) 1.257(6) S(1)-Cd-S(3) 98.82(4) 
Cd-O(1) 2.244(4) S(2)-Cd-S(3) 98.98(4) 
Cd-O(2) 2.447(4) S(1)-Cd-O(1) 121.61(14) 
Cd-S(1) 2.5179(12) S(1)-Cd-O(2) 100.26(10) 
Cd-S(2) 2.5394(13) S(2)-Cd-O(1) 122.92(13) 
Cd-S(3) 2.6091(5) S(2)-Cd-O(2) 90.81(11) 
  S(3)-Cd-O(1) 101.97(11) 
  S(3)-Cd-O(2) 155.10(10) 
  Cd-O(1)-C(41) 98.1(3) 
  Cd-O(2)-C(41) 87.0(3) 
  O(1)-Cd-O(2) 54.08(14) 


























Table 7.  Select bond lengths and angles for [TmBut]CdO2C(9-An) 
Bond Lengths (Å) Bond Angles (˚) 
C41-O(1) 1.253(4) S(1)-Cd-S(2) 105.54(3) 
C41-O(2) 1.243(3) S(1)-Cd-S(3) 99.18(3) 
Cd-O(1) 2.266(2) S(2)-Cd-S(3) 98.06(3) 
Cd-O(2) 2.465(2) S(1)-Cd-O(1) 131.21(7) 
Cd-S(1) 2.5226(9) S(1)-Cd-O(2) 102.34(6) 
Cd-S(2) 2.5504(9) S(2)-Cd-O(1) 114.86(7) 
Cd-S(3) 2.5661(9) S(2)-Cd-O(2) 88.06(7) 
  S(3)-Cd-O(1) 100.99(6) 
  S(3)-Cd-O(2) 98.06(3) 
  Cd-O(1)-C(41) 95.2(2) 
  Cd-O(2)-Cd(41) 86.23(19) 
  O(1)-Cd-O(2) 55.07(8) 









For each of the [TmBut]CdO2CR complexes, the two Cd•••O bond distances were 
found to be similar (!(Cd-O) < 0.25 Å),14 indicating that the benzoate ligands 
coordinate in a bidentate fashion.  The structure of the [TmBut]CdO2CR (R = C6H4-4-F; 
C6H3-3,5-F2; C6H3-2,6-F2; C3H6Ph; 9-An) complexes was geometry optimized using DFT 
calculations, and the lowest energy structures obtained were consistent with our 
experimental observations (Table 8).  The [TmBut]CdO2CR complexes (R = C6H4-4-Me; 
C6H4-4-F; C6H3-3,5-F2; C6H3-2,6-F2; C3H6Ph; 9-An; and tridecyl) were also characterized 
using IR spectroscopy.  Unfortunately the "asym(CO2) and "sym(CO2) stretching bands 




Table 8.  Select experimental and theoretical bond length (Å) data for [TmBut]CdO2CR 
 Experimental Values Theoretical Values 
Compound d(Cd-O1) d(Cd-O2) d(Cd-O1) d(Cd-O2) 
[TmBut]ZnO2C(C6H4-4-F) 2.2782(17) 2.4601(18) 2.294 2.359 
[TmBut]ZnO2C(C6H3-3,5-F2) 2.2595(13) 2.5069(14) 2.297 2.380 
[TmBut]ZnO2C(C6H3-2,6-F2) 2.371(3) 2.351(3) 2.284 2.390 
[TmBut]ZnO2C(C3H6Ph) 2.244(4) 2.447(4) 2.289 2.356 






The molecular geometry of five-coordinate metal complexes can be described 
using the geometric parameter #5 = ($ - %)/60, where % and $ are the two largest central 
angles in the molecule.15  An ideal square-pyramidal geometry is associated with a 
value of #5 = 0, while a value of #5 = 1 indicates an ideal trigonal-bipyramidal geometry.  
Based on their respective #5 parameter values, most of the [TmBu
t]CdO2CR complexes (R 
= C6H4-4-Me; C6H4-4-F; C6H3-3,5-F2; C6H3-2,6-F2; 9-An) were found to assume distorted 
square pyramidal geometries, while the geometry of [TmBut]CdO2C(C3H6Ph) is better 




Table 9.  #5 values for [TmBu
t]CdO2CAr compounds 













2.2.2 Synthesis and structural characterization of [TmBut]ZnO2CR complexes 
A series of [TmBut]ZnO2CR (R = C6H4-4-Me, C6H4-4-F, C6H3-2,6-F2, C6H3-3,5-F2, 9-
An) were prepared in a manner similar to the cadmium analogues presented above. 
Treatment of a solution of [TmBut]ZnMe in C6H6 with a carboxylic acid (Scheme 5) 
resulted in immediate vigorous bubbling due to the elimination of methane, as 
indicated by 1H NMR spectroscopy.  
 
 
Scheme 5.  Preparation of [TmBut]ZnO2CR via Zn-C bond cleavage 
 
The [TmBut]ZnO2CR complexes were characterized using 1H and 13C NMR 
spectroscopy, and the [TmBut]ZnO2CR complexes featuring fluorine substituted 
benzoate (R = C6H4-4-F, C6H3-3,5-F2, C6H3-2,6-F2) ligands were additionally 
characterized using 19F NMR spectroscopy.  As was the case with the cadmium 
analogues, the [TmBut]ZnO2CR fluorinated complexes each displayed a single peak in 
the 19F NMR spectrum, and all of the [TmBut]MO2CR (M = Zn, Cd) peaks appeared at 
very similar chemical shifts, suggesting that the identity of the metal does not have a 
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significant effect on their 19F NMR spectrum (Table 1).  The [TmBut]ZnO2CR complexes 
were structurally characterized by X-ray diffraction (Figure 7-Figure 11), and select 















Table 10.  Select bond lengths and angles for [TmBut]ZnO2C(C6H4-4-Me) 
Bond Lengths (Å) Bond Angles (˚) 
C41-O(1) 1.272(2) S(1)-Zn-S(2) 106.88(2) 
C41-O(2) 1.219(2) S(1)-Zn-S(3) 108.60(2) 
Zn-O(1) 1.9383(14) S(2)-Zn-S(3) 103.68(2) 
Zn•••O(2) 3.0478(15) S(1)-Zn-O(1) 114.29(5) 
Zn-S(1) 2.3314(6) S(2)-Zn-O(1) 121.04(5) 
Zn-S(2) 2.3325(6) S(3)-Zn-O(1) 101.09(5) 
Zn-S(3) 2.3608(6) O(1)-C(41)-O(2) 125.7(2) 



























Table 11.  Select bond lengths and angles for [TmBut]ZnO2C(C6H4-4-F) 
Bond Lengths (Å) Bond Angles (˚) 
C41-O(1) 1.294(6) S(1)-Zn-S(2) 104.61(6) 
C41-O(2) 1.236(6) S(1)-Zn-S(3) 107.71(6) 
Zn-O(1) 1.948(3) S(2)-Zn-S(3) 106.41(5) 
Zn•••O(2) 2.914(3) S(1)-Zn-O(1) 124.15(11) 
Zn-S(1) 2.3153(15) S(2)-Zn-O(1) 101.90(11) 
Zn-S(2) 2.3259(15) S(3)-Zn-O(1) 110.47(11) 
Zn-S(3) 2.3611(15) O(1)-C(41)-O(2) 124.4(5) 


























Table 12.  Select bond lengths and angles for [TmBut]ZnO2C(C6H3-3,5-F2)a 
Bond Lengths (Å) Bond Angles (˚) 
C141-O(11) 1.237(8) S(11)-Zn(1)-S(12) 108.69(7) 
C141-O(12) 1.231(8) S(11)-Zn(1)-S(13) 105.31(7) 
Zn(1)-O(11) 1.968(5) S(12)-Zn(1)-S(13) 106.10(6) 
Zn(1)•••O(12) 2.766(5) S(11)-Zn(1)-O(11) 114.56(15) 
Zn(1)-S(11) 2.3258(19) S(12)-Zn(1)-O(11) 100.41(16) 
Zn(1)-S(12) 2.3400(18) S(13)-Zn(1)-O(11) 120.92(15) 
Zn(1)-S(13) 2.3596(18) O(11)-C(41)-O(12) 125.7(7) 
  Zn1-O(11)-C(141) 110.1(5) 
(a) There are two molecules of [TmBut]ZnO2C(C6H3-3,5-F2) in the asymmetric unit 
 
Table 12 (cont.).  Select bond lengths and angles for [TmBut]ZnO2C(C6H3-3,5-F2). 
Bond Lengths (Å) Bond Angles (˚) 
C241-O(21) 1.304(10) S(21)-Zn(2)-S(22) 110.27(9) 
C241-O(22) 1.304(10) S(21)-Zn(2)-S(23) 105.52(8) 
Zn(2)-O(21) 1.968(5) S(22)-Zn(2)-S(23) 106.39(8) 
Zn(2)•••O(22) 2.856(6) S(21)-Zn(2)-O(21) 112.97(17) 
Zn(2)-S(21) 2.324(20 S(22)-Zn(2)-O(21) 113.52(17) 
Zn(2)-S(22) 2.332(2) S(23)-Zn(2)-O(21) 107.60(18) 
Zn1(2)-S(23) 2.334(2) O(21)-C(41)-O(22) 52.2(2) 




















Table 13.  Select bond lengths and angles for [TmBut]ZnO2C(C6H3-2,6-F2) 
Bond Lengths (Å) Bond Angles (˚) 
C41-O(1) 1.273(4) S(1)-Zn-S(2) 106.35(30 
C41-O(2) 1.227(4) S(1)-Zn-S(3) 106.92(3) 
Zn-O(1) 1.949(2) S(2)-Zn-S(3) 106.18(3) 
Zn•••O(2) 2.997(2) S(1)-Zn-O(1) 120.45(8) 
Zn-S(1) 2.3141(9) S(2)-Zn-O(1) 111.58(8) 
Zn-S(2) 2.3303(9) S(3)-Zn-O(1) 104.45(7) 
Zn-S(3) 2.3581(9) O(1)-C(41)-O(2) 127.3(3) 























Table 14.  Select bond lengths (Å) and angles (˚) for [TmBut]ZnO2C(9-An) 
Bond Lengths (Å) Bond Angles (˚) 
C41-O(1) 1.289(5) S(1)-Zn-S(2) 106.31(4) 
C41-O(2) 1.221(5) S(1)-Zn-S(3) 108.86(4) 
Zn-O(1) 1.933(3) S(2)-Zn-S(3) 104.05(4) 
Zn•••O(2) 3.117(3) S(1)-Zn-O(1) 116.08(90 
Zn-S(1) 2.3170(11) S(2)-Zn-O(1) 118.72(9) 
Zn-S(2) 2.3298(11) S(3)-Zn-O(1) 101.73(9) 
Zn-S(3) 2.3539(12) O(1)-C(41)-O(2) 125.7(4) 
  Zn-O(1)-C(41) 122.3(2) 
 
 
The two Zn•••O distances were found to be significantly different in each of the 
[TmBut]ZnO2CR complexes, with !avg(Zn•••O) = 1.00 Å.  The fact that the elongated 
Zn•••O(2) distance is significantly greater than the sum of the covalent radii for Zn and 
O (1.88 Å),16 suggests that there is no Zn-O(2) bonding interaction present in these 
molecules.  In an attempt to further investigate the coordination mode of the benzoate 
ligands, the [TmBut]ZnO2CR complexes were characterized using IR spectroscopy.  
Unfortunately the "asym(CO2) and "sym(CO2) stretching modes could not be clearly 
identified, as the absorption bands overlapped with peaks due to the [TmBut] ligand.   
 The structures of the [TmBut]ZnO2CR complexes were geometry optimized; 
however the results of these calculations were inconsistent with our experimental 
observations.  For each [TmBut]ZnO2CR complex, the lowest energy structure was 
found to exhibit two similar Zn-O bond distances (!(Zn-O) < 0.25 Å), incorrectly 
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suggesting that the benzoate ligands coordinate to the zinc centers in a bidentate 
fashion (Table 15).  
The molecular geometry of four-coordinate metal complexes can be described 
using the geometric parameter #4 = (360˚ -(% + $))/141˚, where % and $ are the two 
largest central angles in the molecule.17  The value of #4 ranges from zero, for 
complexes featuring ideal square planar geometries, to 1.00 for complexes featuring 
ideal tetrahedral geometries.  Complexes defined by an intermediate geometrical 
parameters, 0 ≤ #4 ≤ 1.00 exhibit seesaw (#4 = 0.07-0.64) or trigonal monopyramidal (#4 = 
0.85) geometries.17  Based on their respective #4 parameters, the geometries of the 
[TmBut]ZnO2CR complexes are best described as distorted trigonal monopyramids with 
#4 values ranging from 0.88-0.93 (Table 16). 
 
Table 15.  Select experimental and theoretical bond length (Å) data for [TmBut]ZnO2CR 
 Experimental Values Theoretical Values 
Compound d(Zn-O1) d(Zn-O2) d(Zn-O1) d(Zn-O2) 
[TmBut]ZnO2C(C6H4-4-Me) 1.9383(14) 3.0478(15) 2.093 2.242 
[TmBut]ZnO2C(C6H4-4-F) 1.948(3) 2.914(3) 2.090 2.259 
[TmBut]ZnO2C(C6H3-3,5-F2) 1.968(5) 2.766(5) 2.076 2.321 
[TmBut]ZnO2C(C6H3-2,6-F2) 1.949(2) 2.997(2) 2.096 2.271 






Table 16.  #4 values for [TmBu
t]ZnO2CAr compounds 









Crystals grown from a solution of [TmBut]ZnMe and excess 9-
anthracenecarboxylic acid in C6H6 were characterized by X-ray diffraction, revealing 
[TmBut]ZnO2C(9-An)•HO2C(9-An), a hydrogen bonded adduct with an O(12)•••O(21) 
distance of 2.568 Å (Figure 12).  This type of hydrogen bonding interaction is also 
observed for the [TmBut]ZnOPh•HOPh complex,11a as well as for the {[Tmp-
Tol]ZnOiPr•HOiPr}+ and [Tm2,6-Me2]ZnO(C6H4-2-CH2OH)•HOCH3 complexes.18  Each of 
these complexes feature an O•••O distance of approximately 2.7 Å. 
 The hydrogen bonding interaction of the 9-anthracene carboxylic acid molecule 
did not significantly affect the core structure of the [TmBut]ZnO2C(9-An) complex.  
[TmBut]ZnO2C(9-An) and [TmBu
t]ZnO2C(9-An)•HO2C(9-An) feature similar Zn•••O bond 
distances as displayed in Table 14 and Table 17, and like [TmBut]ZnO2C(9-An), 
[TmBut]ZnO2C(9-An)•HO2C(9-An) exhibits a distorted trigonal monopyramidal 















Table 17.  Select bond lengths and angles for [TmBut]ZnO2C(9-An)•HO2C(9-An) 
Bond Lengths (Å) Bond Angles (˚) 
C41-O(11) 1.258(2) S(1)-Zn-S(2) 106.797(19) 
C41-O(12) 1.246(2) S(1)-Zn-S(3) 108.451(19) 
Zn-O(11) 1.9727(13) S(2)-Zn-S(3) 107.984(18) 
Zn•••O(12) 2.8538(13) S(1)-Zn-O(11) 117.90(4) 
Zn-S(1) 2.3187(5) S(2)-Zn-O(11) 104.08(4) 
Zn-S(2) 2.3333(5) S(3)-Zn-O(11) 111.09(4) 
Zn-S(3) 2.3411(5) O(11)-C(41)-O(12) 123.97(17) 
O(12)-H(2) 1.68(3) Zn-O(11)-C(41) 113.29(12) 
 
 
2.2.3 Reactivity of [TmBut]MR (M = Zn, Cd; R = Me) towards thiobenzoic acid 
Thiocarboxylate ligands are known to coordinate to metal centers in a variety of 
ways: (i) via X-type ligand interactions, coordinating through either the sulfur or oxygen 
atom, (ii) via LX-type ligand interactions, coordinating through both the sulfur and 
oxygen atoms, or (iii) via bridging interactions.19  Zinc complexes featuring 
thiocarboxylate ligands are rare, with only five complexes listed in the Cambridge 
Structural Database (CSD).20  Typically the thiobenzoate ligand coordinates to the zinc 
center in a unidentate fashion through the sulfur atom.21  Only one example of a zinc 
complex with a bidentate thiobenzoate ligand is listed in the CSD, namely 
[Zn(SOCPh)3]- .22  Cadmium complexes featuring thiobenzoate ligands are slightly 
more common than their zinc analogues, with 13 known cadmium complexes listed in 
the Cambridge Structural database.  Although the most common coordination mode 
 
 86 
assumed by the thiobenzoate is &2-S,O, there are a few examples of &1-S 
coordination,21d,22,23 as well as bridging structures.21d,24  There are, however, no known 
examples of zinc or cadmium complexes with thiobenzoate ligands that coordinate to 
the metal in a &1-O fashion.  
The reactivity of [TmBut]MR (M = Zn, Cd; R = Me) toward thiobenzoic acid 
(Scheme 6) was investigated as we were curious to see what coordination mode the 
thiobenzoate ligand would assume for each metal.  Since carboxylate ligands are 
known to coordinate in a bidentate fashion in the [TmBut]CdO2CR complexes presented 
above, and in a unidentate fashion in their [TmBut]ZnO2CR analogues, we were 
interested to see if the thiobenzoate ligand would show similar coordination behavior.  
The molecular structures of [TmBut]MSC(O)Ph were obtained (Figure 13 and Figure 14) 









Figure 13.  Molecular structure of [TmBut]ZnSC(O)Ph 
 
Table 18.  Select bond lengths and angles for [TmBut]ZnSC(O)Ph 
Bond Lengths (Å) Bond Angles (˚) 
C41-S(4) 1.747(3) S(1)-Zn-S(2) 105.78(3) 
C41-O 1.219(3) S(1)-Zn-S(3) 105.23(3) 
Zn-S(4) 2.3105(7) S(2)-Zn-S(3) 103.55(3) 
Zn•••O 2.9303(18) S(1)-Zn-S(4) 116.63(3) 
Zn-S(1) 2.3363(7) S(2)-Zn-S(4) 103.70(3) 
Zn-S(2) 2.3551(7) S(3)-Zn-S(4) 120.27(3) 
Zn-S(3) 2.3549(7) O-C(41)-S(4) 58.41(4) 





Figure 14.  Molecular structure of [TmBut]CdSC(O)CPh 
 
Table 19.  Select bond lengths and angles for [TmBut]CdSC(O)CPh 
Bond Lengths (Å) Bond Angles (˚) 
C41-S(4) 1.729(3) S(1)-Cd-S(2) 97.26(2) 
C41-O 1.203(4) S(1)-Cd-S(3) 102.68(2) 
Cd-S(4) 2.4784(8) S(2)-Cd-S(3) 95.43(2) 
Cd•••O 2.982 S(1)-Cd-S(4) 123.81(3) 
Cd-S(1) 2.5340(7) S(2)-Cd-S(4) 123.58(3) 
Cd-S(2) 2.5616(7) S(3)-Cd-S(4) 109.04(3) 
Cd-S(3) 2.5854(7) O-C(41)-S(4) 121.5(2) 
  Cd-S(4)-C(41) 94.70(10) 
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The molecular structure of [TmBut]ZnSC(O)Ph (Figure 13) revealed a Zn-S(4) 
bond length of 2.3105(7), which is typical of zinc complexes featuring thiobenzoate 
ligands (davg = 2.31 Å).25  The Zn•••O distance was determined to be 2.9303(18) Å, 
which is significantly longer than the sum of the covalent radii for Zn and O (1.88 Å),16 
suggesting that there is no Zn-O bonding interaction present in the molecule.  
Therefore, the thiobenzoate ligand can be assigned as coordinating in a unidentate 
fashion, and the molecular geometry of [TmBut]ZnSC(O)Ph is best described as a 
distorted trigonal monopyramid (#4 = 0.87).17 
Like [TmBut]ZnSC(O)Ph, the thiobenzoate ligand in [TmBut]CdSC(O)Ph exhibits 
&1-S1 unidentate coordination.  The molecular geometry of [TmBu
t]CdSC(O)Ph is best 
described as a distorted trigonal monopyramid (#4 = 0.80).17  The Cd-S4 bond length is 
2.4784(8) Å, which is typical for cadmium complexes featuring thiobenzoate ligands 
(davg = 2.53 Å).26  The Cd•••O distance was determined to be 2.982 Å, which is 
significantly longer than the sum of the covalent radii for Cd and O (2.1 Å),16 which 
suggests that there is no Cd-O bonding interaction present in the molecule.   
 
 
2.2.4 Degenerate benzoate exchange between [TmBut]MO2CR and HO2CR 
A series of variable temperature NMR experiments were conducted in an 
attempt to investigate the kinetics of degenerate benzoate exchange at a group 12 metal 
center.  In our first study, the exchange of [TmBut]CdO2C(4-C6H4F) with 4-fluorobenzoic 
acid, HO2C(C6H4-4-F), was monitored.  We were curious to see how the identity of the 
metal in the [TmBut]MO2C(4-C6H4F) complex would effect the exchange kinetics, so a 
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second study was performed in which degenerate benzoate exchange between 
[TmBut]ZnO2C(4-C6H4F) and HO2C(C6H4-4-F) was investigated. 
Degenerate benzoate exchange between [TmBut]MO2CR (M = Zn, Cd) and HO2CR 
was found to be rapid on the 1H NMR timescale, such that the exchange kinetics could 
not be properly investigated.  At room temperature, the 1H NMR spectrum of a 
mixture of [TmBut]MO2C(4-C6H4F) and HO2CR (M = Zn, Cd) displays exchange 
averaged signals for the O2C(4-C6H4F) moieties.  This means that the value of kobs (s-1) 
for dynamic benzoate exchange must be greater than the frequency difference between 
the resonance peaks of the two species (!").27  For example, the chemical shift of the o-
protons of pure HO2C(C6H4-4-F) and [TmBu
t]CdO2C(4-C6H4F) differ in resonance 
frequency by 278 Hz on a 500 MHz NMR spectrometer.  The fact that only one set of 
peaks is observed for the two species indicates that under these conditions kobs > 278 s-1.  
Cooling the mixture sufficiently slows the rate of dynamic exchange such that the 
exchange averaged signals for the O2C(4-C6H4F) moieties broaden.  However, even at 
195K the rate of benzoate exchange is so rapid that decoalescence of the resonance 
signals is not observed.  
 The fluorinated [TmBut]MO2C(4-C6H4F) (M = Zn, Cd) complexes were specifically 
chosen as the model framework for our exchange studies because the chemical shift 
range for 19F NMR is much larger (ca. 400 ppm),28 resulting in a greater difference in 
resonance frequency (!") between [TmBut]MO2C(4-C6H4F) and HO2(C6H4-4-F) (!" = 3360 
Hz when M = Zn, !" = 2960 Hz when M = Cd).  These larger values of !" allow us to 
measure rates an order of magnitude faster than we could measure with 1H NMR 
spectroscopy.  Nevertheless, degenerate benzoate exchange is such a rapid process that 
both low temperature (195 K in the case of the Cd study, 207 K in the case of the Zn 
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study) and low concentrations of [TmBut]MO2C(4-C6H4F) and HO2C(4-C6H4F) (9.8 × 10-4 
M when M = Z; 9.1 × 10-4 M when M = Cd) are required to slow the rate sufficiently to 
observe decoalescence.  
In order to appropriately interpret the kinetics data obtained from line-shape 
analysis, the reaction mechanism must first be determined.  Possible mechanisms for 
[TmBut]MO2C(4-C6H4F) (M = Zn, Cd) benzoate exchange include (i) an associative 
pathway which involves both [TmBut]MO2C(4-C6H4F) and the acid in the rate 
determining step and (ii) a dissociative pathway which involves only [TmBut]MO2C(4-
C6H4F) in the rate-determining step.  If exchange occurs via an associative pathway, the 
concentration of the acid will influence the linewidth of the [TmBut]MO2C(4-C6H4F) 
resonance signal in the 19F-NMR spectrum.  If a dissociative pathway is operative, the 
lineshape of [TmBut]MO2C(4-C6H4F) should be insensitive to the concentration of the free 
acid.  To determine the mechanism of [TmBut]CdO2C(4-C6H4F) benzoate exchange, the 
reaction dynamics were studied as a function of the acid concentration, using 19F NMR 
spectroscopy.  Four samples were prepared in which the concentration of 
[TmBut]CdO2C(4-C6H4F) was kept constant while the concentration of HO2C(4-C6H4F) 
was varied, such that a 1:1, 1:2, 1:3, and 1:4 molar ratio of metal complex to acid was 
achieved.  The 19F NMR spectra for each of the reaction samples were obtained at 195 
K, as the rate of benzoate exchange is in the slow regime at this temperature and the 





Figure 15.  Experimental 19F-NMR spectra for a series of mixtures of 
[TmBut]CdO2C(C6H4-4-F) and HO2C(C6H4-4-F) in C7D8 at 195 K, and the corresponding 
gNMR simulations.  The ! symbol is used to indicate the resonance signal for 
HO2C(C6H4-4-F), while the " symbol is used to indicate the signal for 
[TmBut]CdO2C(C6H4-4-F).  The concentrations of the two species in the reaction samples 
are as follows: a) [TmBut]CdO2C(C6H4-4-F) = 9.1 × 10-4 M, HO2C(C6H4-4-F) = 9.1 × 10-4 M; 
b) [TmBut]CdO2C(C6H4-4-F) = 9.1 × 10-4 M, HO2C(C6H4-4-F) = 1.8 × 10-3 M; c) 
[TmBut]CdO2C(C6H4-4-F) = 9.1 × 10-4 M, HO2C(C6H4-4-F) = 2.7 × 10-3 M; d) 





The experimental spectra obtained for the concentration reactions were 
simulated using gNMR software (Figure 15) to calculate the rate (M s-1) of the exchange 
reactions at each concentration (Table 20).29  The data listed in Table 20 shows that the 
concentration of acid has a direct effect on the overall rate of reaction, which supports 
the assignment of an associative exchange mechanism.   
 
 
Table 20.  Rate (M s-1) of benzoate exchange calculated for a series of mixtures of 
[TmBut]CdO2C(4-C6H4F) and HO2C(4-C6H4F) in C7D8 





a 9.1 × 10-4 M 9.1 × 10-4 M 3.7 
b 9.1 × 10-4 M 1.8 × 10-3 M 7.0 
c 9.1 × 10-4 M 2.7 × 10-3 M 9.9 
d 9.1 × 10-4 M 3.6 × 10-3 14.4 
 
 
Degenerate benzoate exchange can occur by several possible associative 
mechanisms.  One involves direct metathesis of [TmBut]CdO2C(4-C6H4F) and HO2C(4-
C6H4F), with protonation of the carboxylate oxygen resulting in the formation of a new 
Cd-O bond (Scheme 7).  In a second, the formation of a hydrogen-bonded 
[TmBut]CdO2C(4-C6H4F)• HO2C(4-C6H4F) adduct results in the creation of a better 
leaving group, ie. [(4-C6H4F)CO2•••H•••CdO2C(4-C6H4F)].  The rate-determining 
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step for this mechanism involves the dissociation of the [TmBut]CdO2C(4-C6H4F)• 
HO2C(4-C6H4F) adduct to form {[TmBu
t]Cd}+ and [(4-C6H4F)CO2•••H•••CdO2C(4-
C6H4F)] (Scheme 8).   Alternatively, the rate determining step could involve an 
associative reaction between the hydrogen-bonded [TmBut]CdO2C(4-C6H4F)• HO2C(4-
C6H4F) adduct and HO2C(4-C6H4F) (Scheme 9).  It should be noted that each of these 





Scheme 7.  One possible associative mechanism for benzoate exchange between 












Scheme 8.  A second possible associative mechanism for benzoate exchange between 







Scheme 9.  A third possible associative mechanism for benzoate exchange between 






The rate laws used to describe the three proposed reaction mechanisms have 
different acid dependencies; therefore, the results of the acid concentration experiment 
described above can be used to determine the reaction mechanism.  Identification of 
the reaction mechanism is, however, complicated by the fact that benzoic acids are 
known to exist in solution as an equilibrium mixture of the acid monomer and the 
hydrogen-bonded dimer.30  In order to determine the reaction mechanism, the 
concentration of monomer relative to the total concentration of acid must first be 
calculated for each of the reaction mixtures.  Using the literature value for the 
equilibrium constant for the dimerization of 4-fluorobenzoic acid at 298 K (1.95 × 104),30a 
and assuming a value of !S = -16 cal mol-1 K-1,31 the equilibrium constant at 195 K (K = 
2.11 × 108) can be calculated using equations 1-4 in Table 21.  The value obtained for 
K195K can then be applied to equations 5-8 (Table 21) to calculate the concentration of 
acid monomer in each of the reaction samples at 195 K.  By generating a plot of 
ln(Rate) vs. ln[Monomer] the linear equation, ln(Rate) = ln(k) + ln[Cd] + 
n(ln[Monomer]), can be solved to determine the order of reaction in terms of monomer 
concentration, n.  The reaction of degenerate benzoate exchange is found to be second 
order in acid monomer, such that the overall reaction is 3rd order, and is assumed to 








Table 21.  Equations used to calculate the concentration of acid monomer in the 
reaction solution. 
Eq. # Equation 
1 !G298 = -RTlnK298 
2 !H = !G298 + T!S 
3 !G195 = !H - T!S 
4 K195 = e!G195/RT 
5 K = [Dimer]/[Monomer]2 
6 [Acidtotal] = [Monomer]+ 2[Dimer] 
7 [Acidtotal] = [Monomer]+ 2K[Monomer]2 
8 [Monomer] = {[1 + 8KT]0.5 – 1}/4K 
 
 
Assuming that the mechanism of degenerate benzoate exchange is the same for 
both the [TmBut]CdO2C(4-C6H4F) and of [TmBu
t]ZnO2C(4-C6H4F) analogues, we were 
interested in comparing their rates of exchange.  To do so, a variable temperature 19F 
NMR experiment was conducted for the zinc and cadmium analogues, in which 1:1 
mixtures of [TmBut]MO2C(4-C6H4F) and HO2C(4-C6H4F) (when M = Zn, 9.8 × 10-4 M; 
when M = Cd, 9.1 × 10-4 M) in C7D8 were monitored over a range of temperatures.  The 
spectral line shapes were modeled in the slow, intermediate, and fast exchange regimes 
using gNMR software (Figure 16 and Figure 17),29 such that a rate of exchange was 
obtained at each of these temperatures (Table 22 and Table 23).  In order to simulate 
this data, the assumption must be made that the concentration of monomer does not 
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change as the temperature is increased.  This assumption leads to a serious 
oversimplification of the model system; therefore, lineshape analysis cannot be used to 
calculate activation parameters for these reactions.  Nevertheless, a general 
comparison can be made for the rate of benzoate exchange in the Cd system versus the 
Zn system.  The Zn system reaches coalescence at 225 K (Figure 16), while the Cd 
system reaches coalescence at approximately 213 K.  The fact that coalescence is 
achieved at a higher temperature suggests that the rate of benzoate exchange is slower 








Figure 16.  Experimental and simulated variable temperature 19F-NMR spectra 
obtained for a 1:1 mixture of [TmBut]ZnO2C(C6H4-4-F) and HO2C(C6H4-4-F) in C7D8.  
The concentrations of the two species in solution are as follows: [TmBut]ZnO2C(C6H4-4-F) 













Table 22.  Rate of exchange for a mixture of [TmBut]ZnO2C(C6H4-4-F) (1.0 × 10-3 M) and 
HO2C(C6H4-4-F) (1.0 × 10-3 M) at various temperatures. 




















Figure 17.  Experimental and simulated variable temperature 19F-NMR spectra 
obtained for a 1:1 mixture of [TmBut]CdO2C(C6H4-4-F) and HO2C(C6H4-4-F) in C7D8.  
The concentrations of the two species in solution are as follows: [TmBut]CdO2C(C6H4-4-F) 




Table 23.  Rate of exchange for a mixture of [TmBut]CdO2C(C6H4-4-F) (9.1 × 10-4 M) and 
HO2C(C6H4-4-F) (9.1 × 10-4 M) at various temperatures. 










Spectra were also obtained for the zinc and cadmium reaction samples at 187 K, 
however, these spectra were not simulated, as the signal for a third species appeared (! 
= -110.5 ppm) close to the peak for [TmBut]MO2C(4-C6H4F) (Figure 18 and Figure 19).  
The proportion of this third species was found to increase with increasing total 
concentration of the reaction sample.  These results suggest that the third species is 
likely an adduct between 4-fluorobenzoic acid and [TmBut]CdO2C(4-C6H4F), which 
would support the mechanism presented in Scheme 9.  This hypothesis is further 
supported by the molecular structure of the [TmBut]ZnO2C(9-An)•HO2C(9-An) hydrogen 
bonded adduct (Figure 12).  Unfortunately attempts of obtaining a crystal structure of 
a [TmBut]CdO2CR•HO2CR adduct were unsuccessful.  The third species is not visible at 
temperatures between 195-284K when concentrations of 9.8 × 10-4 M and 9.1 × 10-4 M are 
used for the zinc and cadmium studies respectively.  As a result, we only modeled 




Figure 18.  A series of 19F NMR spectra for a 1:1 mixture of [TmBut]ZnO2C(C6H4-4-F) 
and HO2C(C6H4-4-F), taken at 187 K, showing the dependence of the supposed 
[TmBut]ZnO2C(C6H4-4-F)•HO2C(C6H4-4-F) on concentration 
 
 
Figure 19.  A series of 19F NMR spectra for a 1:1 mixture of [TmBut]CdO2C(C6H4-4-F) 
and HO2C(C6H4-4-F), taken at 187 K, showing the dependence of the proposed 




Over the past few decades, ligand exchange at group 12 metal centers has been 
investigated for a variety of systems.,32,33,34,35,36,37  The exchange of acetate between the 
tris(pyrazolyl)hydroborato compound, [TpBut]CdO213CMe, and [Na(kryptofix-
221)][Me13CO2],12 provides the most suitable comparison to our studies on 
[TmBut]CdO2C(C6H4-4-F) benzoate exchange.  Acetate exchange between 
[TpBut]CdO213CMe with [Na(kryptofix-221)][Me13CO2] was monitored by 13C NMR 
spectroscopy, and significant broadening of the 13C resonances for both the free and 
bound acetate suggests that acetate exchange is rapid on the 13C NMR timescale at room 
temperature.  Interestingly, while the mechanism of acetate exchange is proposed to be 
dissociative, we observe an associative mechanism for [TmBut]CdO2C(C6H4-4-F) 
benzoate exchange.  
 
2.3 Summary and Conclusions 
[TmBut]MR (M = Zn, Cd; R = Me) reacts with carboxylic acids via facile M-C bond 
cleavage, and a series of [TmBut]MO2CR (R = C6H4-4-Me; C6H4-4-F; C6H3-3,5-F2; C6H3-2,6-
F2; C3H6Ph; 9-An; and tridecyl) complexes was synthesized and structurally 
characterized using X-ray diffraction.  Likewise, [TmBut]MR (M = Zn, Cd; R = Me) 
reacts with thiobenzoic acid in a similar manner, generating [TmBut]MSC(O)Ph.  The 
[TmBut]MSC(O)Ph (M = Zn, Cd) complexes were structurally characterized using X-ray 
diffraction, and their molecular structures reveal that the thiobenzoate ligand 
coordinates in a monodentate fashion through the sulfur atom.   
Interestingly the [TmBut]MO2CR (M = Zn, Cd) complexes undergo rapid 
degenerate carboxylate exchange in the presence of excess acid.  As carboxylate 
 
 105 
exchange is rapid on the 1H NMR NMR timescale, a series of kinetic studies were 
performed using 19F NMR spectroscopy.  Based on the results of a concentration 
experiment, benzoate exchange operates by an associative mechanism that can be 
characterized by the rate equation: rate = k[Metal][Monomer]2.  Comparison of the 19F 
NMR spectral lineshapes for a 1:1 mixture of [TmBut]MO2CR (M = Zn, Cd) and 
HO2C(C6H4-4-F) over a wide range of temperatures reveals that benzoate exchange is 
slower for [TmBut]ZnO2C(C6H4-4-F) than it is for [TmBu
t]CdO2C(C6H4-4-F).  
 
2.4 Experimental Section 
2.4.1 General Considerations 
All manipulations were performed using a combination of glovebox, high-vacuum, and 
Schlenck techniques under a nitrogen atmosphere,38 except where otherwise stated.  
Solvents were purified and degassed by standard procedures.  NMR solvents were 
purchased from Cambridge Isotope Labs and stored over 3 Å molecular sieves.  NMR 
spectra were measured on Bruker 300 DRX, Bruker 300 DPX, Bruker 400 Avance III, 
Bruker 400 Cyber-enabled Avance III, and Bruker 500 DMX spectrometers.  1H-NMR 
chemical shifts are reported in ppm relative to SiMe4 (' = 0) and were referenced 
internally with respect to the protio solvent impurity (' = 7.16 for C6D5H, 2.08 for C7D8, 
and 7.26 for CHCl3).39 13C-NMR spectra are reported in ppm relative to SiMe4 (' = 0) 
and were referenced internally with respect to the solvent (' = 128.06 for C6D6 and 77.16 
for CDCl3).39  19F-NMR spectra are reported in ppm relative to CFCl3 (' = 0) and were 
referenced internally with respect to a C6F6 standard (' = -164.9).40  Coupling constants 
are reported in hertz.  IR spectra were recorded on a PerkinElmer Spectrum Two 
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spectrometer and the data are reported in reciprocal centimeters (cm-1).  Mass spectra 
were obtained on a JEOL JMS-HX110HF tandem mass spectrometer using fast atom 
bombardment (FAB).  [TmBut]Na was prepared by the literature methods.41  4-
methylbenzoic acid (Aldrich), 4-phenylbutyric acid (Aldrich), 9-anthracenecarboxylic 
acid (Aldrich), thiobenzoic acid (Aldrich), 3,5-difluorobenzoic acid (Aldrich), 2,6-
difluorobenzoic acid (Aldrich), myristic acid (Aldrich), cadmium chloride (anhydrous, 
Aldrich), and Me2Zn (STREM) were commercially obtained and used without further 
purification.  ZnCl2 was purchased from Aldrich and dried using thionyl chloride 
prior to use.  4-fluorobenzoic acid was purchased from Aldrich and was recrystallized 
from a 50% EtOH(aq) solution prior to use.  Me2Cd was purchased from STREM and 
was distilled prior to use.  
 
2.4.2 X-ray Structure Determinations 
X-ray diffraction data were collected on a Bruker Apex II diffractometer.  Crystal data, 
data collection and refinement parameters are summarized in Table 24.  The structures 
were solved using direct methods and standard difference map techniques, and were 
refined by full-matrix least-squares procedures on F2 with SHELXTL (version 6.12).42 
 
2.4.3 Computational Details 
Calculations were carried out using DFT as implemented in the Jaguar 7.7 (release 107) 
suite of ab initio quantum chemistry programs. 43   Geometry optimizations and 
frequency calculations were performed with the B3LYP density functional44 using the 
6-31G** (H, B, C, N, S, O, F) and LACVP (Zn, Cd) basis set.45   
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2.4.4 Kinetics of Benzoate Ligand Exchange  
2.4.4.1 Preparation of [TmBut]CdO2C(4-C6H4F) samples 
All stock solutions and exchange samples were prepared in a N2 glovebox.  A 
8.9 × 10-3 M stock solution of [TmBut]CdO2C(4-C6H4F) in C7D8 was prepared from 32.4 
mg of finely ground [TmBut]CdO2C(4-C6H4F) (0.0443 mmol) in a 5 mL volumetric flask.  
A 2.8 × 10-2 M stock solution of 4-fluorobenzoic acid was prepared from 19.6 mg of 
finely ground 4-fluorobenzoic acid (0.140 mmol) in 5 mL volumetric flask. 
 Four samples containing a 1:1, 1:2, 1:3, or 1:4 molar ratio of [TmBut]CdO2C(4-
C6H4F) (9.1 × 10-4 M) to 4-fluorbenzoic acid (9.1 × 10-4 M, 1.8 × 10-3 M, 2.7 × 10-3 M, and 
3.6 × 10-3 M respectively) were prepared in C7D8.  Each sample mixture was prepared 
according to the following method: a microsyringe was used to measure the 
appropriate amount of the [TmBut]CdO2C(4-C6H4F) stock solution, and the solution was 
transferred to a 1 mL volumetric flask.  A microsyringe was used to measure the 
appropriate amount of the 4-fluorobenzoic acid stock solution and the solution was 
added to the 1 mL volumetric flask.  A microliter syringe was used to measure 1 mL of 
neat C6F6, which was added to the 1 mL volumetric flask and used as an internal 
standard for 19F-NMR.  Additional C7D8 was added to the volumetric flask to dilute the 
sample to 1 mL.  The solution was transferred to a J. Young tube for analysis.  
 A [TmBut]CdO2C(4-C6H4F) reference sample (9.1 × 10-4 M) and four 4-
fluorobenzoic acid reference samples of increasing concentrations (9.1 × 10-4 M, 1.8 × 10-3 
M, 2.7 × 10-3 M, 3.6 × 10-3 M) were prepared in C7D8.  1 µL of neat C6F6 was added to 




2.4.4.2 Preparation of [TmBut]ZnO2C(4-C6H4F) samples 
All stock solutions and exchange samples were prepared in a N2 glovebox.  A 
8.9 × 10-3 M sock solution of [TmBut]ZnO2C(4-C6H4F) in C7D8 was prepared from 32.4 mg 
of finely ground [TmBut]ZnO2C(4-C6H4F) (0.0443 mmol) in a 5 mL volumetric flask.  A 
2.8 × 10-2 M stock solution of 4-fluorobenzoic acid was prepared from 19.6 mg of finely 
ground 4-fluorobenzoic acid (0.140 mmol) in 5 mL volumetric flask. 
 A solution containing a 1:1 molar ratio of [TmBut]ZnO2C(4-C6H4F) (9.8 × 10-4 M) to 
4-fluorbenzoic acid (1.00 × 10-3 M) was prepared in C7D8.  A [TmBu
t]ZnO2C(4-C6H4F) 
(9.8 × 10-4 M) reference sample and a 4-fluorobenzoic acid reference samples (1.00 × 10-3 
M, 1.97) were prepared in C7D8.  1 µL of neat C6F6 was added to each sample and used 
as an internal standard for 19F-NMR.  
 
2.4.5 Variable temperature 19F NMR experiments  
The Bruker 500 NMR spectrometer was cooled to the desired temperature, and a 
methanol temperature calibration standard was used to check the temperature of the 
probe before inserting the sample.  Each sample was inserted, allowed to reach the 
equilibrium temperature (15 min.), and the 1H and 19F-NMR spectra were acquired.  
 
2.4.6 Synthesis of [TmBut]CdMe 
[TmBut]CdMe was prepared by modification of the literature method.11b  Caution: CdMe2 
is highly toxic.  In an ampoule, a suspension of [TmBut]Na (1.110 g, 2.22 mmol) in C6H6 
(ca. 30 mL) was treated with CdCl2 (193.5 mg, 1.06 mmol).  The temperature of the 
reaction mixture was gradually heated to 125˚ C over 30 minutes, and then the 
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temperature was maintained at 125˚ C for 18.5 hours while stirring vigorously.  The 
reaction mixture was a cloudy pale yellow solution, and it was allowed to cool to room 
temperature at which point a white precipitate settled out.  To the reaction mixture 
was added neat CdMe2 (120 µL, 1.67 mmol), and the mixture was stirred at room 
temperature for 1 hour.  The reaction mixture was filtered through a frit in the 
nitrogen glovebox, and the white precipitate was washed with C6H6 (ca. 2 × 5 mL).  A 
white precipitate began to crash out of the filtered solution so additional C6H6 (ca. 10 
mL) was added to dissolve the precipitate.  The solution was transferred to a Schlenck 
flask, and the volatile components removed in vacuo, yielding [TmBut]CdMe as a white 
solid (984 mg, 77.0%). 
 
2.4.7 Synthesis of [TmBut]CdO2C(C6H4-4-Me)  
2.4.7.1   Synthetic method A via Cd-C bond cleavage 
A solution of [TmBut]CdMe (201 mg, 0.332 mmol) in C6H6 (ca. 9 mL) was treated with 4-
methylbenzoic acid (56 mg, 0.41 mmol), resulting in immediate bubbling.  The solution 
was stirred at room temperature for 1 hour.  The volatile components were removed in 
vacuo, and the resulting powder was washed with Et2O (ca. 2 mL), yielding 
[TmBut]CdO2C(C6H4-4-Me) as a white solid (157 mg, 65.2%).  Crystals suitable for X-ray 
diffraction were obtained from a solution of Et2O.  Analysis calcd. for 
[TmBut]CdO2C(C6H4-4-Me): C, 48.0%; H, 5.7%; N, 11.6%.  Found: C, 47.5%; H, 5.7%; N, 
11.3%.  1H NMR (C6D6): 1.52 [s, 27H, HB{C2N2H2[C(CH3)3]CS}3], 1.98 [s, 3H, 
CdO2C(C6H4-4-CH3)], 6.43 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 6.69 [d, 3JH-H = 2, 
3H, HB{C2N2H2[C(CH3)3]CS}3], 6.95 [d, 3JH-H = 8, 2H, CdO2C(C6H4-4-Me)], 8.60 [d, 3JH-H = 
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8, 2H, CdO2C(C6H4-4-Me)].  13C{1H} NMR (C6D6): 21.4 [1C, CdO2C(C6H4-4-CH3)], 28.9 
[9C, HB{C2N2H2[C(CH3)3]CS}3], 59.5 [3C, HB{C2N2H2[C(CH3)3]CS}3], 117.0 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 122.9 [3C, HB{C2N2H2[C(CH3)3]CS}3], 128.6 [2C, CdO2C(C6H4-
4-Me)], 131.5 [2C, CdO2C(C6H4-4-Me)], 132.9 [1C, CdO2C(C6H4-4-Me)] 140.4 [1C, 
CdO2C(C6H4-4-Me)], 157.6 [3C, HB{C2N2H2[C(CH3)3]CS}3], 175.1 [1C, CdO2C(C6H4-4-
Me)].  IR Data for [TmBut]CdO2C(C6H4-4-Me) (ATR, cm-1): 3183 (w), 2977 (w), 2923 (w), 
2414 (w), 2324 (w), 2162 (w), 2051 (w), 1980 (w), 1608 (m), 1590 (m), 1535 (s), 1482 (w), 
1458 (w), 1397 (vs), 1358 (vs), 1293 (m), 1253 (m), 1229 (m), 1195 (s), 1172 (s), 1132 (m), 
1119 (m), 1099 (m), 1061 (m), 1047 (m), 1021 (m), 984 (w), 929 (w), 860 (m), 821 (m), 787 
(m), 767 (s), 727 (s), 687 (s), 639 (w), 621 (m), 589 (m), 552 (m), 493 (w), 476 (m).  FAB-
MS: m/z = 541.1 [M - O2C(C6H4-4-Me)]+, M = [TmBu
t]ZnO2C(C6H4-4-Me).  FAB-MS: m/z 
= 591.1 [M – O2C(C6H4-4-Me)]+, M = [TmBu
t]CdO2C(C6H4-4-Me). 
2.4.7.2  Synthetic method B via Cd-C bond cleavage 
In a large scintillation vial, a solution of CdMe2 (36 mL, 0.50 mmol) in C6H6 (ca. 4 mL) 
was treated with [TmBut]Na (251 mg, 0.501 mmol) while stirring.  4-methylbenzoic acid 
(137 mg, 1.01 mmol) was immediately added to the reaction mixture, resulting in 
vigorous bubbling, and the formation of a cloudy jelly-like precipitate.  The solution 
was stirred for 45 minutes.  The mixture was filtered through a filter pipette and the 
volatile component were removed in vacuo to give [TmBut]CdO2C(C6H4-4-Me) as a white 
solid (150 mg, 41.3%).  
2.4.7.3  Synthetic method C via salt formation 
A sample of Cd(O2C(C6H4C-4-Me))2 was generated by treating a solution of 4-
methylbenzoic acid (1.402 g, 10.30 mmol) in toluene (ca. 5 mL) with neat CdMe2 (370 µL, 
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5.16 mmol) while stirring.  Note: The CdMe2 reacts vigorously with the acid, so it was added 
slowly.  A thick gummy precipitate immediately formed upon addition of CdMe2.  
Pentane (ca. 20 mL) was added to the reaction flask, generating a white precipitate.  
The reaction mixture was stirred at room temperature for 30 minutes, and the 
precipitate was isolated using a frit.  The precipitate was washed with pentane (2 × 10 
mL) and dried under vacuum, yielding Cd(O2C(C6H4-4-Me))2 as a white solid (1.886 g, 
95.7%).  A suspension of Cd(O2C(C6H4-4-Me))2 (139 mg, 0.363 mmol) in C6H6 (ca. 5 mL) 
was treated with [TmBut]Na (181 mg, 0.362 mmol) while stirring vigorously.  A cloudy, 
jelly-like suspension was generated which was stirred for 30 minutes.  The reaction 
mixture was centrifuged (2 × 3 min. at 7000 rpm), and the resulting solution filtered 
through a filter pipette.  The volatile components were removed in vacuo, and the 
resulting white powder was washed with Et2O (ca. 2 × 1 mL), yielding [TmBu
t]CdO2C(4-
C6H4-4-Me) as a white solid (147 mg, 56.1%). 
 
2.4.8 Synthesis of [TmBut]CdO2C(C6H4-4-F)  
2.4.8.1 ! Synthetic Method A via Cd-C bond cleavage 
A solution of [TmBut]CdMe (528 mg, 0.873 mmol) in C6H6 (ca. 40 mL) was treated with 4-
fluorobenzoic acid (122 mg, 0.871 mmol), resulting in immediate bubbling.  The 
solution was stirred at room temperature for 45 minutes.  The volatile components 
were removed in vacuo, yielding [TmBut]CdO2C(C6H4-4-F) as a white solid (534 mg, 
84.1%).  The solid was further purified by extracting the solid into Et2O (ca. 50 mL); 
using a warm water bath to help the compound dissolve.  Pentane was added (ca. 10 
mL) to help induce crystallization, and the solution was concentrated until a 
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microcrystalline precipitate was generated.  The precipitate was filtered and dried in 
vacuo.  Crystals suitable for X-ray diffraction were obtained via slow diffusion of 
pentane into a solution in C6H6.  Analysis calcd. for [TmBu
t]CdO2C(C6H4-4-F): C, 46.1%; 
H, 5.3%; N, 11.5%.  Found: C, 46.5%; H, 5.2%; N, 11.2%.  1H NMR (C6D6): 1.52 [s, 27H, 
HB{C2N2H2[C(CH3)3]CS}3], 6.42 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 6.68 [d, 3JH-H = 
2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 6.72 [m, 2H, CdO2C(C6H4-4-F)], 8.47 [m, 2H, 
CdO2C(C6H4-4-F)].  13C{1H} NMR (C6D6): 28.9 [9C, HB{C2N2H2[C(CH3)3]CS}3], 59.5 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 114.5 [d, 3JC-F = 20, 2C, CdO2C(C6H4-4-F)], 117.0 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 123.0 [3C, HB{C2N2H2[C(CH3)3]CS}3], 131.8 [d, 4JC-F = 3, 1C, 
CdO2C(C6H4-4-F)], 133.6 [d, 2JC-F = 9, 2C, CdO2C(C6H4-4-F)], 157.5 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 165.0 [d, 1JC-F = 247, 1C, CdO2C(C6H4-4-F)], 173.8 [1C, 
CdO2C(C6H4-4-F)].  19F NMR (C6D6): -113.17 (m).  IR Data for [TmBu
t]CdO2C(C6H4-4-F) 
(ATR, cm-1): 3177 (w), 3145 (w), 2979 (w), 2920 (w), 2662 (w), 2417 (w), 2324 (w), 2289 
(w), 2239 (w), 2162 (w), 2116 (w), 2051 (w), 1981 (w), 1608 (m), 1602 (m), 1546 (m), 1507 
(w), 1483 (m), 1458 (w), 1428 (m), 1416 (m), 1397 (s), 1370 (s), 1356 (vs), 1305 (m), 1255 
(w), 1223 (s), 1192 (vs), 1175 (s), 1151 (m), 1133 (m), 1087 (m), 1070 (m), 1030 (w), 1016 
(w), 989 (w), 929 (w), 864 (m), 822 (m), 785 (s), 757 (s), 735 (s), 724 (s), 685 (s), 621 (vs), 
587 (m), 550 (m), 493 (m), 457 (m).  FAB-MS: m/z = 591.2 [M – O2C(C6H4-4-F)]+, M = 
[TmBut]CdO2C(C6H4-4-F). 
2.4.8.2  Synthetic method B via salt formation 
In a large scintillation vial, a solution of CdMe2 (36 µL, 0.50 mmol) in C6H6 (ca. 4 mL) 
was treated with [TmBut]Na (247 mg, 0.49 mmol) while stirring.  4-fluorobenzoic acid 
(134 mg, 0.956 mmol) was added to the reaction mixture, resulting in vigorous 
bubbling, as CH4 was produced, and the immediate formation of sodium 4-
 
 113 
fluorobenzoate as a white jelly-like precipitate.  The solution was stirred for 30 minutes 
and allowed to settle for 30 minutes.  The mixture was filtered through a filter pipette 
and the volatile components were removed in vacuo to give [TmBut]CdO2C(C6H4-4-F) as a 
white solid (124 mg, 35.6%).  
 
2.4.9 Synthesis of [TmBut]CdO2C(C6H3-3,5-F2)  
A solution of [TmBut]CdMe (407 mg, 0.673 mmol) in C6H6 (ca. 10 mL) was treated with 
3,5-fluorobenzoic acid (107 mg, 0.677 mmol), resulting in immediate bubbling.  The 
solution was stirred at room temperature for 30 minutes.  The volatile components 
were removed in vacuo, and the resulting powder was washed with Et2O (ca. 2 mL) 
yielding [TmBut]CdO2C(C6H3-3,5-F2) as a white solid (0.25 g, 50%).  Crystals suitable for 
X-ray diffraction were obtained from a cold solution in Et2O.  Analysis calcd. for 
[TmBut]CdO2C(C6H3-3,5-F2)•Et2O: C, 46.8%; H, 5.8%; N, 10.2%.  Found: C, 46.2%; H, 
4.9%; N, 9.5%.  1H NMR (C6D6): 1.50 [s, 27H, HB{C2N2H2[C(CH3)3]CS}3], 6.41 [d, 3JH-H = 
2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 6.44 [m, 1H, CdO2C(C6H3-3,5-F2)], 6.67 [d, 3JH-H = 2, 3H, 
HB{C2N2H2[C(CH3)3]CS}3], 8.07 [m, 2H, CdO2C(C6H3-3,5-F2)].  13C{1H} NMR (C6D6): 28.8 
[9C, HB{C2N2H2[C(CH3)3]CS}3], 59.5 [3C, HB{C2N2H2[C(CH3)3]CS}3], 105.8 [t, 2JC-F = 26, 
1C, CdO2C(C6H3-3,5-F2)], 113.8 [dd, 2JC-F = 20, 4JC-F = 5, 2C, CdO2C(C6H3-3,5-F2)], 117.1 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 123.0 [3C, HB{C2N2H2[C(CH3)3]CS}3], 139.5 [t, 3JC-F = 8, 1C, 
CdO2C(3,5-C6H3F2)], 157.2 [3C, HB{C2N2H2[C(CH3)3]CS}3], 162.9 [dd, 1JC-F = 248, 3JC-F = 11, 
2C, CdO2C(C6H3-3,5-F2)] 172.2, [t, 4JC-F = 3, 1C, CdO2C(C6H3-3,5-F2)].  19F NMR (C6D6): -
113.36.  IR Data for [TmBut]CdO2C(C6H4-3,5-F2) (ATR, cm-1): 3148 (w), 2978 (w), 2927 
(w), 2414 (w), 2235 (w), 2165 (w), 2051 (w), 1982 (w), 1620 (w), 1566 (s), 1482 (w), 1468 
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(w), 1418 (m), 1393 (s), 1357 (vs), 1305 (m), 1260 (w), 1228 (m), 1193 (vs), 1173 (vs), 1132 
(m), 1114 (s), 1071 (m), 1031 (w), 982 (s), 949 (w), 929 (w), 892 (w), 850 (w), 822 (m), 777 
(s), 760 (s), 725 (s), 685 (s), 668 (m), 590 (m), 552 (m), 495 (m) 455 (m).  FAB-MS: m/z = 
591.1 [M – O2C(C6H3-3,5-F2)]+, M = [TmBu
t]CdO2C(C6H3-3,5-F2). 
 
2.4.10  Synthesis of [TmBut]CdO2C(C6H3-2,6-F2)  
A solution of [TmBut]CdMe (209 mg, 0.345 mmol) in C6H6 (ca. 9 mL) was treated with 
2,6-fluorobenzoic acid (55 mg, 0.35 mmol), resulting in immediate bubbling.  The 
solution was stirred vigorously at room temperature for 1 hour, resulting in the 
formation of a fluffy precipitate.  The reaction mixture was allowed to settle for 30 
minutes, then filtered through a filter pipette.  The volatile components were removed 
in vacuo, and the resulting powder was washed with Et2O (ca. 2 × 1 mL) yielding 
[TmBut]CdO2C(C6H3-2,6-F2) as a white solid (0.103 g, 39.9%).  Crystals suitable for X-ray 
diffraction were obtained from a cold solution in Et2O.  Analysis calcd. for 
[TmBut]CdO2C(C6H3-2,6-F2): C, 45.0%; H, 5.0%; N, 11.3%.  Found: C, 45.1%; H, 4.9%; N, 
11.1%.  1H NMR (C6D6): 1.51 [s, 27H, HB{C2N2H2[C(CH3)3]CS}3], 6.40 [d, 3JH-H = 2, 3H, 
HB{C2N2H2[C(CH3)3]CS}3], 6.45 [m, 3H, CdO2C(C6H3-2,6-F2)], 6.66 [d, 3JH-H = 2, 3H, 
HB{C2N2H2[C(CH3)3]CS}3].  13C{1H} NMR (C6D6): 28.8 [9C, HB{C2N2H2[C(CH3)3]CS}3], 
59.6 [3C, HB{C2N2H2[C(CH3)3]CS}3], 111.3 [dd, 2JC-F = 20, 4JC-F = 5, 2C, CdO2C(C6H3-2,6-
F2)], 117.1 [3C, HB{C2N2H2[C(CH3)3]CS}3], 118.1 [t, 2JC-F = 23, 1C, CdO2C(C6H3-2,6-F2)], 
122.9 [3C, HB{C2N2H2[C(CH3)3]CS}3], 128.8 [t, 3JC-F = 10, 1C, CdO2C(C6H3-2,6-F2)], 157.2 
[3C, HB{C2N2H2[C(CH3)3]CS}3], 160.5 [dd, 1JC-F = 250, 3JC-F = 9, 2C, CdO2C(C6H3-2,6-F2)], 
169.1 [1C, CdO2C(C6H3-2,6-F2)].  19F NMR (C6D6): -113.37  
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(m).  IR Data for [TmBut]CdO2C(C6H4-2,6-F2) (ATR, cm-1): 2982 (w), 2375 (w), 2222 (w), 
2165 (w), 2050 (w), 1981 (w), 1622 (m), 1567 (m), 1463 (m), 1417 (m), 1396 (s), 1359 (vs), 
1304 (m), 1266 (w), 1231 (m), 1193 (s), 1172 (s), 1128 (m), 1060 (m), 1032 (m), 1004 (s), 929 
(w), 854 (m), 820 (m), 755 (m), 731 (s), 688 (s), 587 (s), 552 (m), 521 (m), 494 (m).  FAB-
MS: m/z = 591.2 [M – O2C(C6H3-2,6-F2)]+, M = [TmBu
t]CdO2C(C6H3-2,6-F2). 
 
2.4.11  Synthesis of [TmBut]CdO2C(C3H6Ph)  
A solution of [TmBut]CdMe (215 mg, 0.355 mmol) in C6H6 (ca. 9 mL) was treated with 4-
phenylbutyric acid (74 mg, 0.45 mmol), resulting in immediate bubbling.  The solution 
was stirred at room temperature for 1 hour.  The volatile components were removed in 
vacuo, and the resulting powder was washed with Et2O (ca. 2 mL), yielding 
[TmBut]CdO2C(C3H6Ph) as a white solid (145 mg, 54.2%).  Crystals suitable for X-ray 
diffraction were obtained from Et2O.  Analysis calcd. for [TmBu
t]CdO2C(C3H6Ph): C, 
49.4%; H, 6.0%; N, 11.2%.  Found: C, 49.7%; H, 5.5%; N, 10.6%.  1H NMR (C6D6): 1.52 
[s, 27H, HB{C2N2H2[C(CH3)3]CS}3], 2.12 [q, 3JH-H = 8, 2H, CdO2C(C3H6Ph)], 2.58 [t, 3JH-H = 
7, 2H, CdO2C(C3H6Ph)], 2.67 [t, 3JH-H = 8, 2H, CdO2C(C3H6Ph)], 6.43 [d, 3JH-H = 2, 3H, 
HB{C2N2H2[C(CH3)3]CS}3], 6.67 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 7.04 [m, 1H, 
CdO2C(C3H6Ph)], 7.13 [m, 4H, CdO2C(C3H6Ph)].  13C{1H} NMR (C6D6): 28.9 [9C, 
HB{C2N2H2[C(CH3)3]CS}3], 29.2 [1C, CdO2C(C3H6Ph)], 35.2 [1C, CdO2C(C3H6Ph)], 36.2 
[1C, CdO2C(C3H6Ph)], 59.4 [3C, HB{C2N2H2[C(CH3)3]CS}3], 117.0 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 122.9 [3C, HB{C2N2H2[C(CH3)3]CS}3], 125.6 [1C, 
CdO2C(C3H6Ph)], 128.4 [2C, CdO2C(C3H6Ph)], 129.1 [2C, CdO2C(C3H6Ph)], 143.5 [1C, 
CdO2C(C3H6Ph)], 157.6 [3C, HB{C2N2H2[C(CH3)3]CS}3], 181.7 [1C, CdO2C(C3H6Ph)].  IR 
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Data for [TmBut]CdO2C(C3H6Ph) (ATR, cm-1): 2975 (w), 2924 (w), 1550 (s), 1496 (m), 1481 
(m), 1453 (m), 1415 (s), 1358 (vs), 1295 (m), 1255 (m), 1228 (m), 1195 (s), 1165 (s), 1119 
(m), 1061 (m), 1030 (m), 929 (w), 821 (m), 724 (s), 699 (s), 685 (s), 591 (m), 554 (m), 494 
(m).  FAB-MS: m/z = 591.2 [M – O2C(C3H6Ph)]+, M = [TmBu
t]CdO2C(C3H6Ph). 
 
2.4.12  Synthesis of [TmBut]CdO2C(9-An) 
A solution of [TmBut]CdMe (144 mg, 0.238 mmol) in C6H6 (ca. 9 mL) was treated with 9-
anthracenecarboxylic acid (73 mg, 0.33 mmol), resulting in immediate bubbling.  The 
resulting cloudy solution was stirred vigorously at room temperature for 2.5 hours.  
The volatile components were removed in vacuo, and the resulting powder was washed 
with Et2O (ca. 2 mL), yielding [TmBu
t]CdO2C(9-An) as a pale yellow solid (142 mg, 
73.5%).  Crystals suitable for X-ray diffraction were obtained from a solution in C6D6.  
Analysis calcd. for [TmBut]CdO2C(9-An): C, 53.3%; H, 5.3%; N, 10.4%.  Found: C, 53.3%; 
H, 4.4%; N, 9.6%.  1H NMR (C6D6): 1.56 [s, 27H, HB{C2N2H2[C(CH3)3]CS}3], 6.45 [d, 3JH-H 
= 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 6.72 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 7.21 
[t, 3JH-H = 8, 2H, CdO2C(C14H9)], 7.29 [t, 3JH-H = 7, 2H, CdO2C(C14H9)], 7.74 [d, 3JH-H = 7, 2H, 
CdO2C(C14H9)], 8.09 [s, 1H, CdO2C(C14H9)], 8.88 [d, 3JH-H = 9, 2H, CdO2C(C14H9)].  
13C{1H} NMR (C6D6): 28.9 [9C, HB{C2N2H2[C(CH3)3]CS}3], 59.6 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 117.1 [3C, HB{C2N2H2[C(CH3)3]CS}3], 123.0 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 125.1 [2C, CdO2C(C14H9)], 125.3 [2C, CdO2C(C14H9)], 126.5 
[1C, CdO2C(C14H9)], 128.1 [4C, CdO2C(C14H9)], 128.7 [2C, CdO2C(C14H9)], 128.8 [2C, 
CdO2C(C14H9)], 132.0 [1C, CdO2C(C14H9)], 157.5 [3C, HB{C2N2H2[C(CH3)3]CS}3], 177.5 
[1C, CdO2C(C3H6Ph)].  IR Data for [TmBu
t]CdO2C(C14H9) (ATR, cm-1): 3185 (w), 2969 
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(w), 2918 (w), 2411 (w), 2324 (w), 2162 (w), 2051 (w), 1981 (w), 1552 (s), 1483 (m), 1416 
(s), 1395 (m), 1359 (vs) 1317 (s), 1276 (m), 1229 (m), 1192 (s), 1172 (s), 1131 (m), 1061 (w), 
1015 (w), 956 (w), 928 (w), 881 (m), 868 (m), 845 (m), 821 (m), 796 (w), 777 (s), 759 (s), 730 
(vs),  721 (s), 689 (s), 669 (m), 639 (m), 588 (m), 555 (m), 527 (m), 494 (m), 479 (m).  
FAB-MS: m/z = 591.2 [M – O2C(C14H9)]+, M = [TmBu
t]CdO2C(C14H9). 
 
2.4.13 Synthesis of [TmBut]CdO2C(tridecyl) 
A solution of [TmBut]CdMe (104.5 mg, 0.173 mmol) in C6H6 (ca. 9 mL) was treated with 
tetradecanoic acid (39.9 mg, 0.175 mmol), resulting in immediate bubbling.  The 
resulting cloudy solution was stirred vigorously at room temperature for 1 hour.  The 
volatile components were removed in vacuo, and the resulting powder was washed with 
a mixture of Et2O (ca. 0.5 mL) and pentane (ca. 2 mL).  Yield: 99.7 mg (70.62%).  
Analysis calcd. for [TmBut]CdO2C(tridecyl): C, 51.43%; H, 7.52%; N, 10.28%.  Found: C, 
51.21%; H, 7.69%; N, 9.71%.  1H NMR (C6D6): 0.92 [t, 3JH-H = 7, 3H of CdO2C(C13H27)], 
1.27 [m, 18H of CdO2C(C13H27)], 1.40 [m, 2H of CdO2C(C13H27)], 1.53 [s, 27H of 
HB{C2N2H2[C(CH3)3]CS}3], 1.89 [q, 3JH-H = 8, 2H of CdO2C(C13H27)], 2.60 [t, 3JH-H = 7, 2H of 
CdO2C(C13H27)], 6.40 [d, 3JH-H = 2, 3H of HB{C2N2H2[C(CH3)3]CS}3], 6.68 [d, 3JH-H = 2, 3H of 
HB{C2N2H2[C(CH3)3]CS}3].  13C{1H} NMR (CD2Cl2): 14.39 [1C,, CdO2C(C13H27)], 23.14 
[1C,, CdO2C(C13H27)], 27.20 [1C,, CdO2C(C13H27)], 28.57 [1C,, CdO2C(C13H27)], 28.90 [9C, 
HB{C2N2H2[C(CH3)3]CS}3], 29.87 [1C,, CdO2C(C13H27)], 30.11 [1C,, CdO2C(C13H27)], 30.18 
[1C,, CdO2C(C13H27)], 30.23 [1C,, CdO2C(C13H27)], 32.38 [1C,, CdO2C(C13H27)], 35.77 [1C,, 
CdO2C(C13H27)], 59.43 [3C,, HB{C2N2H2[C(CH3)3]CS}3], 116.94 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 122.88 [3C, HB{C2N2H2[C(CH3)3]CS}3], 157.67 [3C,, 
HB{C2N2H2[C(CH3)3]CS}3], 181.45 [1C,, CdO2C(C13H27)].  IR Data for 
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[TmBut]CdO2C(tridecyl) (ATR, cm-1): 3189 (w), 3150 (w), 2920 (m), 2851 (m), 2322 (w), 
2172 (w), 2056 (w), 1983 (w), 1736 (w), 1544 (m), 1470 (m), 1417 (m), 1398 (m), 1358 (vs), 
1302 (m), 1264 (w), 1232 (m), 1196 (s), 1172 (s), 1132 (m), 1101 (m), 1071 (m), 1031 (w), 
929 (w), 822 (m), 777 (m), 758 (m), 725 (m), 686 (m), 646 (w), 591 (w), 546 (w), 494 (w), 
468 (w).  FAB-MS: m/z = 591.2 [M – O2C(C13H27)]+, M = [TmBu
t]CdO2C(C13H27). 
 
2.4.14  Synthesis of [TmBut]CdSC(O)Ph  
A solution of [TmBut]CdMe (201 mg, 0.332 mmol) in C6H6 (ca. 9 mL) was treated with 
thiobenzoic acid (48 µL, 0.41 mmol), resulting in immediate bubbling.  The solution 
was stirred at room temperature for 45 minutes.  The volatile components were 
removed in vacuo, and the resulting powder was washed with Et2O (ca. 2 × 1 mL), 
yielding [TmBut]CdSC(O)Ph as a pale yellow solid (159 mg, 65.8%).  Crystals suitable 
for X-ray diffraction were obtained via slow diffusion of pentane into a solution in C6D6.  
Analysis calcd. for [TmBut]CdSC(O)Ph: C, 46.3%; H, 5.4%; N, 11.6%.  Found: C, 47.0%; 
H, 5.2%; N, 11.4%.  1H NMR (C6D6): 1.52 [s, 27H, HB{C2N2H2[C(CH3)3]CS}3], 6.44 [d, 3JH-
H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 6.69 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 7.06 
[m, 3H, CdSC(O)C6H5], 8.58 [m, 2H, CdSC(O)C6H5].  13C{1H} NMR (C6D6): 28.9 [9C, 
HB{C2N2H2[C(CH3)3]CS}3], 59.5 [3C, HB{C2N2H2[C(CH3)3]CS}3], 117.0 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 122.9 [3C, HB{C2N2H2[C(CH3)3]CS}3], 128.1 [1C, 
CdSC(O)C6H5], 129.6 [2C, CdSC(O)C6H5], 131.3 [2C, CdSC(O)C6H5], 141.6 [1C, 
CdSC(O)C6H5], 157.7 [3C, HB{C2N2H2[C(CH3)3]CS}3], 203.7 [1C, CdSC(O)Ph].  IR Data 
for [TmBut]CdSC(O)Ph (ATR, cm-1): 3136 (w), 3055 (w), 2966 (w), 2928 (w), 2658 (w), 2409 
(w), 2324 (w), 2233 (w), 2167 (w), 2051 (w), 1980 (w), 1587 (m), 1559 (m) 1483 (w), 1445 
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(w), 1427 (m), 1417 (s), 1396 (m), 1358 (vs), 1304 (m), 1254 (w), 1229 (m), 1192 (vs), 1175 
(vs), 1133 (m), 1070 (m), 1062 (m), 1025 (m), 1000 (w), 986 (w), 928 (s), 856 (w), 822 (m), 
781 (m), 759 (s), 743 (s), 724 (vs), 692 (vs), 685 (vs), 668 (m), 653 (s), 617 (w), 588 (m), 552 
(m), 495 (m), 455 (m).  FAB-MS: m/z = 589.2 [M – SC(O)Ph]+, M = [TmBut]CdSC(O)Ph. 
 
2.4.15 Synthesis of [TmBut]ZnMe 
[TmBut]ZnMe was prepared by modification of the literature method.11a Caution: ZnMe2 
is a pyrophoric. Great care must be taken to prevent exposure of the reaction solution to water or 
acid.  All glassware was dried in the oven overnight. In an ampoule, a suspension of 
[TmBut]Na (384.5 mg, 0.768 mmol) in C6H6 (ca. 10 mL) was treated with ZnCl2 (51.2 mg, 
0.376 mmol).  The reaction mixture was stirred vigorously at room temperature for 48 
hours.  At this point the reaction mixture was a thick white suspension.  To the 
reaction mixture was added neat ZnMe2 (157.8 mg, 1.65 mmol), and the mixture was 
stirred at room temperature for 22 hours.  The reaction mixture was centrifuged, the 
mother liquor was filtered through a filter pipette, and the resulting pellet was 
dissolved in ca. 8 mL C6H6 and centrifuged.  The resulting mother liquor was filtered 
and combined with the rest of the solution and the solvent was removed under 
vacuum, yielding [TmBut]ZnMe as a white solid (0.2350 g, 56.07%). 
 
2.4.16  Synthesis of [TmBut]ZnO2C(C6H4-4-Me) 
A solution of [TmBut]ZnMe (132.0 mg, 0.237 mmol) in C6H6 (ca. 5 mL) was treated with 4-
methylbenzoic acid (33.2 mg, 0.244 mmol), resulting in immediate bubbling.  The 
solution was stirred at room temperature for 45 minutes.  The volatile components 
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were removed in vacuo, and the resulting powder was washed with Et2O (ca. 2 mL), 
yielding [TmBut]ZnO2C(C6H4-4-Me) as a white solid (110.8 mg, 69.07%).  Crystals 
suitable for X-ray diffraction were obtained from a solution in Et2O.  Analysis calcd. for 
[TmBut]ZnO2C(C6H4-4-Me): C, 51.37%; H, 6.09%; N, 12.39%.  Found: C, 51.18%; H, 
6.20%; N, 12.32%.  1H NMR (C6D6): 1.50 [s, 27 H, HB{C3N2H2[C(CH3)3]S}3], 2.00 [s, 3 H, 
ZnO2C(C6H4-4-CH3)], 6.39 [d, 3JH-H = 2, 3 H, HB{C3N2H2[C(CH3)3]S}3], 6.67 [d, 3JH-H = 2, 3 
H, HB{C3N2H2[C(CH3)3]S}3], 6.97 [d, 3JH-H = 8, 2 H, ZnO2C(C6H4-4-Me)], 8.64 [d, 3JH-H = 8, 
2 H, ZnO2C(C6H4-4-Me)].  13C{1H} NMR (C6D6): 21.36 [1 C, ZnO2C(C6H4-4-CH3)], 28.92 
[9 C, HB{C2N2H2[C(CH3)3]CS}3], 59.59 [3 C, HB{C2N2H2[C(CH3)3]CS}3], 117.00 [3 C, 
HB{C2N2H2[C(CH3)3]CS}3], 122.96 [3 C, HB{C2N2H2[C(CH3)3]CS}3], 128.48 [2 C, 
ZnO2C(C6H4-4-Me)], 131.20 [2 C, ZnO2C(C6H4-4-Me)], 134.48 [1 C, ZnO2C(C6H4-4-Me)], 
139.84 [1 C, ZnO2C(C6H4-4-Me)], 157.84 [3C, HB{C2N2H2[C(CH3)3]CS}3], 172.37 [1 C, 
ZnO2C(C6H4-4-Me)].  IR Data for [TmBu
t]ZnO2C(C6H4-4-Me) (ATR, cm-1): 3183 (w), 3146 
(w), 2976 (w), 2923 (w), 2420 (w), 1619 (m), 1568 (m), 1481 (w), 1421 (m), 1398(w), 1365 
(vs), 1344 (vs), 1315 (m), 1261 (w), 1228 (w), 1195 (vs), 1174 (s), 1132 (m), 1072 (m), 1030 
(w), 929 (w), 844 (w), 822 (m), 766 (s), 730 (s), 688 (s), 623 (m), 591 (m), 553 (m), 494 (w), 
474 (m), 457 (w), 410 (m).  FAB-MS: m/z = 541.1 [M - O2C(C6H4-4-Me)]+, M = 
[TmBut]ZnO2C(C6H4-4-Me). 
 
2.4.17 Synthesis of [TmBut]ZnO2C(C6H4-4-F) 
A solution of [TmBut]ZnMe (370.2 mg, 0.663 mmol) in C6H6 (ca. 10 mL)was treated with 
4-fluorobenzoic acid (95.2 mg, 0.679 mmol), resulting in immediate bubbling.  The 
solution was stirred at room temperature for 1 hour.  The volatile components were 
removed in vacuo and the resulting solid was washed with 2 mL Et2O, yielding 
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[TmBut]ZnO2C(C6H4-4-F) as a white solid (443.9 mg, 98.1%).  The product was further 
purified by transferring the product to an ampoule, adding 3 mL C6H6, and heating at 
70˚C until the powder completely dissolved.  Upon cooling [TmBut]ZnO2C(C6H4-4-F) 
precipitated out as a microcrystalline powder.  The powder was filtered and dried in 
vacuo.  Crystals suitable for X-ray diffraction were obtained via slow diffusion of 
pentane into a solution in C6H6.  Analysis calcd. for [TmBu
t]ZnO2C(C6H4-4-F): C, 49.31%; 
H, 5.62%; N, 12.32%.  Found: C, 49.02%; H, 5.20%; N, 11.97%.  1H NMR (C6D6): 1.51 [s, 
27 H, HB{C3N2H2[C(CH3)3]S}3], 6.40 [d, 3JH-H = 2, 3H, HB{C3N2H2[C(CH3)3]S}3], 6.66 [d, 3JH-
H = 2, 3H, HB{C3N2H2[C(CH3)3]S}3], 6.75 [m, 2H, ZnO2C(C6H4-4-F)], 8.52 [m, 2H, 
ZnO2C(C6H4-4-F)].  13C{1H} NMR (C6D6): 28.91 [9 C, HB{C2N2H2[C(CH3)3]CS}3], 59.62 [3 
C, HB{C2N2H2[C(CH3)3]CS}3], 114.34 [d, 2JC-F = 21, 2 C, ZnO2C(C6H4-4-F)], 117.03 [3 C, 
HB{C2N2H2[C(CH3)3]CS}3], 123.02 [3 C, HB{C2N2H2[C(CH3)3]CS}3], 133.23 [d, 4JC-F = 9, 1 C, 
ZnO2C(C6H4-4-F)], 133.37 [d, 1JC-F = 3, 1 C, ZnO2C(C6H4-4-F)], 157.69 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 164.83 [d, 4JC-F = 247, 2 C, ZnO2C(C6H4-4-F)], 171.04 [1 C, 
ZnO2C(C6H4-4-F)].  19F NMR (C6D6): -114.02.  IR Data for [TmBu
t]ZnO2C(C6H4-4-F) 
(ATR, cm-1): 3146 (w), 3069(w), 3029 (w), 2979 (w), 2928 (w), 2459 (w), 1823 (w), 1621 
(m), 1598 (m), 1586 (w), 1569 (w), 1500 (m), 1479 (m), 1423 (m), 1398 (m), 1354 (vs), 1311 
(m), 1269 (w), 1229 (m), 1215 (m), 1196 (s), 1178 (s), 1145 (m), 1137 (m), 1083 (m), 1074 
(m), 1033 (m), 1010 (w), 979 (w), 928 (w), 859 (m), 823 (m), 782 (m), 764 (m), 744 (m), 732 
(m), 723 (m), 680 (vs), 625 (s), 592 (m), 553 (m), 504 (m), 495 (m), 456 (w), 428 (m).  FAB-





2.4.18 Synthesis of [TmBut]ZnO2C(C6H3-3,5-F2) 
A solution of [TmBut]ZnMe (108.8 mg, 0.217 mmol) in C6H6 (ca. 5 mL) was treated with 
3,5-fluorobenzoic acid (34.2 mg, 0.216 mmol), resulting in immediate bubbling.  The 
solution was stirred at room temperature for 40 minutes.  The volatile components 
were removed in vacuo, yielding [TmBut]ZnO2C(C6H3-3,5-F2) as a white solid.  The 
resulting powder was dissolved in Et2O (ca. 3 mL), and crystals of [TmBu
t]ZnO2C(C6H3-
3,5-F2), suitable for X-ray diffraction began to grow after just a few minutes.  The Et2O 
was decanted and the crystals were dried under vacuum, (115.1, 76.0%) .  Analysis 
calcd. for [TmBut]ZnO2C(C6H3-3,5-F2)• Et2O: C, 48.04%; H, 5.33%; N, 12.01%.  Found: C, 
48.30%; H, 5.03%; N, 11.46%.  1H NMR (C6D6): 1.49 [s, 27 H, HB{C3N2H2[C(CH3)3]S}3], 
6.40 [d, 3JH-H= 2, 3H, HB{C3N2H2[C(CH3)3]S}3], 6.46 [m, 1H, ZnO2C(C6H3-3,5-F2)], 6.66 [d, 
3JH-H= 2, 3H, HB{C3N2H2[C(CH3)3]S}3], 8.11 [m, 2H, ZnO2C(C6H3-3,5-F2)].  13C{1H} NMR 
(C6D6): 28.85 [9 C, HB{C2N2H2[C(CH3)3]CS}3], 59.65 [3 C, HB{C2N2H2[C(CH3)3]CS}3], 
105.26 [t, 2JC-F = 235, 1 C, ZnO2C(C6H3-3,5-F2)], 113.44 [dd, 2JC-F = 25, 4JC-F = 14, 2 C, 
ZnO2C(C6H3-3,5-F2)], 117.13 [3 C, HB{C2N2H2[C(CH3)3]CS}3], 123.10 [3 C, 
HB{C2N2H2[C(CH3)3]CS}3], 141.48 [t, 3JC-F = 8, 1 C, ZnO2C(C6H3-3,5-F2)], 157.33 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 162.93 [dd, 1JC-F = 259, 3JC-F = 233, 2 C, ZnO2C(C6H3-3,5-F2)], 
169.26 [1C, ZnO2C(C6H3-3,5-F2)].  19F{1H} NMR (C6D6): -113.67.  IR Data for 
[TmBut]ZnO2C(C6H3-3,5-F2) (ATR, cm-1): 3147 (w), 2978 (w), 2420 (w), 1635 (m), 1591 (m), 
1569 (w), 1482 (w), 1420 (m), 1398 (w), 1357 (vs), 1307 (w), 1229 (w), 1193 (s), 1174 (s), 
1133 (w), 1112 (m), 1071 (w), 1031 (w), 982 (m), 943 (w), 891 (w), 849 (w), 822 (w), 785 
(m), 761 (s), 728 (s), 687 (s), 668 (w), 590 (m), 553 (m), 493 (m), 457 (w).  FAB-MS: m/z = 




2.4.19 Synthesis of [TmBut]ZnO2C(C6H3-2,6-F2) 
A solution of [TmBut]ZnMe (125.6 mg, 0.225 mmol) in C6H6 (ca. 5 mL) was treated with 
2,6-fluorobenzoic acid (36.9 mg, 0.233 mmol), resulting in immediate bubbling.  The 
solution was stirred vigorously at room temperature for 30 minutes.  The volatile 
components were removed in vacuo, and the resulting powder was washed with Et2O 
(ca. 3 mL) yielding [TmBut]ZnO2C(C6H3-2,6-F2) as a white solid (0.1018 g, 64.6%).  
Crystals suitable for X-ray diffraction were obtained from a cold solution in Et2O.  
Analysis calcd. for [TmBut]ZnO2C(C6H3-2,6-F2): C, 48.04%; H, 5.33%; N, 12.01%.  Found: 
C, 48.11%; H, 4.96%; N, 11.15%.  1H NMR (C6D6): 1.50 [s, 27H, HB{C3N2H2[C(CH3)3]S}3], 
6.38 [d, 3JH-H = 2, 3H, HB{C3N2H2[C(CH3)3]S}3], 6.47 [m, 3H, ZnO2C(C6H3-2,6-F2)], 6.64 [d, 
3JH-H = 2, 3H, HB{C3N2H2[C(CH3)3]S}3.  13C{1H} NMR (CDCl3): 29.20 [9 C, 
HB{C2N2H2[C(CH3)3]CS}3], 59.89 [3 C, HB{C2N2H2[C(CH3)3]CS}3], 111.23 [dd, 2JC-F = 26, 
4JC-F = 16, 2 C, ZnO2C(C6H3-2,6-F2)], 117.02 [3 C, HB{C2N2H2[C(CH3)3]CS}3], 123.31 [3 C, 
HB{C2N2H2[C(CH3)3]CS}3], 128.60 [1 C, ZnO2C(C6H3-2,6-F2)], 156.07 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 159.95 [dd, 1JC-F = 258, 4JC-F = 239, 2C, ZnO2C(C6H3-2,6-F2)], 
166.15 [1 C, ZnO2C(C6H3-2,6-F2)].  19F{1H} NMR (C6D6): -114.36.  IR Data for 
[TmBut]ZnO2C(C6H3-2,6-F2) (ATR, cm-1): 3186 (w), 3148 (w), 2969 (w), 2924 (w), 2419 (w), 
2234 (w), 1642 (s), 1622 (m), 1590 (w), 1566 (w), 1464 (m), 1419 (m), 1399 (m), 1357 (vs), 
1307 (m), 1255 (w), 1232 (m), 1191 (s), 1174 (s), 1131 (w), 1071 (m), 1032 (w), 1006 (s), 958 
(w), 929 (w), 842 (m), 821 (m), 798 (m), 758 (m), 724 (s), 686 (s), 634 (w), 601 (m), 581 (m), 





2.4.20 Synthesis of [TmBut]ZnO2C(9-An) 
A solution of [TmBut]ZnMe (124.6 mg, 0.223 mmol) in C6H6 (ca. 10 mL) was treated with 
9-anthracenecarboxylic acid (49.6 mg, 0.223 mmol), resulting in immediate bubbling.  
The solution was stirred vigorously at room temperature for 1.5 hours.  The volatile 
components were removed in vacuo, and the resulting powder was washed with Et2O 
(ca. 2 mL), yielding [TmBut]ZnO2C(9-An) as a pale yellow solid (142.4 mg, 83.5 
%).  Crystals suitable for X-ray diffraction were obtained from a solution in C6D6.  
Analysis calcd. for [TmBut]ZnO2C(9-An)•0.5THF: C, 57.0%; H, 5.9%; N, 10.5%.  Found: 
C, 57.3%; H, 6.2%; N, 9.9%.  1H NMR (C6D6): 1.56 [s, 27 H, HB{C3N2H2[C(CH3)3]S}3], 6.45 
[d, 3JH-H = 2.0, 3H, HB{C3N2H2[C(CH3)3]S}3], 6.71 [d, 3JH-H = 2.0, 3H, 
HB{C3N2H2[C(CH3)3]S}3], 7.21 [t, 3JH-H = 8, 2H, ZnO2C(C14H9)], 7.29 [t, 3JH-H = 8, 2H, 
ZnO2C(C14H9)]3, 7.74 [d, 3JH-H = 8, 2H, ZnO2C(C14H9)], 8.09 [s, 1H, ZnO2C(C14H9)], 8.88 [d, 
3JH-H = 9, 2H, ZnO2C(C14H9)].  13C{1H} NMR (C6D6): 28.91 [9 C, 
HB{C2N2H2[C(CH3)3]CS}3], 59.64 [3 C, HB{C2N2H2[C(CH3)3]CS}3], 117.13 [3 C, 
HB{C2N2H2[C(CH3)3]CS}3], 123.05 [3 C, HB{C2N2H2[C(CH3)3]CS}3], 125.10 [2 C, 
ZnO2C(C14H9)], 125.30 [2 C, ZnO2C(C14H9)], 126.46 [1 C, ZnO2C(C14H9)], 128.06 [4C, 
ZnO2C(C14H9)], 128.71 [2 C, ZnO2C(C14H9)], 128.75 [2 C, ZnO2C(C14H9)], 131.05 [1 C, 
ZnO2C(C14H9)], 157.42 [3 C, HB{C2N2H2[C(CH3)3]CS}3], 177.50 [1 C, ZnO2C(C14H9)].  IR 
Data for [TmBut]ZnO2C(9-An) (ATR, cm-1): 3145 (w), 2974 (w), 1620 (m), 1567 (m), 1482 
(w), 1418 (m), 1397 (m), 1360 (vs), 1304 (s), 1267 (m), 1229 (m), 1192 (s), 1065 (m), 1013 
(m), 882 (m), 864 (m), 846 (m), 821 (m), 798 (w), 762 (m), 731 (vs), 693 (m), 669 (w), 638 





2.4.21 Synthesis of [TmBut]ZnO2C(9-An)•HO2C(9-An) 
A solution of [TmBut]ZnMe (172.1 mg, 0.308mmol) in C6H6 (ca. 6 mL) was treated with 9-
anthracenecarboxylic acid (137.8 mg, 0.620mmol), resulting in immediate bubbling.  
The solution was stirred vigorously at room temperature for 30 minutes.  The volatile 
components were removed in vacuo, yielding [TmBut]ZnO2C(9-An)• HO2C(9-An) as a 
pale yellow solid (274.9 mg, 90.4%).  Crystals suitable for X-ray diffraction were 
obtained from a solution in C6D6.  Analysis calcd. for [TmBu
t]ZnO2C(9-An)•HO2C(9-
An)•2THF: C, 62.7%; H, 6.2%; N, 7.4%.  Found: C, 63.5%; H, 5.2%; N, 7.4%.  1H NMR 
(C6D6): 1.56 [s, 27 H, HB{C3N2H2[C(CH3)3]S}3], 6.45 [d, 3JH-H = 2.0, 3H, 
HB{C3N2H2[C(CH3)3]S}3], 6.71 [d, 3JH-H = 2.0, 3H, HB{C3N2H2[C(CH3)3]S}3], 7.21 [t, 3JH-H = 
8, 2H, ZnO2C(C14H9)], 7.29 [t, 3JH-H = 8, 2H, ZnO2C(C14H9)]3, 7.74 [d, 3JH-H = 8, 2H, 
ZnO2C(C14H9)], 8.09 [s, 1H, ZnO2C(C14H9)], 8.88 [d, 3JH-H = 9, 2H, ZnO2C(C14H9)].  IR 
Data for [TmBut]ZnO2C(9-An)• HO2C(9-An) (ATR, cm-1): 2973 (w), 1712 (m), 1540 (m), 
1483 (m), 1446 (m), 1419 (m), 1398 (m), 1363 (vs), 1321 (m), 1282 (m), 1261 (m), 1193 (vs), 
1173 (s), 1131 (m), 1064 (m), 1013 (m), 903 (m), 883 (m), 869 (m), 850 (m), 820 (m), 796 
(m), 778 (m), 759 (m), 732 (vs), 688 (s), 670 (m), 659 (m), 643 (m), 591 (m), 555 (m), 524 
(w), 475 (m).  FAB-MS: m/z = 541.3 [M - O2C(9-An)]+, M = [TmBu
t]ZnO2C(9-An). 
 
2.4.22 Synthesis of [TmBut]ZnSC(O)Ph 
A solution of [TmBut]ZnMe (274.0 mg, 0.491 mmol) in C6H6 (ca. 5 mL) was treated with 
thiobenzoic acid (90 µL, 0.765 mmol), resulting in immediate bubbling.  The solution 
was stirred at room temperature for 30 minutes.  The volatile components were 
removed in vacuo.  The resulting bright yellow powder was washed with pentane (2 × 
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ca. 3 mL) followed by Et2O (3 × ca. 3 mL) yielding [TmBu
t]ZnSC(O)Ph as a pale yellow 
solid (185.8 mg, 55.63%).  Crystals suitable for X-ray diffraction were obtained via slow 
evaporation of a solution of Et2O.  Analysis calcd. for [TmBu
t]ZnSC(O)Ph: C, 49.5%; H, 
5.8%; N, 12.4%.  Found: C, 49.3%; H, 5.7%; N, 12.1%.  1H NMR (CD2Cl2): 1.76 [s, 27 H, 
HB{C3N2H2[C(CH3)3]S}3], 6.89 [d, 3JH-H = 2, 3H, HB{C3N2H2[C(CH3)3]S}3], 7.06 [d, 3JH-H = 2, 
3H, HB{C3N2H2[C(CH3)3]S}3], 7.36 [t, 1H, ZnSC(O)(C6H5)], 7.43 [m, 2H, ZnSC(O)(C6H5)], 
8.09 [2, 2H, ZnSC(O)(C6H5)}3.  13C{1H} NMR (CD2Cl2): 29.2 [9 C, 
HB{C2N2H2[C(CH3)3]CS}3], 59.9 [3 C, HB{C2N2H2[C(CH3)3]CS}3], 117.2 [3 C, 
HB{C2N2H2[C(CH3)3]CS}3], 123.5 [3 C, HB{C2N2H2[C(CH3)3]CS}3], 128.0 [1 C, 
ZnSC(O)(C6H5)], 128.7 [2 C, ZnSC(O)(C6H5)], 131.4 [2 C, ZnSC(O)(C6H5)], 142.0 [ 1C, 
ZnSC(O)(C6H5)], 156.6 [3C, HB{C2N2H2[C(CH3)3]CS}3], 200.0 [1 C, ZnSC(O)(C6H5)].  IR 
Data for [TmBut]ZnSC(O)Ph (ATR, cm-1): 3182 (w), 2973 (w), 2926 (w), 2421 (w), 1599 (m), 
1567 (m), 1480 (w), 1419 (m), 1398 (w), 1363 (vs), 1308 (m), 1260 (w), 1227 (w), 1195 (vs), 
1171 (s), 1131 (m), 1071 (m), 1030 (w), 925 (s), 822 (m), 774 (m), 759 (m), 728 (s), 688 (vs), 












2.5 Crystallographic Data 





lattice Monoclinic Monoclinic 
formula C31H46BCdN6O2.50S3 C40H50BCdFN6O2S3 
formula weight 762.13 885.25 
space group C2/c Ps(1)/n 
a/Å 27.313(3) 12.9391(17) 
b/Å 12.1451(12) 13.6148(18) 
c/Å 24.104(2) 24.852(4) 
%/˚ 90 90 
$/˚ 112.2410(10) 104.782(2) 
(/˚ 90 90 
V/Å3 7400.9(12) 4233.2(10) 
Z 8 4 
temperature (K) 150(2) 150(2) 
radiation (), Å) 0.71073 0.71073 
* (calcd.), g cm-3 1.368 1.389 
µ (Mo K%), mm-1 0.796 0.709 
+ max, deg. 30.52 30.66 
no. of data collected 58570 65990 
no. of data used 11318 13067 
no. of parameters 427 500 
R1 [I > 2,(I)] 0.0548 0.0384 
wR2 [I > 2,(I)] 0.0722 0.0768 
R1 [all data] 0.1605 0.0622 
wR2 [all data] 0.0923 0.0868 
GOF 1.009 1.033 











lattice Monoclinic Monoclinic 
formula C32H47BCdF2N6O3S3 C28H37BCdF2N6O2S3 
formula weight 821.15 747.03 
space group P2(1)/c P2(1)/n 
a/Å 11.0534(7) 10.0324(7) 
b/Å 18.2044(11) 11.0195(8) 
c/Å 18.9143(11) 30.106(2) 
%/˚ 90 90 
$/˚ 90.5360(10) 90.4850(10) 
(/˚ 90 90 
V/Å3 3805.8(4) 3328.2(4) 
Z 4 4 
temperature (K) 130(2) 150(2) 
radiation (), Å) 0.71073 0.71073 
* (calcd.), g cm-3 1.433 1.491 
µ (Mo K%), mm-1 0.788 0.891 
+ max, deg. 30.51 30.61 
no. of data collected 60420 53280 
no. of data used 11617 10252 
no. of parameters 448 401 
R1 [I > 2,(I)] 0.0290 0.0526 
wR2 [I > 2,(I)] 0.0669 0.0872 
R1 [all data] 0.0394 0.1237 
wR2 [all data] 0.0728 0.1082 
GOF 1.035 0.992 












lattice Monoclinic Monoclinic 
formula C31H45BCdN6O2S3 C42H49BCdN6O2S3 
formula weight 753.12 889.26 
space group P2(1)/c P2(1)/c 
a/Å 19.603(3) 19.0524(17) 
b/Å 11.4701(15) 10.7547(9) 
c/Å 15.472(2) 22.323(2) 
%/˚ 90 90 
$/˚ 97.844(2) 113.1060(10) 
(/˚ 90 90 
V/Å3 3446.5(8) 4207.1(6) 
Z 4 4 
temperature (K) 150(2) 150(2) 
radiation (), Å) 0.71073 0.71073 
* (calcd.), g cm-3 1.451 1.404 
µ (Mo K%), mm-1 0.853 0.711 
+ max, deg. 30.83 30.68 
no. of data collected 54741 67089 
no. of data used 10769 13021 
no. of parameters 410 554 
R1 [I > 2,(I)] 0.0660 0.0526 
wR2 [I > 2,(I)] 0.1035 0.0888 
R1 [all data] 0.1699 0.1206 
wR2 [all data] 0.1312 0.1101 
GOF 1.012 1.005 












lattice Monoclinic Monoclinic 
formula C29H41BN6O2S3Zn C28H38BFN6O2S3Zn 
formula weight 678.04 682.00 
space group P2(1)/n P2(1)/n 
a/Å 11.7250(13) 11.8193(18) 
b/Å 20.938(2) 20.059(3) 
c/Å 13.8716(15) 14.006(2) 
a/˚ 90 90 
b/˚ 90 94.036(2) 
g/˚ 90 90 
V/Å3 3405.5(6) 3312.4(9) 
Z 4 4 
temperature (K) 150(2) 150(2) 
radiation (l, Å) 0.71073 0.71073 
r (calcd.), g cm-3 1.322 1.368 
m (Mo Ka), mm-1 0.940 0.971 
q max, deg. 30.66 30.62 
no. of data collected 44067 53247 
no. of data used 9305 10152 
no. of parameters 393 392 
R1 [I > 2s(I)] 0.0386 0.0728 
wR2 [I > 2s(I)] 0.0613 0.0857 
R1 [all data] 0.0924 0.2630 
wR2 [all data] 0.0706 0.1237 
GOF 0.723 0.943 












lattice Monoclinic Orthorhombic 
formula C56H74B2F4N12O4S6Zn2 C28H37BF2N6O2S3Zn 
formula weight 1399.99 700.00 
space group P2(1)/n Pbca 
a/Å 19.7159(14) 11.1475(11) 
b/Å 18.1788(12) 19.133(2) 
c/Å 19.2039(13) 30.653(3) 
a/˚ 90 90 
b/˚ 109.5010(10) 90 
g/˚ 90 90 
V/Å3 6488.1(8) 6537.6(12) 
Z 4 8 
temperature (K) 130(2) 110(2) 
radiation (l, Å) 0.71073 0.71073 
r (calcd.), g cm-3 1.433 1.422 
m (Mo Ka), mm-1 0.998 0.990 
q max, deg. 26.37 26.37 
no. of data collected 77813 75045 
no. of data used 13270 6678 
no. of parameters 783 401 
R1 [I > 2s(I)] 0.0737 0.0447 
wR2 [I > 2s(I)] 0.1677 0.0872 
R1 [all data] 0.1740 0.0776 
wR2 [all data] 0.2154 0.1010 
GOF 1.028 1.017 












lattice Monoclinic Monoclinic 
formula C36H43BN6O2S3Zn C51H53BN6O4S3Zn 
formula weight 764.12 986.35 
space group P2(1)/n P2(1)/n 
a/Å 17.6728(19) 14.8531(8) 
b/Å 10.7366(11) 21.0894(11) 
c/Å 19.990(2) 15.4793(8) 
a/˚ 90 90 
b/˚ 102.553(2) 95.2540(2) 
g/˚ 90 90 
V/Å3 3702.4(7) 4828.4(4) 
Z 4 4 
temperature (K) 130(2) 130(2) 
radiation (l, Å) 0.71073 0.71073 
r (calcd.), g cm-3 1.371 1.357 
m (Mo Ka), mm-1 0.874 0.690 
q max, deg. 26.37 30.61 
no. of data collected 43696 77793 
no. of data used 7575 14826 
no. of parameters 455 612 
R1 [I > 2s(I)] 0.0533 0.0418 
wR2 [I > 2s(I)] 0.1055 0.0911 
R1 [all data] 0.1015 0.0731 
wR2 [all data] 0.1252 0.1041 
GOF 1.023 1.012 












lattice Orthorhombic Triclinic 
formula C28H39BN6OS4Zn C34H45BCdN6OS4 
formula weight 680.07 805.21 
space group Pbca P-1 
a/Å 18.591(2) 10.6011(15) 
b/Å 18.646(2) 11.0621(16) 
c/Å 19.528(2) 15.950(2) 
a/˚ 90 87.140(2) 
b/˚ 90 87.683(2) 
g/˚ 90 86.158(2) 
V/Å3 6769.6(13) 1862.6(4) 
Z 8 2 
temperature (K) 130(2) 150(2) 
radiation (l, Å) 0.71073 0.71073 
r (calcd.), g cm-3 1.335 1.436 
m (Mo Ka), mm-1 1.003 0.847 
q max, deg. 30.59 30.51 
no. of data collected 104868 29077 
no. of data used 10364 11263 
no. of parameters 383 437 
R1 [I > 2s(I)] 0.0443 0.0447 
wR2 [I > 2s(I)] 0.0784 0.0807 
R1 [all data] 0.1090 0.0749 
wR2 [all data] 0.0989 0.0909 
GOF 1.002 1.013 
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Our study of facile carboxylate ligand exchange at a cadmium center, as presented 
in Chapter 2 of this thesis, inspired us to perform a comparative study on thiolate 
exchange.  Thiolate ligands are known to exhibit interesting coordination chemistry 
with both transition and main group metals,1 and have found major applications in the 
fields of bioinorganic chemistry2 and nanoscience.3  For example, [TmR]ZnSR 
complexes have been developed to model the active site of cysteine-rich zinc enzymes 
and proteins.4  A study completed by Parkin on the mechanism of thiolate exchange in 
[TmR]ZnSR complexes has provided insight into the mechanism of zinc-thiolate 
alkylation in enzymes and proteins.4a  The study of the coordination and exchange 
chemistry of cadmium thiolates is of equal importance as the toxicity of cadmium is due 
in large part to its high thiophilicity, which causes it to bind to the sulfur-rich active 
sites of biological enzymes.5  However, a similar thiolate exchange study has not yet 
been performed using the [TmR]CdSR analogue. 
A series of new [TmBut]CdSAr (Ar = C6H4-4-F, C6H4-4-But, C6H4-4-OMe, C6H4-3-
OMe) complexes were synthesized and structurally characterized, and the reactivity of 
[TmBut]CdS(4-C6H4F) towards various aryl thiols, HSAr (Ar = C6H4-4-F, C6H4-4-But, 
C6H4-4-OMe, C6H4-3-OMe, C6H4-4-NO2), and phenols, ArOH (Ar = C6H5, 2,6-Ph2C6H3), 
was investigated.  [TmBut]CdS(C6H4-4-F) was chosen for the model system as the 
fluorine substituent provides a useful 19F NMR handle by which to monitor the 
exchange reactions.  As the chemical shift range of 19F NMR is large (ca. 400 ppm)6 the 
issue of overlapping signals, which is common in 1H NMR spectroscopy, is usually 
 
 142 
eliminated.  The reactions were monitored using both 1H and 19F NMR spectroscopy, 
and equilibrium constants were calculated for each of these reactions.   
Metal complexes featuring heterocyclic thiolate and selenolate ligands have been 
of interest for the past few decades due to the versatile coordination behavior of these 
ligands.7  Although there are a handful of examples of monomeric cadmium 
complexes that feature 2-mercaptopyridine ligands listed in the Cambridge Structural 
Database (CSD),8 their 2-selenopyridine counterparts are extremely rare, with only one 
reported structure listed in the CSD.7g  It is therefore significant that we report the 
synthesis and structural characterization of two new, monomeric [TmBut]CdE(2-C5H4N) 
(E = S, Se) complexes.   
 
3.2 Results and Discussion 
3.2.1 Synthesis and characterization of [TmBut]CdSAr complexes 
The original synthetic method used to access a series of [Tmp-Tol]CdSAr (Ar = Bz; 
Ph; p-Tol; C6F5)9 and [TmBu
t]CdSAr (Ar = Ph, p-Tolyl, C6F5)10 complexes involved the 
reaction of [TmR]CdBr with TlSAr (Ar = Bz; Ph; p-Tolyl; C6F5) (Scheme 1).  Although 
this method generated the desired [TmR]CdSAr compounds in good yield, a major 
drawback is that the thallium thiolate compounds are not commercially available.  The 
treatment of [TmBut]CdMe with commercially available thiols has since been shown to 
be a convenient method for accessing [TmBut]CdSAr via Cd-C bond cleavage (Scheme 
2).11  Using this synthetic method, we were able to synthesize a series of new 
[TmBut]CdSAr (Ar = C6H4-4-F, C6H4-4-But, C6H4-4-OMe, C6H4-3-OMe) complexes for use 












Scheme 2. Preparation of [TmBut]CdSAr via Cd-C bond cleavage. 
 
 
Each of the [TmBut]CdSAr (Ar = C6H4-4-F, C6H4-4-But, C6H4-4-OMe, C6H4-3-OMe) 
complexes were fully characterized using 1H and 13C NMR spectroscopy.  The 
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[TmBut]CdS(C6H4-4-F) derivative was additionally characterized by a signal at ! -125.09 
in the 19F NMR spectrum, which is significantly upfield from the signal observed for 4-
fluorothiophenolate (! -118.9).  The molecular structures of the [TmBut]CdSAr (Ar = 
C6H4-4-F, C6H4-4-But, C6H4-4-OMe, C6H4-3-OMe) complexes were obtained by X-ray 











Figure 1. Molecular structure of [TmBut]CdS(C6H4-4-F). 
 
 
Table 1. Select bond lengths and angles for [TmBut]CdS(C6H4-4-F) 
Bond Lengths (Å) Bond Angles (˚) 
Cd-S(1) 2.5621(8) S(1)-Cd-S(2) 102.95(2) 
Cd-S(2) 2.5475(7) S(1)-Cd-S(3) 97.54(2) 
Cd-S(3) 2.5560(7) S(2)-Cd-S(3) 102.49(2) 
Cd-S(4) 2.4565(7) S(2)-Cd-S(4) 107.39(2) 





Figure 2. Molecular structure of [TmBut]CdS(C6H4-4-But).  
 
Table 2. Select bond lengths and angles for [TmBut]CdS(C6H4-4-But) 
Bond Lengths (Å) Bond Angles (˚) 
Cd-S(1) 2.5597(6) S(1)-Cd-S(2) 102.443(19) 
Cd-S(2) 2.5601(7) S(1)-Cd-S(3) 95.82(2) 
Cd-S(3) 2.5648(6) S(1)-Cd-S(4) 122.81(2) 
Cd-S(4) 2.4419(7) S(2)-Cd-S(3) 103.09(5) 
  S(2)-Cd-S(4) 103.152(19) 





Figure 3. Molecular structure of [TmBut]CdS(C6H4-4-OMe). 
 
Table 3. Select bond lengths and angles [TmBut]CdS(C6H4-4-OMe) 
Bond Lengths (Å) Bond Angles (˚) 
Cd-S(1) 2.5576(7) S(1)-Cd-S(2) 99.52(2) 
Cd-S(2) 2.5672(7) S(1)-Cd-S(3) 98.68(2) 
Cd-S(3) 2.5681(7) S(1)-Cd-S(4) 126.52(2) 
Cd-S(4) 2.4308(7) S(2)-Cd-S(3) 99.18(2) 
  S(2)-Cd-S(4) 121.17(2) 




Figure 4. Molecular structure of [TmBut]CdS(C6H4-3-OMe). 
 
Table 4. Select bond lengths and angles [TmBut]CdS(C6H4-3-OMe) 
Bond Lengths (Å) Bond Angles (˚) 
Cd-S(1) 2.5536(5) S(1)-Cd-S(2) 98.900(15) 
Cd-S(2) 2.5596(5) S(1)-Cd-S(3) 97.878(17) 
Cd-S(3) 2.5579(5) S(1)-Cd-S(4) 134.208(16) 
Cd-S(4) 2.4462(5) S(2)-Cd-S(3) 103.193(16) 
  S(2)-Cd-S(4) 105.422(17) 




The [TmBut] ligand coordinates to the cadmium center in a !3-S3 manner in 
[TmBut]CdSAr (Ar = C6H4-4-F, C6H4-4-But, C6H4-4-OMe, C6H4-3-OMe), which is the 
typical coordination mode assumed by [TmR]Cd complexes.12  The molecular 
geometries of the [TmBut]CdSAr complexes can be described using the geometric 
parameter "4 = (360˚ -(# + $))/141˚, where # and $ are the two largest central angles in 
the molecule.  A four-coordinate complex featuring an ideal square planar geometries 
has a "4 value of zero, while a complex featuring an ideal tetrahedral geometry has a 
value of 1.00.13  Intermediate values of 0 ≤ "4 ≤ 1.00 describe complexes that exhibit 
seesaw ("4 = 0.07-0.64) or trigonal monopyramidal ("4 = 0.85) geometries.18  Each of the 
[TmBut]CdSAr (Ar = C6H4-4-F, C6H4-4-But, C6H4-4-OMe, C6H4-3-OMe) complexes 
assumes a trigonal monopyramidal geometry with "4 values ranging from 0.788-0.826 
(Table 5).  There are two other [TmBut]CdSAr (Ar = Ph, p-Tol) complexes known in the 
literature, which have been structurally characterized and found to exhibit a trigonal 
monopyramidal geometry.11  The [TmBut]Cd moieties of the [TmBut]CdSAr complexes 
feature Cd-S bond lengths that are all approximately equal and in the range of the 




















(a) See reference 11 
 
It is interesting to note that the Cd-SAr moiety is able to rotate freely about the Cd-S 
bond, such that the Cd-S(4)-Cipso-Cortho torsion angle (Figure 5) varies significantly 
between the [TmBut]CdSAr complexes (Table 6).  Of the complexes listed in Table 6, 
[TmBut]CdS(C6H4-4-F) complex features the smallest Cd-S(4)-Cipso-Cortho torsion angle 
(2.09˚), while [TmBut]CdS(C6H4-4-OMe) features the largest torsion angle (42.81˚).    
 
 




Table 6. Cd-S(4)-Cipso-Cortho torsion angle in [TmBu
t]CdSEAr 







(a) see reference 11 
 
 
3.2.2 Synthesis and characterization of [TmBut]CdE(2-C5H4N)  
2-mercaptopyridine ligands have been shown to coordinate to metal centers in a 
variety of ways.  In its protonated form, the thione can coordinate to the metal in an L-
type fashion.14,15  Once deprotonated, 2-mercaptopyridine can coordinate either as an 
X-type or LX-type ligand, and has even been shown to bridge metals in multinuclear 
complexes.15d,g  A number of cadmium complexes featuring protonated and 
deprotonated 2-mercaptopyridine ligands have been structurally characterized; 
however, in most cases the mercaptopyridine ligands feature substituent groups, such 
as a carboxyl,16 CF3,5a or silyl group.17  Very few cadmium complexes featuring non-
substituted 2-mercaptopyridine complexes have been reported.18 
Several metal complexes featuring 2-selenopyridine ligands have also been 
structurally characterized, and have been shown to coordinate to metal centers in a 
manner similar to 2-mercaptopyridine.19  Interestingly, cadmium complexes featuring 
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2-selenopyridine ligands are rare, with only two complexes listed in the Cambridge 
Structural Database.20  Additionally, there are no known examples of [TmR]M 
complexes featuring 2-mercapto or 2-selenopyridine ligands.  Therefore, we were 
interested in investigating the synthesis and structure of [TmBut]CdE(2-C5H4N) (E = S, 
Se) complexes.   
[TmBut]CdE(2-C5H4N) compounds (E = S, Se) were synthesized via the reaction of 
[TmBut]CdMe with 2-mercaptopyridine or 2-selenopyridine (Scheme 3).  The molecular 
structures of these complexes were obtained (Figure 6 and Figure 8), revealing them to 










Figure 6. Molecular structure of [TmBut]CdS(2-C5H4N) 
 
Table 7. Select bond lengths and angles for [TmBut]CdS(2-C5H4N) 
Bond Lengths (Å) Bond Angles (˚) 
Cd-S(1) 2.5509(7) S(1)-Cd-S(2) 99.78(2) 
Cd-S(2) 2.5633(7) S(1)-Cd-S(3) 99.47(2) 
Cd-S(3) 2.6438(7) S(2)-Cd-S(3) 97.43(2) 
Cd-S(4) 2.4946(8) S(1)-Cd-S(4) 129.26(3) 
Cd•••N(41) 2.766 S(2)-Cd-S(4) 125.88(3) 
  S(3)-Cd-S(4) 95.63(2) 
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There are only three cadmium 2-mercaptopyridine complexes listed in the 
Cambridge Structural Database that feature an L-type bonding interaction between the 
cadmium and the nitrogen of the 2-mercaptopyridine ligand.15c,d  The average Cd-N 
bond length for these complexes is 2.482 Å, which is slightly longer than the average 
Cd-N bond length (2.341 Å) for all complexes listed in the Cambridge Structural 
Database.8  In order for this type of Cd-N bonding interaction to take place, the 
pyridine ring must be oriented such that the Cd-S-C-N torsion angle is close to 0˚ 
(Figure 7).   
 
 
Figure 7. Cd-S-C-N torsion angles in cadmium complexes featuring 2-mercaptopyridine 




The Cd-N(41) bond distance (2.766 Å) in [TmBut]CdS(2-C5H4N) is longer than the 
average Cd-N bond length for all cadmium 2-mercaptopyridine complexes listed in the 
Cambridge Structural Database (2.482 Å).  Nevertheless, [TmBut]CdS(2-C5H4N) has a 
Cd-S(4)-C(41)-N(41) torsion angle of only 0.35˚, which suggests that the pyridine ring is 
oriented in a position that could promote a weak Cd-N(41), L-type bonding interaction.  
This weak Cd-N(41) secondary interaction is represented in the molecular structure by 
drawing a hollow bond (Figure 6).   
As presented in Table 7, the Cd-S(2-C5H4N) bond length in [TmBu
t]CdS(2-C5H4N) 
is 2.4946(8) Å, which is comparable to the average Cd-S(2-C5H4N) bond length (2.526 Å) 
for cadmium complexes featuring 2-mercaptopyridine ligands listed in the Cambridge 
structural Database.  The Cd-S(2-C5H4N) bond length in [TmBu
t]CdS(2-C5H4N) is 
similar in magnitude to the Cd-SAr bond lengths of the [TmBut]CdSAr complexes listed 
above (Table 1-Table 4).  This result suggests that internal substitution of the aromatic 
ring does not affect the Cd-SAr (Ar = C6H4-4-F, C6H4-4-But, C6H4-4-OMe, C6H4-3-OMe, 2-
C5H4N) bond length.  Unlike the [TmBu
t]CdSAr compounds, however, [TmBut]CdS(2-
C5H4N) features a Cd-S(3) bond that is significantly longer (2.6438(7) Å) than the other 
two Cd-S bonds in the [TmBut]Cd moiety (2.5509(7) Å and 2.5633(7) Å).  Due to the 
weak Cd•••N(41) interaction, the molecular geometry of [TmBut]CdS(2-C5H4N) is not 
easily described; however, it is easiest to consider [TmBut]CdS(2-C5H4N) as a four-
coordinate complex.  With a value of "4 = 0.74, [TmBu
t]CdS(2-C5H4N) can be said to 
exhibit a distorted trigonal monopyramidal geometry.13  
As stated above, there are only two cadmium complexes featuring 
selenopyridine ligands listed in the Cambridge Structural Database, namely 
[Cd(SeC5H4N)2(tmeda)]7g and Cd(Se-2-NC5H4)2.20  [Cd(SeC5H4N)2(tmeda)] is a 
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monomeric compound in which the Cd-Se bond length is 2.73 Å, which is slightly 
longer than the average Cd-Se bond length for all cadmium selenolate complexes listed 
in the Cambridge Structural Database (2.657 Å).  Cd(Se-2-NC5H4)2 is a polymeric 
complex featuring bridging selenopyridine ligands, for which the Cd-Se bond length 
ranges from 2.654-3.105 Å.  In comparison to the [Cd(SeC5H4N)2(tmeda)] and Cd(Se-2-
NC5H4)2 compounds, the Cd-Se bond length in the [TmBu
t]CdSe(2-C5H4N) complex is 









Figure 8. Molecular structure of [TmBut]CdSe(2-C5H4N) 
 
Table 8. Select bond lengths and angles for [TmBut]CdSe(2-C5H4N) 
Bond Lengths (Å) Bond Angles (˚) 
Cd-S(1) 2.5513(6) S(1)-Cd-S(2) 99.115(17) 
Cd-S(2) 2.5594(6) S(1)-Cd-S(3) 99.490(19) 
Cd-S(3) 2.6361(5) S(2)-Cd-S(3) 98.50(2) 
Cd-Se 2.5709(4) S(1)-Cd-Se 127.095(17) 
Cd•••N(41) 3.000 S(2)-Cd-Se 127.408(14) 
  S(3)-Cd-Se 97.125(17) 
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The Cd-Se-C(41)-N(41) torsion angle in [TmBut]CdSe(2-C5H4N) is only 0.95˚, 
which suggests that the pyridine ring is oriented in a position that could promote a Cd-
N bonding interaction.  However, in comparison to the range of Cd•••N distances 
(2.328-2.444 Å) exhibited by the [Cd(SeC5H4N)2(tmeda)] and Cd(Se-2-NC5H4)2 
complexes, the Cd•••N distance in [TmBut]CdSe(2-C5H4N) is significantly longer (3.000 
Å), indicating that there is in fact no Cd-N bonding interaction.  The molecular 
geometry of [TmBut]CdSe(2-C5H4N) is best described as a distorted trigonal 
monopyramid ("4 = 0.75),13 with the 2-selenopyridine ligand coordinating to the 
cadmium in a unidentate, X-type fashion.14 
 
 
3.2.3 Ligand exchange at a cadmium center 
3.2.3.1 Degenerate thiolate ligand exchange 
As presented in Chapter 2 of this thesis, degenerate benzoate exchange between 
[TmBut]CdO2C(C6H4-4-F) and 4-fluorobenzoic acid was found to be extremely rapid on 
the NMR timescale, which triggered our interest in investigating other exchange 
reactions.  Herein, we describe a study on the degenerate thiolate exchange between 
[TmBut]CdS(C6H4-4-F) and 4-fluorothiophenol in C6D6 (Scheme 4).  Unlike carboxylate 
exchange, thiolate exchange was found to be slow on the 19F and 1H NMR timescales, 
such that the signals for both the [TmBut]CdS(C6H4-4-F) and 4-fluorothiophenol species 











Figure 9. 1H NMR spectrum of the reaction of [TmBut]CdS(C6H4-4-F) with (C6H4-4-F)SH 
in C6D6 at 25˚ C.  The ! symbol indicates the signals for [TmBu
t]CdS(C6H4-4-F).  The " 




Figure 10. 19F NMR spectrum of the reaction of [TmBut]CdS(C6H4-4-F) with (C6H4-4-F)SH 
in C6D6 at 25˚ C.  The ! symbol indicates the signal for [TmBu
t]CdS(C6H4-4-F).  The " 
symbol indicates the signal for (C6H4-4-F)SH. 
 
High temperature 1H NMR spectroscopy was performed in an attempt to 
observe thiolate exchange; however, the two sets of signals remained resolved even at 
345 K with minimal line broadening.  As the process of degenerate ligand exchange 
could not be verified by variable temperature 1H NMR spectroscopy, we used 2D-EXSY 
experiments to investigate the potential for magnetization transfer between 
[TmBut]CdS(C6H4-4-F) and 4-fluorothiophenol.21  Overlapping signals in the aromatic 
region of the 1H NMR spectrum made the results of the 1H 2D-EXSY experiment 
difficult to interpret;22 however, an 19F 2D-EXSY experiment proved to be a useful tool 
as the signals corresponding to the [TmBut]CdS(C6H4-4-F) complex and 4-
fluorothiophenol are sufficiently separated, appearing at ! -125.09 and ! -118.9 
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respectively.  As displayed in Figure 11, cross signals appear at (! -125.09, ! -118.9) and 
(! -118.9, !  -125.09) in the 19F NMR 2D-EXSY spectrum.  The fact that these signals are 
in phase with the diagonal demonstrates that magnetization is transferred as the 
S(C6H4-4-F) groups of the [TmBu
t]CdS(C6H4-4-F) and free HS(C6H4-4-F) species are 
exchanged; thus a dynamic exchange process is occurring.23 
 
 
Figure 11. 19F 2D-EXSY experiment (298 K) demonstrates the transfer of magnetization 
between the S(C6H4-4-F) groups of [TmBu
t]CdS(C6H4-4-F) and HS(C6H4-4-F). 
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3.2.3.2 Non-degenerate thiolate ligand exchange 
In addition to degenerate thiolate exchange at a cadmium center, we were also 
interested in investigating the exchange between [TmBut]CdS(C6H4-4-F) and different 
substituted thiophenols.  Our goal was to calculate and compare the equilibrium 
constants for these reactions in an attempt to determine whether the type of substituent 
or the position of substitution on the thiophenol ring has a distinct effect on the reaction 
equilibrium.  Three different substituted thiophenols (ArSH) were investigated, 
namely 4-tertbutylthiophenol, 4-methoxythiophenol, and 3-methoxythiophenol.  Three 
samples were prepared in NMR tubes equipped with J. Young valves, in which a 
solution of [TmBut]CdS(C6H4-4-F) in C6D6 was treated with one equivalent of ArSH.  
The reactions were monitored by 1H and 19F NMR spectroscopy, and in each case ArSH 
was found to react with [TmBut]CdS(C6H4-4-F) immediately upon addition,24 such that 
an equilibrium was established between [TmBut]CdS(C6H4-4-F), ArSH and their cross 
products, [TmBut]CdSAr and (C6H4-4-F)SH ( Scheme 5).  As thiolate exchange is slow 
on the 1H NMR timescale, signals for each of these four species were present in the 
spectrum taken at ambient temperature.  As an example, the 1H NMR spectrum 
obtained for the reaction of [TmBut]CdS(C6H4-4-F) with (C6H4-4-But)SH is presented in 
Figure 12.  For each reaction, the 19F NMR spectrum acquired at ambient temperature 
displayed two signals corresponding to [TmBut]CdS(C6H4-4-F) (! -125.09) and (C6H4-4-
F)SH (! -118.9).  As an example, the 19F NMR spectrum obtained for the reaction of 





Scheme 5. Reaction of [TmBut]CdS(C6H4-4-F) with ArSH. 
 
 
Figure 12. 1H NMR spectrum of the reaction of [TmBut]CdS(C6H4-4-F) with (C6H4-4-
But)SH in C6D6 at 25˚ C.  The ! symbol indicates the signals for [TmBu
t]CdS(C6H4-4-F); 
the " symbol indicates the signals for (C6H4-4-F)SH; the ! symbol indicates the signals 






Figure 13. 19F NMR spectrum of the reaction of [TmBut]CdS(C6H4-4-F) with (C6H4-4-
But)SH in C6D6 at 25˚ C.  The ! symbol indicates the signal for [TmBu
t]CdS(C6H4-4-F).  





The relative concentration of each of the four species in solution was calculated 
by integrating the 1H NMR signals.  The relative concentrations of the species were 
used to calculate the equilibrium constant for each reaction, as presented in Table 9.  
The equilibrium constants calculated for each of the exchange reactions were 
indistinguishable, with the equilibrium favoring the [TmBut]CdS(C6H4-4-F) and ArSH 
(Ar = C6H4-4-But, C6H4-4-OMe, C6H4-3-OMe) species.   
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Single point energy calculations were performed using the cc-pVTZ(-f) basis set 
to obtain the energies of each of the equilibrium species (Table 10).  These energies 
were then used to calculate the overall energy of reaction (Table 11).  The results of 
these calculations revealed similar values of &E for the reaction of [TmBut]CdS(C6H4-4-F) 
with (C6H4-4-But)SH (&E = -0.91 kcal mol-1), (C6H4-4-OMe)SH (&E = 2.50 kcal mol-1), and 
(C6H4-3-OMe)SH (&E = 2.26 kcal mol-1).  The fact that the value of &E is approximately 
zero for each of these reactions helps to explain the near unity of the equilibrium 
constants obtained for these reactions.  
 
 
Table 10. Single Point Energies for the [TmBut]CdSAr and ArSH species 
[TmBut]CdSEAr E (kcal mol-1) Thiol E (kcal mol-1) 
[TmBut]CdS(C6H4-4-F) -1.97 × 106 HS(C6H4-4-F) -4.58 × 105 
[TmBut]CdS(C6H4-4- But) -2.01 × 106 HS(C6H4-4-But) -4.94 × 105 
[TmBut]CdS(C6H4-4-OMe) -1.98 × 106 HS(C6H4-4-OMe) -4.68 × 105 




Table 11. &E for the reaction of [TmBut]CdS(C6H4-4-F) with ArSH 





 The reaction mixtures were monitored by 1H and 19F NMR over several days.  In 
each case the integration of the signals did not change over time, suggesting that 
equilibrium had been immediately established upon mixing.  Once we had verified 
that each of the reaction mixtures had reached equilibrium, high temperature 1H and 19F 
NMR studies were conducted in an attempt to monitor the equilibrium constant over 
the temperature range 300-344.5 K.  For each of the reaction mixtures, the 1H and 19F 
NMR spectra obtained at 344.5 K showed significant broadening of the signals; 
however, the relative integration of the signals remained the same.  Therefore, the 
equilibrium constants calculated at this elevated temperature were indistinguishable 
from the equilibrium constants calculated at 25˚ C. 
 The reaction of [TmBut]CdS(C6H4-4-F) with 4-nitrothiophenol was also 
investigated, however, this reaction yielded very different results from the thiolate 
exchange reactions presented above.  A solution of [TmBut]CdS(C6H4-4-F) in C6D6 was 
treated with approximately one equivalent of (C6H4-4-NO2)SH, and the reaction was 
monitored by 1H and 19F NMR spectroscopy.  The 1H and 19FNMR spectra indicated 
that immediately upon addition of (C6H4-4-NO2)SH, [TmBu
t]CdS(C6H4-4-F) converted 
almost completely to the [TmBut]CdS(C6H4-4-NO2) crossproduct.  Unfortunately, due to 
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significant overlap between the peaks in the 1H NMR spectrum, the equilibrium 
constant for this reaction could not be accurately calculated.   
 
 
3.2.3.3 ! Reactivity of [TmBut]CdS(C6H4-4-F) toward phenols. 
A solution of [TmBut]CdS(C6H4-4-F) in C6D6 was treated with approximately one 
equivalent of phenol, and the solution was monitored by using 1H and 19F NMR 
spectroscopy.  [TmBut]CdS(C6H4-4-F) was determined to be unreactive toward phenol, 
as the solution mixture was monitored over several days, with no change in the NMR 
spectra.  The 1H and 19F NMR spectra displayed signals for [TmBut]CdS(C6H4-4-F) and 
phenol; however no signals corresponding to the cross-over products were observed.   
It should be noted that while the [TmBut]CdOAr (Ar = 2,6-C6H3Ph2) complex was 
previously synthesized and isolated by Parkin et al., via the treatment of [TmBut]CdMe 
with ArOH, attempts at synthesizing the [TmBut]CdOPh derivative were unsuccessful, 
with facile ligand redistribution cited as a possible explanation.11  For this reason, we 
decided to test the reactivity of [TmBut]CdS(C6H4-4-F) towards the bulkier 2,6-
diphenylphenol.  A solution of [TmBut]CdS(C6H4-4-F) and 2,6-diphenylphenol in C6D6 
was monitored by 1H and 19F NMR spectroscopy over several days, but no reaction was 
observed.  The 1H and 19F NMR spectra displayed signals for [TmBut]CdS(C6H4-4-F) and 
2,6-diphenylphenol; however no signals corresponding to the cross-over products were 
observed.  High temperature NMR experiments were performed to test the effect of 
heat on the reactivity of [TmBut]CdS(C6H4-4-F) toward phenol and 2,6-diphenylphenol, 
but even at 344.5 K no reaction was observed in either case.  
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The reverse reaction was performed, in which a solution of [TmBut]CdOAr (Ar = 
2,6-C6H3Ph2) was treated with one equivalent of (C6H4-4-F)SH, and the reaction was 
monitored using 1H and 19F NMR spectroscopy.  [TmBut]CdOAr reacts immediately 
with (C6H4-4-F)SH, resulting in complete conversion to [TmBu
t]CdS(C6H4-4-F) and 
ArOH.  Unfortunately a similar reaction could not be performed using [TmBut]CdOPh, 
as this compound cannot be isolated. 
 
3.3 Summary and Conclusions 
A series of new [TmBut]CdSAr (Ar = C6H4-4-F, C6H4-4-But, C6H4-4-OMe, C6H4-3-
OMe) complexes were synthesized and structurally characterized by using single 
crystal X-ray diffraction techniques.  The reactivity of [TmBut]CdS(C6H4-4-F) towards 
different ArSH, was investigated using a variety of NMR techniques, including 1H, 19F, 
2D-EXSY, and variable temperature NMR spectroscopy.  Thiolate exchange was found 
to be slow on the 1H and 19F NMR timescale, even at elevated temperatures; however it 
is rapid enough to be observed using 1H or 19F 2D-EXSY experiments.  The equilibrium 
constants for the reactions of [TmBut]CdS(C6H4-4-F) with ArSH (Ar = C6H4-4-But, C6H4-4-
OMe, C6H4-3-OMe) were calculated and determined to be indistinguishable, with 
equilibrium favoring the [TmBut]CdS(C6H4-4-F) and ArSH species.  The reaction of 
[TmBut]CdS(C6H4-4-F) with (C6H4-4-NO2)SH was also investigated; however, due to 
significant overlap between the peaks in the 1H NMR spectrum, an equilibrium constant 
for the reaction could not be accurately calculated.  Interestingly, [TmBut]CdS(C6H4-4-F) 
is unreactive toward phenol or 2,6-diphenylphenol, even at elevated temperatures.  
[TmBut]CdSOAr (Ar = 2,6-diphenylphenol), however, reacts immediately with (C6H4-4-
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F)SH, resulting in complete conversion to [TmBut]CdS(C6H4-4-F) and free 2,6-
diphenylphenol. 
  [TmBut]CdMe was found to react with 2-mercaptopyridine and 2-selenopyridine, 
via Cd-C bond cleavage, resulting in the formation of [TmBut]CdE(2-C5H4N) (E = S, Se).  
These complexes were isolated and structurally characterized by using X-ray 
diffraction.  The molecular structures of [TmBut]CdE(2-C5H4N) reveal that the 
deprotonated 2-mercaptopyridine ligand coordinates to the cadmium center in a 
bidententate, LX-type fashion; while the deprotonated 2-selenopyridine ligand 
coordinates in a unidentate, X-type fashion.  The structural characterization of these 
complexes is significant as cadmium complexes featuring unsubstituted 2-













3.4 Experimental Section 
3.4.1 General Considerations  
All manipulations were performed using a combination of glovebox, high-vacuum and 
Schlenck techniques under a nitrogen atmosphere,25 except where otherwise stated.  
Solvents were purified and degassed by standard procedures.  NMR solvents were 
purchased from Cambridge Isotope Labs and stored over 3Å molecular sieves.  NMR 
spectra were measured on Bruker 300 DRX, Bruker 300 DPX, Bruker 400 Avance III, 
Bruker 400 Cyber-enabled Avance III, and Bruker 500 DMX spectrometers.  1H NMR 
NMR chemical shifts are reported in ppm relative to SiMe4 (! = 0) and were referenced 
internally with respect to the protio solvent impurity (! 7.16 for C6D5H, and 5.32 for 
CHDCl2.26  13C NMR spectra are reported in ppm relative to SiMe4 (! = 0) and were 
referenced internally with respect to the solvent (! 128.06 for C6D6, and 53.84 for 
CD2Cl2).26  19F NMR spectra are reported in ppm relative to CFCl3 (! = 0) and were 
referenced internally with respect to C6F6 (! = -164.9).27  Coupling constants are given 
in hertz.  IR spectra were recorded on a PerkinElmer Spectrum Two spectrometer and 
the data are reported in reciprocal centimeters (cm-1).  Mass spectra were obtained on a 
JEOL JMS-HX110HF tandem mass spectrometer using fast atom bombardment (FAB).  
4-fluorothiophenol (Aldrich), 4-tert-butylbenzenethiol (Acros), 4-methoxythiophenol 
(Aldrich), 3-methoxythiophenol (Aldrich), 4-nitrothiophenol (Aldrich), phenol 
(Aldrich), 2,6-diphenylphenol (Aldrich), and 2-mercaptopyridine (Aldrich) were 
commercially obtained and used without further purification.  [TmBut]CdMe11 and 2-




3.4.2 X-ray Structure Determinations 
X-ray diffraction data were collected on a Bruker Apex II diffractometer.  Crystal data, 
data collection and refinement parameters are summarized in Table 12.  The structures 
were solved using direct methods and standard difference map techniques, and were 
refined by full-matrix least-squares procedures on F2 with SHELXTL (version 6.1)29 
 
3.4.3 Computational Details 
Calculations were carried out using DFT as implemented in the Jaguar 7.7 (release 107) 
suite of ab initio quantum chemistry programs.30  Geometry optimizations and 
frequency calculations were performed with the B3LYP density functional31 using the 
6-31G** (H, B, C, N, S, Se, O, F), and LACVP (Cd) basis sets.32  The energies of the 
optimized structures were reevaluated by additional single point calculations on each 
optimized geometry using a cc-pVTZ(-f) correlation consistent triple-  basis set.   
 
3.4.4 Synthesis of [TmBut]CdS(C6H4-4-F) 
A solution of [TmBut]CdMe (218 mg, 0.360 mmol) in C6H6 (ca. 9 mL) was treated with 4-
fluorothiophenol (40 µL, 0.38 mmol), resulting in immediate bubbling.  The solution 
was stirred at room temperature for 40 minutes.  The volatile components were 
removed in vacuo, and the resulting powder was washed with Et2O (ca. 2 mL), yielding 
[TmBut]CdS(C6H4-4-F) as a white solid (130 mg, 50.3%).  Crystals suitable for X-ray 
diffraction were obtained via slow diffusion of pentane into a solution in C6D6.  
Analysis calcd. for [TmBut]CdS(C6H4-4-F): C, 45.2%; H, 5.3%; N, 11.7%.  Found: C, 
45.2%; H, 4.9%; N, 11.6%.  1H NMR (C6D6): 1.41 [s, 27H, HB{C2N2H2[C(CH3)3]CS}3], 6.37 
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[d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 6.62 [d, 3JH-H = 2, 3H, 
HB{C2N2H2[C(CH3)3]CS}3], 6.77 [m, 2H, CdS(C6H4-4-F)], 7.86 [m, 2H, CdS(C6H4-4-F)].  
13C{1H} NMR (C6D6): 28.7 [9C, HB{C2N2H2[C(CH3)3]CS}3], 59.4 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 114.7 [d, 2JC-F = 21, 2C, CdS(C6H4-4-F)], 117.0 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 122.9 [3C, HB{C2N2H2[C(CH3)3]CS}3], 135.7 [d, 3JC-F = 7, 2C, 
CdS(C6H4-4-F)], 139.9 [d, 4JC-F = 3, 1C, CdS(C6H4-4-F)], 157.2 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 160.6 [d, 1JC-F = 240, 1C, CdS(C6H4-4-F)].  19F NMR (C6D6): -
125.06.  IR Data for [TmBut]CdS(C6H6-4-F) (ATR, cm-1): 3182 (w), 2977 (w), 2926 (w), 
2404 (w), 2290 (w), 2227 (w), 2162 (w), 2051 (w), 1980 (w), 1719 (w), 1585 (w), 1566 (w), 
1483 (s), 1416 (m), 1397 (m), 1357 (vs), 1304 (m), 1254 (w), 1221 (m), 1192 (vs), 1171 (s), 
1129 (m), 1088 (s), 1070 (m), 1061 (m), 1033 (w), 1014 (w), 984 (w), 929 (w), 819 (s), 773 
(w), 757 (m), 732 (s), 688 (s), 626 (vs), 589 (m), 553 (m), 544 (w),  497 (m), 480 (w), 455 
(w). FAB-MS: m/z = 591.2 [M – S(C6H4-4-F)]+, M = [TmBu
t]CdS(C6H4-4-F). 
 
3.4.5 Synthesis of [TmBut]CdS(C6H4-4-But) 
A solution of [TmBut]CdMe (143.0 mg, 0.256 mmol) in C6H6 (ca. 5 mL) was treated with 
4-tert-butylbenzenethiol (47.5 µL, 0.275 mmol), resulting in immediate bubbling.  The 
solution was stirred at room temperature for 45 minutes.  The volatile components 
were removed in vacuo, and the resulting powder was washed with pentane (ca. 3 mL), 
yielding [TmBut]CdS(C6H4-4-But) as a white solid (117 mg, 60.4%).  Crystals suitable for 
X-ray diffraction were obtained via slow diffusion of pentane into a solution in C6D6.  
Analysis calcd. for [TmBut]CdS(C6H4-4-But)•0.7C6H6: C, 52.2%; H, 6.4%; N, 10.4%.  
Found: C, 51.8%; H, 6.2%; N, 9.5%.  1H NMR (CD2Cl2): 1.24 [s, 9H, CdS(C6H4-4-But)], 
 
 173 
1.71 [s, 27H, HB{C2N2H2[C(CH3)3]CS}3], 6.85 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 
6.97 [d, 3JH-H = 8, 2H, CdS(C6H4-4-But)], 7.03 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 
7.25 [d, 3JH-H = 8, 2H, CdS(C6H4-4-But)].  13C{1H} NMR (C6D6): 29.1 [9C, 
HB{C2N2H2[C(CH3)3]CS}3], 31.6 [3C, CdS(C6H4-4-C(CH3)3], 34.3 [1C, CdS(C6H4-4-
C(CH3)3], 59.8 [3C, HB{C2N2H2[C(CH3)3]CS}3], 117.2 [3C, HB{C2N2H2[C(CH3)3]CS}3], 123.4 
[3C, HB{C2N2H2[C(CH3)3]CS}3], 125.1 [2C, CdS(C6H4-4-But)], 133.2 [2C, CdS(C6H4-4-But)], 
139.4 [1C, CdS(C6H4-4-But)], 145.5 [1C, CdS(C6H4-4-But)], 156.1 [3C, 
HB{C2N2H2[C(CH3)3]CS}3]. 
 
3.4.6 Synthesis of [TmBut]CdS(C6H4-4-OMe) 
A solution of [TmBut]CdMe (142 mg, 0.23 mmol) in C6H6 (ca. 5 mL) was treated with 4-
methoxythiophenol (37.5 µL, 0.30 mmol), resulting in immediate bubbling.  The 
solution was stirred at room temperature for 45 minutes.  The volatile components 
were removed in vacuo, and the resulting powder was washed with pentane (ca. 3 mL), 
yielding [TmBut]CdS(C6H4-4-OMe) as a white solid (107 mg, 62.5%).  Crystals suitable 
for X-ray diffraction were obtained via slow diffusion of pentane into a solution in C6D6.  
Analysis calcd. for [TmBut]CdS(C6H4-4-OMe)•C6H6: C, 50.6%; H, 5.9%; N, 10.4%.  
Found: C, 51.0%; H, 5.7%; N, 10.0%.  1H NMR (C6D6): 1.43 [s, 27H, 
HB{C2N2H2[C(CH3)3]CS}3], 3.34 [s, 3H, CdS(C6H4-4-OCH3)], 6.37 [d, 3JH-H = 2, 3H, 
HB{C2N2H2[C(CH3)3]CS}3], 6.63 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 6.73 [d, 3JH-H = 
8, 2H, CdS(C6H4-4-OMe)], 7.94 [d, 3JH-H = 8, 2H, CdS(C6H4-4-OMe)].  13C{1H} NMR 
(CD2Cl2): 29.1 [9C, HB{C2N2H2[C(CH3)3]CS}3], 55.6 [1C, CdS(C6H4-4-OCH3)], 59.8 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 100.4 [1C, CdS(C6H4-4-OMe)], 113.9 [2C, CdS(C6H4-4-OMe)], 
117.2 [3C, HB{C2N2H2[C(CH3)3]CS}3], 123.4 [3C, HB{C2N2H2[C(CH3)3]CS}3], 134.6 [2C, 
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CdS(C6H4-4-OMe)], 156.2 [3C, HB{C2N2H2[C(CH3)3]CS}3], 156.4 [1C, CdS(C6H4-4-OMe)].  
IR Data for [TmBut]CdS(C6H6-4-OMe) (ATR, cm-1): 3174 (w), 3130 (w), 3097 (w), 2971 (w), 
2833 (w), 2458 (w), 1590 (m), 1565 (m), 1486 (s), 1464 (w), 1416 (m), 1398 (m), 1356 (vs), 
1301 (m), 1279 (w), 1263 (w), 1229 (s), 1192 (s), 1173 (vs), 1132 (m), 1087 (w), 1071 (w), 
1031 (m), 1018 (m), 927 (w), 822 (s), 773 (w), 756 (m), 744 (m), 730 (s), 684 (vs), 638 (m), 
622 (m), 589 (m), 552 (m), 528 (m), 493 (m), 455 (m).  FAB-MS: m/z = 591.2 [M – S(C6H4-
4-OMe)]+, M = [TmBut]CdS(C6H4-4-OMe). 
 
3.4.7 Synthesis of [TmBut]CdS(C6H4-3-OMe) 
A solution of [TmBut]CdMe (106.1 mg, 0.190 mmol) in C6H6 (ca. 10 mL) was treated with 
3-methoxythiophenol (30.0 µL, 0.242 mmol), resulting in immediate bubbling.  The 
solution was stirred at room temperature for 1 hour.  The volatile components were 
removed in vacuo, and the resulting powder was washed with pentane (2 × 3mL) and 
Et2O (ca. 3 mL), yielding [TmBu
t]CdS(C6H4-3-OMe) as a white solid (86 mg, 62.0 %).  
Crystals suitable for X-ray diffraction were obtained via slow diffusion of pentane into a 
solution in C6D6.  Analysis calcd. for [TmBu
t]CdS(C6H4-3-OMe)•C6H6: C, 50.6%; H, 5.9%; 
N, 10.4%.  Found: C, 51.3%; H, 5.6%; N, 9.9%.  1H NMR (C6D6): 1.41 [s, 27H, 
HB{C2N2H2[C(CH3)3]CS}3], 6.37 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 6.62 [d, 3JH-H = 
2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 6.77 [m, 2H, CdS(C6H4-4-OMe)], 7.86 [m, 2H, 
CdS(C6H4-4-OMe)].  13C{1H} NMR (CD2Cl2): 29.1 [9C, HB{C2N2H2[C(CH3)3]CS}3], 55.4 
[1C, CdS(C6H4-3-OCH3)], 59.8 [3C, HB{C2N2H2[C(CH3)3]CS}3], 109.2 [1C, CdS(C6H4-3-
OMe)], 117.2 [3C, HB{C2N2H2[C(CH3)3]CS}3], 118.4 [1C, CdS(C6H4-3-OMe)], 123.5 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 126.4 [1C, CdS(C6H4-3-OCH3)], 128.6 [1C, CdS(C6H4-3-
 
 175 
OCH3)], 156.0 [3C, HB{C2N2H2[C(CH3)3]CS}3], 159.5 [1C, CdS(C6H4-3-OMe)].  IR Data 
for [TmBut]CdS(C6H6-3-OMe) (ATR, cm-1): 3190 (w), 3148 (w), 2974 (w), 2404 (w), 1585 
(m), 1566 (m), 1481 (m), 1467 (m), 1417 (m), 1397 (w), 1357 (vs), 1303 (m), 1274 (m), 1222 
(m), 1191 (s), 1172 (s), 1131 (m), 1097 (w), 1070 (m), 1041 (m), 930 (w), 854 (m), 844 (m), 
820 (m), 757 (m), 733 (s), 686 (vs), 588 (m), 552 (m), 494 (m).  FAB-MS: m/z = 591.2 [M – 
S(C6H4-3-OMe)]+, M = [TmBu
t]CdS(C6H4-3-OMe). 
 
3.4.8 Synthesis of [TmBut]CdS(2-C5H4N) 
A solution of [TmBut]CdMe (83.3 mg, 0.138 mmol) in C6H6 (ca. 5 mL) was treated with 2-
mercaptopyridine (20.2 mg, 0.182 mmol), and the solution was stirred at room 
temperature for 4.5 hours.  The volatile components were removed in vacuo, yielding 
[TmBut]CdS(2-C5H5N) as a yellow powder.  The product was purified by 
recrystallization via slow diffusion of pentane into a solution in C6H6 (60 mg, 62.2%), 
yielding crystals suitable for X-ray diffraction.  Analysis calcd. for [TmBut]CdS(2-
C5H4N): C, 44.6%; H, 5.5%; N, 14.0%.  Found: C, 44.9%; H, 5.5%; N, 13.7%.  1H NMR 
(CD2Cl2): 1.74 [s, 3JH-H = 65, 27H, HB{C2N2H2[C(CH3)3]CS}3], 6.67 [m, 3JH-H = 2, 1H, CdS(2-
C5H4N)], 6.86 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 7.04 [d, 3JH-H = 2, 3H, 
HB{C2N2H2[C(CH3)3]CS}3], 7.23 [m, 1H, CdS(2-C5H4N)], 7.76 [m, 1H, CdS(2-C5H4N)].  
13C{1H} NMR (CD2Cl2): 29.2 [9C, HB{C2N2H2[C(CH3)3]CS}3], 59.6 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 116.0 [1C, CdS(2-C5H4N)], 117.0 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 123.2 [3C, HB{C2N2H2[C(CH3)3]CS}3], 125.1 [1C, CdS(2-
C5H4N)], 136.1 [1C, CdS(2-C5H4N)], 147.3 [1C, CdS(2-C5H4N)], 156.9 [3C, 




(ATR, cm-1): 3173 (w), 3140 (w), 2977 (w), 2923 (w), 2404 (w), 2228 (w), 1686 (w), 1567 
(m), 1545 (w), 1479 (w), 1445 (m), 1411 (m), 1396 (m), 1355 (vs), 1303 (m), 1265 (w), 1227 
(m), 1191 (s), 1172 (s), 1130 (s), 1071 (m), 1044 (w), 1029 (w), 986 (w), 928 (w), 862 (w), 
820 (m), 774 (w), 758 (m), 749 (m), 731 (vs), 688 (s), 627 (w), 589 (m), 553 (m), 545 (m), 
494 (m), 487 (m).  FAB-MS: m/z = 589.1 [M – S(2-C5H4N)]+, M = [TmBu
t]CdS(2-C5H4N). 
 
3.4.9 Synthesis of [TmBut]CdSe(2-C5H4N) 
A solution of [TmBut]CdMe (86.5 mg, 0.143 mmol) in C6H6 (ca. 5 mL) was treated with 2-
selenopyridine (30.3 mg, 0.192 mmol), and the solution was stirred at room temperature 
for 4.5 hours.  The volatile components were removed in vacuo, yielding [TmBut]CdSe(2-
C5H5N) as a dark yellow/orange powder.  The product was purified by 
recrystallization via slow diffusion of pentane into a solution in C6H6 (63 mg, 59%), 
yielding crystals suitable for X-ray diffraction.  Analysis calcd. for [TmBut]CdSe(2-
C5H4N): C, 41.8%; H, 5.1%; N, 13.1%.  Found: C, 41.0%; H, 4.8%; N, 12.7%.  1H NMR 
(CD2Cl2): 1.74 [s, 27H, HB{C2N2H2[C(CH3)3]CS}3], 6.78 [m, 3JH-H = 2, 1H, CdSe(2-C5H4N], 
6.86 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 7.04 [d, 3JH-H = 2, 3H, 
HB{C2N2H2[C(CH3)3]CS}3], 7.17 [m, 3JH-H = 2, 1H, CdSe(2-C5H4N], 7.48 [m, 1H, CdSe(2-
C5H4N)], 7.82 [m, 1H, CdSe(2-C5H4N)].  13C{1H} NMR (CD2Cl2): 29.2 [9C, 
HB{C2N2H2[C(CH3)3]CS}3], 59.6 [3C, HB{C2N2H2[C(CH3)3]CS}3], 117.0 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 117.4 [1C, CdSe(2-C5H4N)], 123.2 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 128.8 [1C, CdSe(2-C5H4N)], 135.4 [1C, CdSe(2-C5H4N)], 148.6 
[1C, CdSe(2-C5H4N)], 156.9 [3C, HB{C2N2H2[C(CH3)3]CS}3] 163.7 [1C, CdSe(2-C5H4N)].  
IR Data for [TmBut]CdSe(2-C5H4N) (ATR, cm-1): 3185 (w), 2975 (w), 2924 (w), 2404 (w), 
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2227 (w), 1686 (w), 1574 (m), 1547 (w), 1480 (w), 1445 (w), 1409 (m), 1396 (w), 1356 (vs), 
1303 (m), 1267 (w), 1227 (m), 1191 (s), 1172 (s), 1129 (m), 1113 (s), 1081 (w), 1070 (w), 
1045 (w), 1030 (w), 983 (w), 929 (w), 864 (w), 821 (m), 774 (w), 757 (m), 750 (m), 731 (vs), 
699 (m), 689 (s), 621 (w), 589 (m), 553 (m), 494 (m), 471 (m), 454 (w).  FAB-MS: m/z = 























3.5 Crystallographic Data 







lattice Monoclinic Monoclinic 
formula C27H38BCdFN6S4 C31H47BCdN6S4 
formula weight 717.08 755.19 
space group P21/c P21/c 
a/Å 10.2278(11) 10.870(3) 
b/Å 33.450(4) 20.191(5) 
c/Å 10.4301(12) 16.929(4) 
#/˚ 90.00 90 
$/˚ 114.637(2) 104.297(3) 
'/˚ 90.00 90 
V/Å3 3243.5(6) 3600.4(14) 
Z 4 4 
temperature (K) 150(2) 130(2) 
radiation ((, Å) 0.71073 0.71073 
) (calcd.), g cm-3 1.468 1.393 
µ (Mo K#), mm-1 0.964 0.869 
* max, deg. 30.03 30.68 
no. of data collected 50097 58632 
no. of data used 9979 11149 
no. of parameters 374 404 
R1 [I > 2+(I)] 0.0431 0.0335 
wR2 [I > 2+(I)] 0.0815 0.0724 
R1 [all data] 0.0750 0.0504 
wR2 [all data] 0.0929 0.0792 
GOF 1.020 1.018 
Rint 0.0663 0.0515 
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lattice Triclinic Monoclinic 
formula C34H47BCdN6OS4 C34H47BCdN6OS4 
formula weight 807.22 807.22 
space group P-1 P21/c 
a/Å 10.643(4) 10.6074(17) 
b/Å 11.195(4) 31.416(5) 
c/Å 15.768(5) 11.3984(19) 
#/˚ 94.945(4) 90 
$/˚ 91.717(5) 95.011(2) 
'/˚ 94.344(4) 90 
V/Å3 1865.1(11) 3783.9(11) 
Z 2 4 
temperature (K) 130(2) 130(2) 
radiation ((, Å) 0.71073 0.71073 
) (calcd.), g cm-3 1.437 1.417 
µ (Mo K#), mm-1 0.846 0.834 
* max, deg. 30.68 30.56 
no. of data collected 30294 60949 
no. of data used 11425 11593 
no. of parameters 438 438 
R1 [I > 2+(I)] 0.0242 0.0295 
wR2 [I > 2+(I)] 0.0635 0.0693 
R1 [all data] 0.0274 0.0306 
wR2 [all data] 0.0652 0.0698 
GOF 1.035 1.255 
Rint 0.0388 0.0395 
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lattice Monoclinic Monoclinic 
formula C26H38BCdN7S4 C26H38BCdN7S3Se 
formula weight 700.08 746.98 
space group P21/c P21/c 
a/Å 10.0057(9) 10.270(2) 
b/Å 32.600(3) 32.396(7) 
c/Å 10.5571(10) 10.672(2) 
#/˚ 90 90 
$/˚ 113.1086(13) 114.875(3) 
'/˚ 90 90 
V/Å3 3167.3(5) 3221.0(11) 
Z 4 4 
temperature (K) 130(2) 130(2) 
radiation ((, Å) 0.71073 0.71073 
) (calcd.), g cm-3 1.468 1.540 
µ (Mo K#), mm-1 0.982 2.031 
* max, deg. 30.645 33.001 
no. of data collected 51921 54544 
no. of data used 9755 11576 
no. of parameters 365 365 
R1 [I > 2+(I)] 0.0421 0.0304 
wR2 [I > 2+(I)] 0.0760 0.0668 
R1 [all data] 0.0785 0.0445 
wR2 [all data] 0.0872 0.0713 
GOF 1.013 1.027 
Rint 0.0843 0.0602 
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4.1 Introduction 
The first example of a structurally characterized monomeric, terminal zinc 
hydride complex was [TpBut]ZnH, reported by Parkin et al. in 1991.1  Interest in zinc 
hydride complexes has since increased due to their widespread applications as (i) 
catalysts,2 and (ii) models of zinc surface sites in heterogeneous Cu/ZnO/Al2O3 CO2 
hydrogenation catalysts.3  Of the 68 molecular structures of zinc hydride complexes 
listed in the Cambridge Structural Database, the majority of these complexes are 
polynuclear, featuring bridging hydride ligands.4  Only 8 of these reported structures 
are of mononuclear zinc complexes featuring terminal hydride ligands.1,5,6  Most of 
these complexes incorporate a tripodal ligand, whether it be [TpR,R’],1 [Tptm],6 or [ToM],5b 
because the substituents on these ligands form a bulky pocket that protects the Zn-H 
from forming bridging interactions.  As is described in Chapter 1, the versatility of the 
tris(mercaptoimidazolyl)hydroborato ligands, [TmR], which stems from their flexibility, 
has led to increased popularity.  Nevertheless, no [TmR]ZnH complexes have been 
reported.  In fact, there are no reported examples of main group or transition metal 
[TmR]MH complexes.  It is therefore significant that we report herein the first 





4.2 Discussion and Results 
4.2.1 Preparation of [TmBu
t
]ZnH  
Five different monomeric tripodal zinc hydride complexes have been reported in 
the literature,1,5 b,d,e,6 and each one of these compounds was accessed by a different 
synthetic method.  For example, [TpBut]ZnH was prepared by treating a solution of 
[TpBut]Tl in THF with an excess of ZnH2,1 while [TpPh,Me]ZnH was synthesized by 
refluxing a mixture of [TpPh,Me]ZnF and Et3SiH in toluene.5e,7  Parkin recently 
demonstrated that [!3-Tptm]ZnH could be obtained by treating [!4-Tptm]ZnOSiR3 (R = 
Me, Ph) with PhSiH3.5g  [TmBu
t]ZnH was prepared by a similar method, treating a 
solution of [TmBut]ZnOPh8 in benzene with PhSiH3, resulting in immediate, complete 
conversion to [TmBut]ZnH (Scheme 1).  [TmBut]ZnH can be isolated in 93 % yield, and 









4.2.2 Characterization and structural analysis of [TmBut]ZnH 
 The molecular structure of [TmBut]ZnH (Figure 1) was determined by single 
crystal X-ray diffraction techniques, revealing that the compound is mononuclear in the 
solid state.  It is presumably the bulkiness of the tert-butyl groups, creating a protective 
pocket around the Zn-H that prevents the hydride from bridging a second Zn center.  
Unlike [TpBut]ZnH and [TpPh,Me]ZnH, in which the terminal hydride ligands were not 
located by X-ray diffraction, the terminal hydride ligand in [TmBut]ZnH could be found 
in the difference density map, revealing a Zn-H bond length of 1.47(3) Å.  The average 
Zn-H bond length for all terminal zinc hydride complexes listed in the Cambridge 
Structural Database is slightly longer (1.551 Å),4 and is approximately equal to the sum 
of the covalent radii of zinc and hydrogen (1.53 Å).9  The molecular structures of a few 
terminal zinc hydride complexes have been obtained by neutron diffraction techniques, 
each of which reveals a longer Zn-H bond length of approximately 1.6 Å.6,10  The 
geometry optimized structure of [TmBut]ZnH has a similar Zn-H bond length of 1.639 Å, 
which significantly longer than the experimentally determined Zn-H bond length 
(1.47(3) Å).  
[TmBut]ZnH adopts a distorted trigonal monopyramidal geometry (" = 0.90),11 
with the [TmBut] moiety coordinating in a !3-manner.  Each of the arms of the [TmBut] 
moiety are related by crystallographic three-fold symmetry.  Table 1 displays select 






Figure 1.  Molecular Structure of [TmBut]ZnH. 
 
Table 1.  Select bond lengths for [!3-TmBut]ZnH. 






The 1H NMR spectrum of [TmBut]ZnH displays a signal at # 5.78 for the Zn-H 
moiety, which is typical for terminal Zn-H compounds, as summarized in Table 2.  
[TmBut]ZnH is further characterized by an IR absorption band at 1716 cm-1, which is in 
the range of frequencies reported in the literature for zinc complexes featuring a 
terminal hydride ligand, as summarized in Table 3. 
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Table 2.  Select 1H NMR data for zinc complexes featuring terminal hydride ligands. 
Compound #ZnH (ppm) Reference 
[TmBut]ZnH 5.78a This work 
[TpBut]ZnH 5.36a 1 
[ToM]ZnH 4.29a 5b 
[Zn(AlH(Ph2pz)3)(H)] 4.72a 5d 
[TpPh,Me]ZnH 4.06b 5e 
[!3-Tptm]ZnH 5.60a 6 
[Tpp-Tol,Me]ZnH 5.23c 7 
(a) 1H NMR obtained in C6D6 
(b) 1H NMR obtained in CDCl3 
(c) 1H NMR obtained in toluene-d8 
 
Table 3.  Select IR data for the zinc complexes featuring terminal hydride ligands. 
Compound $Zn-H (cm-1) Reference 
[TmBut]ZnH 1716a This work 
[TpBut]ZnH 1770b 1 
[ToM]ZnH 1745b 5b 
[Zn(AlH(Ph2pz)3)(H)] 1842b 5d 
[!3-Tptm]ZnH 1729b 6 
[Tpp-Tol,Me]ZnH 1743b 7 
(a) IR spectrum obtained using an ATR spectrometer 





4.2.3 Reactivity of [TmBu
t
]ZnH 
4.2.3.1 ! Reaction of [TmBut]ZnH with ArEH (E = O, S, Se) 
 [TmBut]ZnMe has proven to be a convenient precursor for the synthesis of 
various hydrochalcogenido and phenylchalcogenolate derivatives, [TmBut]ZnEH (E = S, 
Se) and [TmBut]ZnEPh (E = O, S, Se, Te), respectively, via cleavage of the Zn-C bond.8  
Since it is the elimination of CH4 that drives these reactions, we sought to investigate 




Scheme 2.  Preparation of [TmBut]ZnEAr complexes via H2 elimination. 
 
[TmBut]ZnH was treated with ArEH (EAr = OPh, S(C6H4-4-F), SePh) in an NMR 
tube equipped with a J. Young valve, and the reaction was monitored by 1H NMR at 25˚ 
C.  Upon immediate addition of the ArEH reagent, vigorous bubbling ensued, 
concomitant with complete conversion to [TmBut]ZnEAr.  Although [TmBut]ZnEAr (E = 
OPh, SPh, SePh) derivatives are all known compounds,8 [TmBut]ZnS(C6H4-4-F) is not.  
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We were interested in the synthesis of this particular thiolate derivative since the Cd 
analogue was used to investigate the thiolate exchange equilibrium of [TmBut]CdS(C6H4-
4-F) with various substituted thiols, phenols, and substituted pyridines, as described in 
Chapter 3 of this thesis.  A similar study performed using the [TmBut]ZnS(C6H4-4-F) 
analogue could provide a useful comparison for the reactivity of cadmium versus zinc.12  
The molecular structure of [TmBut]ZnS(C6H4-4-F) was obtained (Figure 2), and 
select bond lengths and bond angles are presented in Table 4.  [TmBut]ZnS(C6H4-4-F) is 
isostructural to the Cd derivative,13 with a geometry that is best described as distorted 
trigonal monopyramidal ("4 = 0.90).11  [TmBu
t]ZnS(C6H4-4-F) is characterized by a signal 
at # -125.3 in the 19F NMR spectrum, which is very similar to the chemical shift of the Cd 











Figure 2.  Molecular structure of [TmBut]ZnS(C6H4-4-F). 
 
Table 4.  Select bond lengths and angles for [TmBut]ZnS(C6H4-4-F). 









Zn-S(3) 2.3682(19) S(2)-Zn-S(3) 102.37(7) 
Zn-S(4) 2.265(2) S(2)-Zn-S(4) 111.44(7) 





It is significant that the treatment of [TmBut]ZnH with phenol regenerated 
[TmBut]ZnOPh, as this implies that [TmBut]ZnH could be used as a possible catalyst in 
the production of H2 from silanes in a manner similar to that reported by Sattler and 




4.2.3.2  Reaction of [TmBut]ZnH with CO2 and formic acid!
The use of CO2 as a chemical feedstock has become a major area of focus in 
recent years due to environmental concerns.14  CO2 has been shown to insert into the 
Zn-H bonds of zinc hydride complexes,1,5e,6,15 resulting in the production of the zinc 
formate derivative.  Zinc formate complexes are of particular importance, as they are 
the proposed intermediates in the ZnO- and Cu/ZnO-catalyzed syntheses of methanol.3  
For this reason we were interested in testing the reactivity of [TmBut]ZnH toward CO2.  
Indeed, [TmBut]ZnH was found to react rapidly with CO2, resulting in the formation of 
[TmBut]ZnO2CH via CO2 insertion into the Zn-H bond (Scheme 3).  
As formic acid has potential in H2 storage,16 it was important to determine 
whether [TmBut]ZnO2CH could also be accessed via reaction of [TmBu
t]ZnH with formic 
acid.17  A solution of [TmBut]ZnH in C6D6 in an NMR tube equipped with a septum was 
treated with formic acid (Scheme 3), and the reaction was monitored by 1H NMR.  
Immediately upon addition of the acid, vigorous bubbling ensued, resulting in 
complete conversion to [TmBut]ZnO2CH via H2 elimination, as evidenced by the 
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appearance of a H2 signal at # 4.47.  [TmBu
t]ZnO2CH was characterized by the 
appearance of a singlet at # 9.15, corresponding to the single proton on the formate 




Scheme 3.  Preparation of [TmBut]ZnO2CH via CO2 insertion or H2 elimination. 
 
 
The molecular structure of this compound was obtained (Figure 3), revealing a 
distorted tetrahedral geometry ("4 = 0.95).  As listed in Table 5, the Zn•••O(2) distance 
(d = 2.907 Å) is significantly longer than that of Zn-O(1) (d =1.941 Å), which suggests the 
formate ligand coordinates to the zinc center in a unidentate fashion.  The IR spectrum 
of [TmBut]ZnH shows two strong absorption bands at 1630 and 1193 cm-1, which is 
characteristic of the CO asymmetric and symmetric stretching bands respectively, for 
metal formate complexes.6,15c,e  The separation of the bands (%$ = 437cm-1) is indicative 




Figure 3.  Molecular structure of [TmBut]ZnO2CH. 
 
Table 5.  Select bond lengths and angles for [TmBut]ZnO2CH. 









Zn-S(1) 2.3190(8) S(2)-Zn-S(3) 108.14(3) 
Zn-S(2) 2.3381(7) O(1)-Zn-S(1) 115.44(6) 
Zn-S(2) 2.3600(8) O(1)-Zn-S(2) 111.00(6) 
C(41)-O(1) 1.273(3) O(1)-Zn-S(3) 107.85(6) 
C(41)-O(2) 1.211(4)   
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4.2.3.3 Reactivity of [TmBut]ZnH toward Et2Zn 
 The first stable molecular compound containing a direct Zn-Zn bond, namely 
[Zn2Cp*2], was synthesized in 2004 via the reaction of Et2Zn with ZnCp*2.19  Et2Zn is 
also known to react with transition metal hydrides such as CpM(CO)3H (M = Mo, W), 
resulting in the formation of [C5H5(CO)3M]2Zn complexes that feature direct metal-
metal bonds.20  Based on these previous studies, we considered the possibility that 
[TmBut]ZnH might be used as a precursor for the synthesis of complexes featuring 
metal-metal bonds.  For this reason, we decided to investigate the reactivity of 
[TmBut]ZnH toward Et2Zn.  [TmBu
t]ZnH was found to react vigorously with Et2Zn at 
ambient temperature, generating a dark gray precipitate that is likely Zn(0).  The 
reaction was monitored by 1H NMR spectroscopy, revealing the rapid and complete 








[TpR]ZnR and [TmR]ZnR (R = Me, Et) alkyl compounds are typically prepared by 
analogous methods via the reaction of [TpR]Tl or [TmR]Tl with a R2Zn.21,22,23  It is rather 
interesting that, although the molecular structures of several [TpR]ZnEt complexes have 
been reported,21d,e,24 there are no reports of the [TmR]ZnEt analogues.  Therefore, it is 
significant that we report here the molecular structure of [TmBut]ZnEt.  [TmBut]ZnEt 
was isolated, and characterized by a 1H NMR triplet at # 2.0 and a multiplet at # 1.08, 
corresponding to the bound Zn-Et moiety.  The molecular structure was determined 
using X-ray diffraction (Figure 4), and select bond lengths are presented in Table 6.  
Unlike [TmBut]HgEt,25 in which the [TmBut] moiety assumes a !1 mode coordination 
mode, the [TmBut] moiety was found to coordinate to the Zn center in a !3 coordination 
mode.  The Zn-C(1) bond length of the trigonal monopyramidal ("4 = 0.87) [TmBu
t]ZnEt 









Figure 4.  Molecular Structure of [TmBut]ZnEt. 
 
Table 6.  Select bond lengths for [TmBut]ZnEt. 








4.2.3.4 Reactivity of![TmBut]ZnH toward group 6 metal hydrides!
There are several examples in which transition metal hydride complexes have 
been shown to react with Cp2Zn or Et2Zn, resulting in the formation of a Zn-M bond via 
the elimination of an alkane.27  We anticipated that CpM(CO)3H complexes might react 
in a similar manner with [TmBut]ZnH, such that the elimination of H2 would drive the 
formation of a Zn-Mo bond.  
A solution of [TmBut]ZnH in C6D6 was prepared in an NMR tube equipped with a 
J. Young valve.  CpMo(CO)3H was added to the solution (Scheme 5), at which point 
vigorous bubbling ensued.  The 1H NMR spectrum showed the absence of the Zn-H 
signal, the absence of the Mo-H signal, and the appearance of an H2 signal, indicating 











 Crystals were grown from the reaction solution, and the molecular structure of a 
novel [TmBut]ZnMoCp(CO)3 heterobimetallic complex was obtained.  Further details on 
the synthesis and structure of [TmBut]ZnMoCp(CO)3 will be provided in Chapter 5. It 
should, however, be noted that the synthesis of [TmBut]ZnMoCp(CO)3 was possibly the 
most significant result obtained in this study on the reactivity of [TmBut]ZnH, as small 
molecules exhibiting direct M-M bonds of early Group 12 and Group 6 metals are 
exceedingly rare.  There are no reported structures of heterobimetallic compounds 
featuring a [TmR] ligand. 
After the successful isolation of [TmBut]ZnMoCp(CO)3, our study on the reactivity 
of [TmBut]ZnH towards transition metal hydrides was expanded to include 
Mo(PMe3)5H2.  A solution of [TmBu
t]ZnH in C6D6 was treated with Mo(PMe3)5H2, and 
the reaction was monitored by 1H NMR spectroscopy (Scheme 6).  Upon addition of 
Mo(PMe3)5H2, a signal corresponding to free PMe3 appeared in the 1H NMR spectrum. 
After heating at 60˚C for 24 hours, the 1H NMR spectrum indicated that [TmBut]ZnH had 
completely decomposed to [TmBut]2Zn.  Nevertheless, the appearance of a new hydride 










Crystals were grown from the reaction solution, and two different types of crystals 
could easily be identified in the crystallization vial.  The first crystals were [TmBut]2Zn.  
A molecular structure was obtained for the other crystals, revealing a novel trinuclear 
complex, namely Zn[(µ-H)2Mo(H)(PMe3)4]2 (Figure 5).  Select bond lengths are 




Figure 5.  Molecular structure of Zn[(µ-H)2Mo(H)(PMe3)4]2. 
 
Table 7.  Select bond lengths for Zn[(µ-H)2Mo(H)(PMe3)4]2. 
Bond Lengths (Å) 
Mo•••Zn 2.6614(3) Mo-H(1) 1.664 
Mo-P(1) 2.4142(6) Mo-H(2) 1.744 
Mo-P(2) 2.4162(6) Mo-H(3) 1.738 
Mo-P(3) 2.41919(6) Zn-H(2) 1.673 




The molecular structure of (&5-C5H5)2MoH2•ZnBr2•DMF, which features a Zn-Mo 
bond supported by two bridging hydrides, has been reported;28 however, the type of 
{M(µ-H)2}2Zn double bridging motif exhibited by the new Zn[(µ-H)2Mo(H)(PMe3)4]2 
complex is unprecedented in the literature for Zn-Mo complexes.29  The Mo-Zn 
distance in Zn[(µ-H)2Mo(H)(PMe3)4]2 is 2.6614(3) (Table 7), which is slightly shorter than 
the sum of the covalent radii of Mo and Zn (2.76 Å),30 and it is on the order of the 
average Zn-M bond length (2.651 Å) listed in the Cambridge Structural Database.  This 
result suggests that there could be some bonding interaction between the Zn and Mo 
metal centers.  Likewise, the geometry optimized structure of Zn[(µ-
H)2Mo(H)(PMe3)4]2 yielded a similar Zn-Mo bond length of 2.779 Å, which further 
supports the presence of a direct Zn-Mo bonding interaction.. 
Fenske-Hall orbital calculations were performed on the Zn[(µ-H)2Mo(H)(PMe3)4]2 
complex in an attempt to quantify the degree of Mo-Zn bonding interaction; however, 
no significant orbital overlap was observed between the Mo and Zn atoms.  This result 
indicates that there is in fact no direct Mo-Zn bond, but rather the structure is solely 





Figure 6.  '-bonding Fenske-Hall orbital interaction between the Zn atom and the 
bridging hydride ligands Zn[(µ-H)2Mo(H)(PMe3)4]2.  
 
Based on the results of the Fenske-Hall orbital calculations, the bonding within 
Zn[(µ-H)2Mo(H)(PMe3)4]2 can best be described by the structure-bonding representation 
provided in Figure 7.  This representation predicts an 18-electron configuration for 
each of the (µ-H)2Mo(L4X) moieties,31 and the bridging hydride ligands in Zn[(µ-
H)2Mo(H)(PMe3)4]2 can best be described as exhibiting Class I µ-X 3-center 2-electron 
interactions.31c  
 
Figure 7.  Structure-bonding representation of Zn[(µ-H)2Mo(H)(PMe3)4]2. 
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As it is difficult to isolate Zn[(µ-H)2Mo(H)(PMe3)4]2 from [TmBu
t]2Zn by typical 
purification techniques, we attempted to access Zn[(µ-H)2Mo(H)(PMe3)4]2 by a different 
method.  A solution of Mo(PMe3)4H2 in C6D6 was prepared in an NMR tube equipped 
with a J. Young valve and treated with ZnH2 (Scheme 7).  Upon heating, a new signal 
appeared at # -3.9 ppm in the 1H NMR spectrum, matching the spectrum obtained for 
the reaction of [TmBut]ZnH with Mo(PMe3)5H2.  A signal also appeared for free PMe3, 
suggesting that ZnH2 reacts with Mo(PMe3)5H2 in a similar fashion to that of the 
[TmBut]ZnH; however, further work will be required to develop an appropriate 
preparation of this complex. 
 
Scheme 7.  Preparation of Zn[(µ-H)2Mo(H)(PMe3)4]2 via a ZnH2 precursor. 
 
4.3 Summary and Conclusions 
A new tris(2-mercapto-1-t-butylimidazolyl)hydroborato zinc hydride complex, 
[TmBut]ZnH, was synthesized via treatment of [TmBut]ZnOPh with PhSiH3.  The 
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molecular structure was obtained, revealing that, unlike most Zn-H compounds, which 
exhibit bridging hydrides, [TmBut]ZnH exists in the solid state as a mononuclear 
compound with a terminal hydride.  The reactivity of [TmBut]ZnH toward a wide 
variety of reagents was investigated.  [TmBut]ZnH proved a useful precursor in the 
synthesis of [TmBut]ZnEAr phenylchalcogenolate derivatives (EAr = OPh, S(C6H4-4-F), 
SePh), as well as [TmBut]ZnO2CH and [TmBu
t]ZnEt.  A novel [TmBut]ZnMoCp(CO)3 
compound was synthesized by treatment of [TmBut]ZnH with CpMo(CO)3H, and this 
complex represents the first reported heterobimetallic compound featuring a [TmR] 
ligand.  Reaction of [TmBut]ZnH with Mo(PMe3)5H2 resulted in the synthesis of Zn[(µ-
H)2Mo(H)(PMe3)4]2, featuring a {Mo(µ-H)2}2Zn double bridging motif unprecedented in 












4.4 Experimental Section 
4.4.1 General Considerations 
All manipulations were performed using a combination of glovebox, high-vacuum and 
Schlenck techniques under a nitrogen atmosphere,32 except where otherwise stated.  
Solvents were purified and degassed by standard procedures.  NMR solvents were 
purchased from Cambridge Isotope Labs and stored over 3Å molecular sieves.  NMR 
spectra were measured on Bruker 300 DRX, Bruker 300 DPX, Bruker 400 Avance III, 
Bruker 400 Cyber-enabled Avance III, and Bruker 500 DMX spectrometers.  1H NMR 
chemical shifts are reported in ppm relative to SiMe4 (# = 0) and were referenced 
internally with respect to the protio solvent impurity (# 7.16 for C6D5H).33  13C NMR 
spectra are reported in ppm relative to SiMe4 (# = 0) and were referenced internally with 
respect to the solvent (# 128.06 for C6D6).33  19F NMR spectra are reported in ppm 
relative to CFCl3 (# = 0) and were referenced internally with respect to C6F6 (# = -164.9).34  
Coupling constants are given in hertz.  IR spectra were recorded on a PerkinElmer 
Spectrum Two spectrometer and are reported in reciprocal centimeters (cm-1).  Mass 
spectra were obtained on a JEOL JMS-HX110HF tandem mass spectrometer using fast 
atom bombardment (FAB).  [TmBut]ZnOPh,8 Mo(PMe3)5H2,35 and CpMo(CO)3H36 were 
prepared according to the literature procedures.  Phenol (Aldrich), phenylsilane 
(Acros), 4-fluorothiophenol (Aldrich), benzeneselenol (Aldrich), formic acid (Aldrich), 




4.4.2 X-ray Structure Determinations 
X-ray diffraction data were collected on a Bruker Apex II diffractometer.  Crystal data, 
data collection and refinement parameters are summarized in Table 8.  The structures 
were solved using direct methods and standard difference map techniques, and were 
refined by full-matrix least-squares procedures on F2 with SHELXTL (Version 2008/4).37 
 
4.4.3 Computational Details 
Calculations were carried out using DFT as implemented in the Jaguar 7.7 (release 107) 
suite of ab initio quantum chemistry programs.38  Geometry optimizations and 
frequency calculations were performed with the B3LYP** density functional39 using the 
6-31G** (H, B, C, N, S, P, O, F) and LACVP** (Mo, Zn) basis set.40  Molecular orbital 
analyses were performed with the aid of JIMP2,41 which employs Fenske-Hall 
calculations and visualization using MOPLOT.42 
 
4.4.4 Synthesis of [TmBut]ZnH  
A solution of [TmBut]ZnOPh (162 mg, 0.255 mmol) in C6H6 (ca. 6 mL) was treated with 
phenylsilane (35 µL, 0.28 mmol).  The solution was stirred at room temperature for 1 
hour, becoming a cloudy suspension over time.  The volatile components were 
removed in vacuo, and the resulting powder was washed with a mixture of pentane and 
Et2O (2 × 3 mL pentane/2 mL Et2O), yielding [TmBu
t]ZnH as a white powder (130 mg, 
93.8%).  Crystals suitable for X-ray diffraction were obtained from a solution in C6D6.  
Analysis calcd. for [TmBut]ZnH•0.5C6D6: C, 49.5%; H, 6.6%; N, 14.4%.  Found: C, 50.2%; 
H, 6.4%; N, 13.9%.  1H NMR (C6D6): 1.50 [s, 27H, HB{C2N2H2[C(CH3)3]CS}3], 5.78 [s, 1H, 
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ZnH], 6.39 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 6.70 [d, 3JH-H = 2, 3H, 
HB{C2N2H2[C(CH3)3]CS}3].  13C{1H} NMR (C6D6): 28.8 [9C, HB{C2N2H2[C(CH3)3]CS}3], 
59.2 [3C, HB{C2N2H2[C(CH3)3]CS}3], 116.4 [3C, HB{C2N2H2[C(CH3)3]CS}3], 122.5 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 159.5 [3C, HB{C2N2H2[C(CH3)3]CS}3.  IR Data for [TmBu
t]ZnH 
(ATR, cm-1): 3185 (w), 3146 (w), 2980 (w), 2910 (w), 2443 (w), 1716 (m), 1564 (w), 1477 
(w), 1412 (m), 1396 (m), 1356 (vs), 1302 (m), 1254 (w), 1228 (w), 1190 (s), 1170 (s), 1129 
(w), 1062 (m), 1028 (w), 926 (w), 820 (m), 755 (m), 724 (s), 686 (m), 674 (s), 587 (m), 550 
(m), 501 (m), 469 (s).  FAB-MS: m/z = 541.6 [M – H]+, M = [TmBut]ZnH. 
 
4.4.6 Reaction of [TmBut]ZnH with PhOH  
A solution of [TmBut]ZnH (8 mg, 0.015 mmol) in C6D6 (ca. 0.7 mL) was prepared in an 
NMR tube equipped with a J. Young valve and treated with PhOH (3 mg, 0.032 mmol), 
resulting in immediate bubbling.  1H NMR showed complete conversion to the 
[TmBut]ZnOPh derivative.  For the complete characterization of [TmBut]ZnOPh see 
reference 8. 
 
4.4.7 Synthesis of [TmBut]ZnS(C6H4-4-F)  
A solution of [TmBut]ZnH (8 mg, 0.015 mmol) in C6D6 (ca. 0.7 mL) was prepared in an 
NMR tube equipped with a septum and treated with 4-fluorothiophenol (1.6 µL, 0.015 
mmol), resulting in immediate bubbling.  The 1H NMR showed complete conversion to 
the [TmBut]ZnS(C6H4-4-F) derivative.  The volatile components were removed by 
lyophilization, yielding a white powder.  The powder was redissolved in Et2O (ca. 1 
mL), and slow evaporation of the Et2O yielded a microcrystalline powder of 
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[TmBut]ZnS(C6H4-4-F) (7 mg, 71.0%).  Crystals suitable for X-ray diffraction were 
obtained via slow diffusion of pentane into a solution in C6D6.  Analysis calcd. for 
[TmBut]ZnS(C6H4-4-F)•C6H6: C, 53.0%; H, 5.9%; N, 11.2%.  Found: C, 52.7%; H, 5.8%; N, 
11.3%.  1H NMR (C6D6): 1.41 [s, 27H, HB{C2N2H2[C(CH3)3]CS}3], 6.37 [d, 3JH-H = 2, 3H, 
HB{C2N2H2[C(CH3)3]CS}3], 6.62 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 6.77 [m, 2H, 
CdS(C6H4-4-F)], 7.86 [m, 2H, CdS(C6H4-4-F)].  13C{1H} NMR (C6D6): 28.7 [9C, 
HB{C2N2H2[C(CH3)3]CS}3], 59.4 [3C, HB{C2N2H2[C(CH3)3]CS}3], 114.7 [d, 2JC-F = 21, 2C, 
CdS(C6H4-4-F)], 117.0 [3C, HB{C2N2H2[C(CH3)3]CS}3], 122.9 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 135.7 [d, 3JC-F = 7, 2C, CdS(C6H4-4-F)], 139.9 [d, 4JC-F = 3, 1C, 
CdS(C6H4-4-F)], 157.2 [3C, HB{C2N2H2[C(CH3)3]CS}3], 160.6 [d, 1JC-F = 240, 1C, CdS(C6H4-
4-F)].  19F NMR (C6D6): 125.31 (multiplet).  IR Data for [TmBu
t]ZnS(C6H6-4-F) (ATR, cm-
1): 3180 (w), 3147 (w), 2976 (w), 2928 (w), 2417 (w), 2233 (w), 1860 (w), 1687 (w), 1565 
(m), 1480 (s), 1420 (m), 1398 (w), 1362 (vs), 1310 (m), 1259 (w), 1221 (m), 1194 (vs), 1174 
(vs), 1130 (m), 1087 (m), 1071 (m), 1031 (w), 1014 (w), 928 (w), 816 (s), 759 (s), 732 (vs), 
688 (s), 626 (s), 590 (m), 554 (m), 494 (s), 458 (w).  
 
4.4.8 Reaction of [TmBut]ZnH with PhSeH  
A solution of [TmBut]ZnH (10 mg, 0.018 mmol) in C6D6 (ca. 0.7 mL) was prepared in an 
NMR tube equipped with a septum and treated with PhSeH (2 µL, 0.019 mmol), 
resulting in immediate bubbling.  1H NMR showed complete conversion to the 





4.4.9 Synthesis of [TmBut]ZnO2CH  
(a) A solution of [TmBut]ZnH (25 mg, 0.046 mmol) in C6D6 was prepared in an 
NMR tube equipped with a septum and treated with formic acid (1.8 µL, 0.048 mmol), 
resulting in immediate bubbling.  The 1H NMR showed complete conversion to the 
[TmBut]ZnO2CH derivative.  The volatile components were removed by lyophilization 
yielding [TmBut]ZnO2CH as a white powder (24 mg, 89%).  Crystals suitable for X-ray 
diffraction were obtained via slow diffusion of pentane into a solution in C6D6.  
Analysis calcd. for [TmBut]ZnO2CH•C6H6: C, 50.5%; H, 6.2%; N, 12.6%.  Found: C, 
49.7%; H, 6.9%; N, 12.0%.  1H NMR (C6D6): 1.48 [s, 27H, HB{C2N2H2[C(CH3)3]CS}3], 6.37 
[d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 6.64 [d, 3JH-H = 2, 3H, 
HB{C2N2H2[C(CH3)3]CS}3], 9.15 [s, 1 H, O2CH].  13C{1H} NMR (C6D6): 28.9 [9C, 
HB{C2N2H2[C(CH3)3]CS}3], 59.6 [3C, HB{C2N2H2[C(CH3)3]CS}3], 117.1 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 123.0 [3C, HB{C2N2H2[C(CH3)3]CS}3], 157.5 [3C, 
HB{C2N2H2[C(CH3)3]CS}3, 167.4 [1C of O2CH].  IR Data for [TmBu
t]ZnO2CH (ATR, cm-1): 
3144 (w), 2977 (w), 2926(w), 2801 (w), 2420 (w), 1630 (s), 1567 (w), 1480 (w), 1419 (m), 
1398 (m), 1362 (vs), 1305 (m), 1229 (w), 1193 (vs), 1174 (vs), 1133 (w), 1071 (w), 1031 (w), 
929 (w), 821 (m), 760 (m), 728 (s), 685 (s), 590 (m), 553 (m), 495 (m), 456 (w).  FAB-MS: 
m/z = 541.5 [M – O2CH]+, M = [TmBu
t]ZnO2CH. 
 (b) A solution of [TmBut]ZnH (11 mg, 0.020 mmol) in C6D6 was prepared in an 
NMR tube equipped with a J. Young valve.  To the solution was added CO2 (ca. 1.3 
atm).  The reaction was monitored by 1H NMR spectroscopy, revealing rapid and 




4.4.10 Synthesis of [TmBut]ZnEt  
A solution of [TmBut]ZnH (10 mg, 0.018 mmol) in C6D6 (ca. 0.7 mL) was prepared in an 
NMR tube equipped with a J. Young valve and treated with Et2Zn (ca. 25 µL of a 0.9 M 
solution in C6D6, 0.023 mmol), resulting in vigorous bubbling.  1H NMR showed 
complete conversion to the [TmBut]ZnEt derivative.  During the reaction a dark gray 
precipitate was generated, so the solution was filtered through a filter pipette.  The 
volatile components were removed by lyophilization, yielding [TmBut]ZnEt as a white 
powder (6 mg, 57%).  Crystals suitable for X-ray diffraction were obtained via slow 
diffusion of pentane into a solution in C6D6.  Analysis calcd. for [TmBu
t]ZnEt: C, 48.3%; 
H, 6.9%; N, 14.7%.  Found: C, 48.0%; H, 7.1%; N, 14.3%.  1H NMR (C6D6): 1.08 [m, 2H 
of ZnCH2CH3], 1.53 [s, 27H, HB{C2N2H2[C(CH3)3]CS}3], 2.00 [t, 3JH-H = 8, 3H, ZnCH2CH3], 
6.40 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 6.71 [d, 3JH-H = 2, 3H, 
HB{C2N2H2[C(CH3)3]CS}3].  13C{1H} NMR (C6D6): 5.4 [1C of ZnCH2CH3], 14.9 [1C of 
ZnCH2CH3], 28.8 [9C, HB{C2N2H2[C(CH3)3]CS}3], 59.0 [3C, HB{C2N2H2[C(CH3)3]CS}3], 
116.3 [3C, HB{C2N2H2[C(CH3)3]CS}3], 122.5 [3C, HB{C2N2H2[C(CH3)3]CS}3], 159.6 [3C, 
HB{C2N2H2[C(CH3)3]CS}3.  IR Data for [TmBu
t]ZnEt (ATR, cm-1): 3134 (w), 2976 (w), 2925 
(w), 2878 (w), 2415 (w), 2294 (w), 2237 (w), 1566 (w), 1481 (w), 1417 (m), 1396 (w), 1360 
(vs), 1299 (m), 1255 (w), 1228 (w), 1193 (vs), 1174 (vs), 1133 (w), 1069 (m), 1029 (w), 980 
(w), 929 (w), 908 (w), 821 (m), 757 (m), 725 (s), 686 (s), 634 (w), 588 (m), 554 (m), 495 (m), 




4.4.11 Synthesis of Zn[(µ-H)2Mo(H)(PMe3)4]2  
(a) A solution of [TmBut]ZnH (18.9 mg, 0.035 mmol) in C6D6 (ca. 0.7 mL) was 
prepared in an NMR tube equipped with a J. young valve and treated with 
Mo(PMe3)5H2 (9.8 mg, 0.020 mmol), generating a cloudy orange/brown solution.  The 
reaction was monitored by 1H NMR spectroscopy.  The reaction mixture was allowed 
to sit at room temperature for two days, at which point the formation of [TmBut]2Zn was 
evident by corresponding signals in the 1H NMR spectrum.  The mixture was heated at 
60˚ C for 24 hours, at which point the 1H NMR showed a signal at -3.8 ppm indicating 
the formation of a new metal hydride compound, as well as the signals for [TmBut]2Zn  
The cloudy mixture was filtered through a filter pipette.  Crystals of [TmBut]2Zn and 
Zn[(µ-H)2Mo(H)(PMe3)4]2, suitable for X-ray diffraction were obtained via slow diffusion 
of hexane into a solution in C6D6.  
(b) A solution of Mo(PMe3)5H2 (10.2 mg, 0.021 mmol) in C6D6 (ca. 0.7 mL) was 
prepared in an NMR tube equipped with a J. Young valve and treated with ZnH2 (3 mg, 
0.045 mmol), generating a cloudy greenish/brown solution and some black precipitate.  
The reaction was monitored by 1H NMR spectroscopy.  The reaction mixture was 
heated at 60˚ C for 5 hours, followed by heating at 80˚ C for 24 hours.  At this point a 
new signal at # -3.8 ppm appeared in the 1H NMR, indicating the formation of Zn[(µ-
H)2Mo(H)(PMe3)4]2.  After heating at 100˚ C for 24 hours the signals for the starting 
materials were gone.  The cloudy dark brown solution was filtered through a filter 
pipette and the solution was set up to grow crystals via slow diffusion of pentane into a 
solution in C6D6.  Crystals did not grow over time, but rather a dark black powder was 




4.4.12 Synthesis of [TmBut]ZnMoCp(CO)3  
A solution of [TmBut]ZnH (12 mg, 0.022 mmol) in C6D6 (ca. 0.7 mL) was prepared in an 
NMR tube equipped with a J. Young valve and treated with CpMo(CO)3H (12 mg, 0.049 
mmol), resulting in immediate bubbling.  The 1H NMR showed complete conversion to 
the [TmBut]ZnMoCp(CO)3 derivative.  The solution was filtered to remove excess 
CpMo(CO)3H.  The volatile components were removed in vacuo, yielding 
[TmBut]ZnMoCp(CO)3 as a pale pink colored powder (10 mg, 57.5%).  Crystals suitable 
for X-ray diffraction were obtained via slow diffusion of pentane into a solution in C6D6. 


















4.5 Crystallographic Data  








lattice Rhombohedral Monoclinic 
formula C48H76B2N12S6Zn2 C27H38BFN6S4Zn 
formula weight 1165.93 670.05 
space group R-3 P21/n 
a/Å 13.3984(11) 13.199(5) 
b/Å 13.3984(11) 17.979(6) 
c/Å 27.542(2) 13.504(5) 
(/˚ 90 90 
)/˚ 90 92.785(5) 
*/˚ 120 90 
V/Å3 4281.9(6) 3200.9(19) 
Z 3 4 
temperature (K) 130(2) 130(2) 
radiation (+, Å) 0.71073 0.71073 
, (calcd.), g cm-3 1.356 1.390 
µ (Mo K(), mm-1 1.104 1.062 
- max, deg. 32.77 24.71 
no. of data collected 22244 32894 
no. of data used 3358 5464 
no. of parameters 113 374 
R1 [I > 2'(I)] 0.0373 0.0642 
wR2 [I > 2'(I)] 0.0739 0.1167 
R1 [all data] 0.0651 0.1471 
wR2 [all data] 0.0799 0.1477 
GOF 1.005 1.010 
Rint 0.0755 0.2241 
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lattice Monoclinic Rhombohedral 
formula C34H47BN6O2S3Zn C24.5H40.5BN6S3Zn 
formula weight 744.14 591.49 
space group P2/1 R-3 
a/Å 10.356(8) 13.4730(14) 
b/Å 19.5721(15) 13.4730(14) 
c/Å 10.5278(11) 67.359(7) 
(/˚ 90.00 90 
)/˚ 119.4240(1) 90 
*/˚ 90.00 120 
V/Å3 1858.8(3) 10589(2) 
Z 2 12 
temperature (K) 130(2) 130(2) 
radiation (+, Å) 0.71073 0.71073 
, (calcd.), g cm-3 1.330 1.113 
µ (Mo K(), mm-1 0.868 0.894 
- max, deg. 30.97 30.708 
no. of data collected 30599 44812 
no. of data used 11621 3526 
no. of parameters 442 121 
R1 [I > 2'(I)] 0.0467 0.0446 
wR2 [I > 2'(I)] 0.0785 0.1501 
R1 [all data] 0.0694 0.0570 
wR2 [all data] 0.0858 0.1156 
GOF 1.007 1.106 
Rint 0.0576 0.0578 
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formula weight 871.87 









temperature (K) 130(2) 
radiation (+, Å) 0.71073 
, (calcd.), g cm-3 1.354 
µ (Mo K(), mm-1 1.446 
- max, deg. 30.80 
no. of data collected 34037 
no. of data used 6691 
no. of parameters 183 
R1 [I > 2'(I)] 0.0316 
wR2 [I > 2'(I)] 0.0676 
R1 [all data] 0.0509 
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5.1 Introduction 
Bimetallic compounds are known to exhibit unique structural and chemical 
properties, with cooperation of the metals resulting in an overall enhanced reactivity.1  
As the proximity of the neighboring metal atoms is key to their chemical 
communication,1 the synthesis of complexes featuring direct metal-metal bonds has 
been a major area of research over the past century.2,3  Complexes that feature metal-
metal bonds have found a wide range of applications in the fields of (i) catalysis4, (ii) 
bioinorganic chemistry and medicine,5 and (iii) supramolecular chemistry.6  The 
increased use of X-ray crystallography over the past few decades has played a 
significant part in the structural characterization of complexes containing metal-metal 
bonds, particularly in compounds that feature a metal-metal bond supported by 
bridging ligands.1a,7  Despite the fact that the existence of complexes featuring a metal-
metal bond between a group 6 transition metal and a group 12 metal has been reported 









Figure 1.  Distribution of structurally characterized heterobimetallic compounds 
featuring a metal-metal bond between a group 6 (M’) and a group 12 (M) metal.10 
 
The molecular structure of [(C10H8N2)Mo(CO)3(HgCl)Cl]8o was the first to be 
reported for a compound featuring a metal-metal (M’-M)11 bond between a group 6 
(M’) and a group 12 (M) metal.  Since this initial report, a number of molecular 
structures have been listed in the Cambridge Structural Database for complexes 
featuring a Hg-Mo or Zn-Mo bond, while only one crystal structure has been reported 
in which a Cd-Mo bond has been identified.  A few molecular structures have been 
reported for complexes featuring a Hg-W bond, while only one structure has been 
reported for a compound featuring a Zn-W bond, namely (CH3)2N(CH2)3ZnW(!-
C5H5)(CO)3.12  The molecular structures of compounds featuring group 12 M-Cr bonds 
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are exceedingly rare, with only two molecular structures reported for compounds 
featuring Hg-Cr bonds13 and only one crystal structure reported featuring a Cd-Cr 
bond.14  No crystal structure has been reported for a compound featuring either a Zn-
Cr or a Cd-W bond.  For this reason, it is significant that we report the synthesis and 
structural analysis of a series of [TmBut]M-M’Cp(CO)3 (M = Zn, Cd; M’ = Cr, Mo, W; 
TmBut = tris(2-mercapto-1-tert-butylimidazolyl)hydroborato; Cp = cyclopentadienyl) 
heterobimetallic complexes.  Most importantly, we report the first molecular structures 




5.2 Discussion and Results 
5.2.1 Preparation of [TmBut]M-M’Cp(CO)3 complexes 
As presented in chapter 4, [TmBut]Zn-MoCp(CO)3 was first accessed via the 
addition of CpMo(CO)3H to a solution of [TmBu
t]ZnH in benzene (Scheme1).  There 




Scheme 1.  Preparation of [TmBut]Zn-MoCp(CO)3 via H2 elimination. 
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Although [TmBut]ZnH proved to be a convenient precursor in the synthesis of 
[TmBut]Zn-MoCp(CO)3, the [TmBu
t]Cd-MoCp(CO)3 analogue could not be accessed 
through a similar method, as [TmBut]CdH has not yet been successfully isolated due to 
limited stability of the compound at ambient temperature.  We anticipated that 
[TmBut]MCH3 (M = Zn, Cd) might be an appropriate alternative precursor, since acidic 
transition metal hydrides are known to protolytically cleave the metal-carbon bond of 
alkylzinc and alkylcadmium complexes, resulting in the formation of metal-metal 
bonds.8g,t,u,w,15  As anticipated, [TmBut]MCH3 (M = Zn, Cd) reacted rapidly with 
CpM’(CO)3H (M’ = Cr, Mo, W) at ambient temperature, generating [TmBu
t]M-
M’Cp(CO)3 via cleavage of the M-C bond and elimination of CH4 (Scheme 2).  
 
 
Scheme 2.  Preparation of [TmBut]M-M’Cp(CO)3 via CH4 elimination. 
 
Heterobimetallic compounds exhibiting Zn-M’ and Cd-M’ bonds (M’ = Cr, Mo, 
W) were synthesized and fully characterized for each of the Group 6 transition metals, 
but Hg-M’ analogues were not readily isolated.  [TmBut]HgMe was synthesized in situ 
in an NMR tube equipped with a J. Young valve,16 and approximately one equivalent of 
CpM’(CO)3H (M’ = Mo, W) was added to the solution (Scheme 3).  Vigorous bubbling 
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suggested the elimination of CH4, which was verified by the presence of a singlet at 
" 0.16.  The singlet corresponding to the protons of the cyclopentadienyl ligand in 
CpM’(CO)3H shifted from " 4.44 to " 5.10 for the Mo derivative and from " 4.52 to " 5.08 
for the W derivatives, providing further evidence for the generation of [TmBut]Hg-
M’Cp(CO)3 (M’ = Mo, W).   
The reaction of [TmBut]HgMe with CpM’(CO)3H (M’ = Mo, W) was monitored by 
1H NMR spectroscopy over 24 hours, revealing the formation of Me2Hg, as evident from 
the appearance of a singlet (" 0.13) featuring 119Hg satellites with a coupling constant of 
2J119Hg-H = 100 Hz.17  This was an unexpected observation, as the formation of dialkyl 
metal byproducts was not observed in the synthesis of the zinc and cadmium [TmBut]M-
M’Cp(CO)3 analogues.  Due to the formation of such byproducts, the reactions were 
intractable mixtures and the [!3-TmBut]Hg-M’Cp(CO)3 (M’ = Cr, Mo, W) analogues were 






Scheme 3.  Synthesis of [TmBut]Hg-M’Cp(CO)3 via CH4 elimination. 
 
 
5.2.2 Characterization and structural analysis of [TmBut]M-M’Cp(CO)3 
The 1H NMR spectra of the CpM’(CO)3H (M’ = Cr, Mo, W) complexes display 
signals near " -5, corresponding to the hydride.  The disappearance of this signal upon 
addition to either [TmBut]ZnH or [TmBut]MCH3 (M = Zn, Cd), is accompanied by the 
appearance of a signal for H2 or CH4, respectively.  The 1H resonance for the Cp ligand 
in the [TmBut]M-M’Cp(CO)3 complexes (M = Zn, Cd; M’ = Cr, Mo, W) is shifted 
downfield from the resonance corresponding to the Cp ligand in CpM(CO)3H (Table 1).  
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Table 1.  Select 1H NMR chemical shift data (ppm) for [TmBut]M-M’Cp(CO)3 in CD2Cl2. 









Each of the [TmBut]M-M’Cp(CO)3 complexes (M = Zn, Cd; M’ = Cr, Mo, W) were 
also characterized by 13C NMR spectroscopy, with the chemical shift of the Cp signals 
varying only slightly between complexes.  It should be noted that signals for the 
carbonyl ligands were not observed in the 13C NMR spectra of the [TmBut]M-M’Cp(CO)3 
complexes.  The absence of these carbonyl signals has been reported for other 
transition metal carbonyl complexes and may be attributed to line broadening due to 
quadrupole-induced relaxation by the metal nuclei.18  
The fact that the 1H NMR and 13C NMR spectra vary only slightly between each 
of the [TmBut]M-M’Cp(CO)3 complexes suggests that these compounds are likely 
isostructural.  The molecular structure of each of the [TmBut]M-M’Cp(CO)3 compounds 
was determined by X-ray diffraction, and are displayed in Figures 2-7.  Select bond 
lengths and angles for these compounds are presented in Tables 2-7.  The molecular 
structures of [TmBut]Zn-CrCp(CO)3 and [TmBu
t]Cd-WCp(CO)3 are significant as they 
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represent the first ever reported structures of complexes containing a Zn-Cr or Cd-W 











Table 2.  Select bond lengths and angles for [TmBut]Zn-CrCp(CO)3a. 
Bond Lengths (Å) Bond Angles (˚) 
Zn-Cr 2.6611(4) Zn-Cr-C(1) 65.00(7) 
Zn-C(1) 2.515(2) Zn-Cr-C(2) 66.53(6) 
Zn-C(2) 2.561(2) Zn-Cr-C(3) 129.11(9) 
Cr-C(1) 1.814(3) C(1)-Cr-C(2) 103.55(10) 
Cr-C(2) 1.836(2) C(1)-Cr-C(3) 82.94(12) 
Cr-C(3) 1.836(2) C(2)-Cr-C(3) 85.63(11) 
C(1)-O(1) 1.159(3) Cr-C(1)-O(1) 173.8(2) 
C(2)-O(2) 1.153(3) Cr-C(2)-O(2) 173.72(18) 
C(3)-O(3) 1.164(3) Cr-C(3)-O(3) 179.1(3) 
(a) There are two molecules of [TmBut]Zn-CrCp(CO)3 in the asymmetric unit, one of 
which contains a disordered Cp ligand and two disordered carbonyl ligands.  




Figure 3.  Molecular structure of [TmBut]Zn-MoCp(CO)3. 
 
Table 3.  Select bond lengths and angles for [TmBut]Zn-MoCp(CO)3. 
Bond Lengths (Å) Bond Angles (˚) 
Zn-Mo 2.7526(4) Zn-Mo-C(1) 64.09(6) 
Zn-C(1) 2.589(2) Zn-Mo-C(2) 64.76(6) 
Zn-C(2) 2.611(2) Zn-Mo-C(3) 124.36(7) 
Mo-C(1) 1.959(2) C(1)-Mo-C(2) 101.34(9) 
Mo-C(2) 1.961(2) C(1)-Mo-C(3) 81.11(9) 
Mo-C(3) 1.955(2) C(2)-Mo-C(3) 82.89(9) 
C(1)-O(1) 1.160(3) Mo-C(1)-O(1) 174.46(19) 
C(2)-O(2) 1.158(3) Mo-C(2)-O(2) 173.67(19) 




Figure 4.  Molecular structure of [TmBut]Zn-WCp(CO)3. 
 
Table 4.  Select bond lengths and angles for [TmBut]Zn-WCp(CO)3. 
Bond Lengths (Å) Bond Angles (˚) 
Zn-W 2.7628(4) Zn-W-C(1) 66.14(9) 
Zn-C(1) 2.664(3) Zn-W-C(2) 65.01(8) 
Zn-C(2) 2.625(3) Zn-W-C(3) 126.86(9) 
W-C(1) 1.960(3) C(1)-W-C(2) 100.70(12) 
W-C(2) 1.956(3) C(1)-W-C(3) 81.45(12) 
W-C(3) 1.956(3) C(2)-W-C(3) 82.36(13) 
C(1)-O(1) 1.167(4) W-C(1)-O(1) 175.2(3) 
C(2)-O(2) 1.174(4) W-C(2)-O(2) 174.9(2) 




Figure 5.  Molecular structure of [TmBut]Cd-CrCp(CO)3. 
 
Table 5.  Select bond lengths and angles for [TmBut]Cd-CrCp(CO)3. 
Bond Lengths (Å) Bond Angles (˚) 
Cd-Cr 2.7928(4) Cd-Cr-C(1) 67.85(7) 
Cd-C(1) 2.706(2) Cd-Cr-C(2) 66.40(7) 
Cd-C(2) 2.660(2) Cd-Cr-C(3) 130.26(10) 
Cr-C(1) 1.849(3) C(1)-Cr-C(2) 102.85(11) 
Cr-C(2) 1.842(2) C(1)-Cr-C(3) 80.90(13) 
Cr-C(3) 1.828(3) C(2)-Cr-C(3) 85.23(11) 
C(1)-O(1) 1.163(3) Cr-C(1)-O(1) 173.8(2) 
C(2)-O(2) 1.154(3) Cr-C(2)-O(2) 174.3(3) 




Figure 6.  Molecular structure of [TmBut]Cd-MoCp(CO)3. 
 
Table 6.  Select bond lengths and angles for [TmBut]Cd-MoCp(CO)3. 
Bond Lengths (Å) Bond Angles (˚) 
Cd-Mo 2.8683(11) Cd-Mo-C(1) 67.13(9) 
Cd-C(1) 2.777(3) Cd-Mo-C(2) 67.86(9) 
Cd-C(2) 2.804(3) Cd-Mo-C(3) 129.81(10) 
Mo-C(1) 1.968(3) C(1)-Mo-C(2) 99.36(13) 
Mo-C(2) 1.980(3) C(1)-Mo-C(3) 81.41(13) 
Mo-C(3) 1.970(3) C(2)-Mo-C(3) 80.68(14) 
C(1)-O(1) 1.170(4) Mo-C(1)-O(1) 174.2(3) 
C(2)-O(2) 1.159(4) Mo-C(2)-O(2) 174.6(3) 




Figure 7.  Molecular structure of [TmBut]Cd-WCp(CO)3. 
 
Table 7.  Select bond lengths and angles for [TmBut]Cd-WCp(CO)3. 
Bond Lengths (Å) Bond Angles (˚) 
Cd-W 2.8679(2) Cd-W-C(1) 67.72(5) 
Cd-C(1) 2.789(2) Cd-W-C(2) 67.53(6) 
Cd-C(2) 2.7970(18) Cd-W-C(3) 129.31(6) 
W-C(1) 1.9712(19) C(1)-W-C(2) 101.21(8) 
W-C(2) 1.966(2) C(1)-W-C(3) 82.96(8) 
W-C(3) 1.952(2) C(2)-W-C(3) 79.65(9) 
C(1)-O(1) 1.159(2) W-C(1)-O(1) 174.80(16) 
C(2)-O(2) 1.167(2) W-C(2)-O(2) 174.73(18) 
C(3)-O(3) 1.163(3) W-C(3)-O(3) 177.53(17) 
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The molecular structures of the [TmBut]M-M’Cp(CO)3 complexes revealed that, in 
each case, the [TmBut] moiety coordinates to the group 12 metal in a !3 manner, which is 
typical of zinc and cadmium complexes that feature the [TmBut] ligand.19  The M centers 
in the [TmBut]M-M’ moieties all feature a slightly distorted trigonal monopyramidal 
geometry, with #4 values ranging from 0.83 to 0.91 (Table 8).20   
 
Table 8.  #4 values for the [TmBu
t]M-M’ moieties in [TmBut]M-M’Cp(CO)3. 








The experimentally determined M-M’ bond lengths for the [TmBut]M-M’Cp(CO)3 
complexes are generally similar to the average M-M’ (M = Zn, Cd; M = Cr, Mo, W) bond 
lengths reported in the Cambridge Structural Database.21,22  Geometry optimized 
structures of the [TmBut]M-M’Cp(CO)3 complexes reveal M-M’ bond lengths that are in 
close agreement with the experimentally determined M-M’ bond lengths, as presented 





Table 9.  Select experimental and theoretical bond length data for  
[TmBut]M-M’Cp(CO)3. 
Compound Experimental d(M-M’)/Å Theoretical d(M-M’)/Å 
[TmBut]Zn-CrCp(CO)3 2.6584a 2.664 
[TmBut]Zn-MoCp(CO)3 2.7526(4) 2.791 
[TmBut]Zn-WCp(CO)3 2.7628(4) 2.805 
[TmBut]Cd-CrCp(CO)3 2.7928(4) 2.824 
[TmBut]Cd-MoCp(CO)3 2.8683(11) 2.943 
[TmBut]Cd-WCp(CO)3 2.8679(2) 2.961 
(a) There are two molecules of [TmBut]Zn-CrCp(CO)3 in the asymmetric unit, one of 
which contains a disordered Cp ligand and two disordered carbonyl ligands.  
The experimental value given above is the davg(Zn-Cr).  
 
 The M-M’-C(1) and M-M’-C(2) angles of the M-M’Cp(CO)3 moieties are 
significantly smaller than the C(1)-M’-C(3) and C(2)-M’-C(3) angles (Table 10), such that 
the geometry about the group 6 metal center can best be described as distorted “four-
legged piano stool”.  This geometry is typical of CpML’4 (L’ = H, CO, PH3, SiH3, Cl, Li, 









Table 10.  Select bond angles (˚) for [TmBut]M-M’Cp(CO)3 
Compound M-M’-C(1) M-M’-C(2) C(1)-M’-C(3) C(2)-M’-C(3) 
[TmBut]Zn-CrCp(CO)3a 65.00(7) 66.53(6) 82.94(12) 85.63(11) 
[TmBut]Zn-MoCp(CO)3 42.90(5) 64.76(6) 81.11(9) 82.89(9) 
[TmBut]Zn-WCp(CO)3 66.14(9) 65.01(8) 81.45(12) 82.36(13) 
[TmBut]Cd-CrCp(CO)3 67.85(7) 66.40(7) 80.90(13) 85.23(11) 
[TmBut]Cd-MoCp(CO)3 67.13(9) 67.86(9) 81.41(13) 80.68(14) 
[TmBut]Cd-WCp(CO)3 67.72(5) 67.53(6) 82.96(8) 79.65(9) 
(a)  There are two molecules of [TmBut]Zn-CrCp(CO)3 in the asymmetric unit, one of 
which contains a disordered Cp ligand and two disordered carbonyl ligands.  The data 
for the disordered molecule are omitted in the table above. 
 
For each of the [TmBut]M-M’Cp(CO)3 complexes, the M-C(1) and M-C(2) distances 
are larger than the sum of the covalent radii of M and C,24 which would suggest that 
there is no bonding interaction between the carbonyl carbon atoms and the group 12 
metal.  However, the distortion of the M-M’-C(1) and M-M’-C(2) angles (Table 10), as 
well as the distortion of the M’-C(1)-O(1) and M’-C(2)-O(2) angles from 180˚suggests 
that the C(1) and C(2) carbonyl ligands partially bridge the two neighboring metals.  
This type of bridging interaction has been reported for other transition metal complexes 
featuring CpM’(CO)nM moieties (n = 2-3),25 and the degree of bridge asymmetry can be 
described using the asymmetry parameter a = (D2-D1)/D1,25a where D2 and D1 are equal 
to the longest M-C and shortest M’-C distances for the bridging carbonyl ligand, 
respectively (Figure 8).  The smaller the value of a, the more bridging character 





Figure 8.  Representation of the particular CpM’(CO)nM bond lengths used to calculate 
the degree of bridge asymmetry.26 
Table 11 lists the bridge asymmetry parameters for the series of [TmBut]M-
M’Cp(CO)3 complexes.  The bridge asymmetry parameters fall within the range 
reported for Cp2Cr2(CO)4 (a = 0.29),25a Cp2Mo2(CO)4 (a = 0.20),25b [!5-EtO2CC5H4W(CO)3]2 
(a = 0.31),25c and Cr2Hg(CO)6(C8H9O2)2 (a = 0.47),25d which are all complexes described as 
featuring semi-bridging carbonyl ligands.  This result suggests that two of the carbonyl 
ligands of [TmBut]M-M’Cp(CO)3 may be described as exhibiting minor bridging 
character. 
 
Table 11.  Bridge asymmetry parameters (a) for [TmBut]M-M’Cp(CO)3. 
Compound aC1a aC2b 
[TmBut]Zn-CrCp(CO)3 0.39 0.39 
[TmBut]Zn-MoCp(CO)3 0.32 0.33 
[TmBut]Zn-WCp(CO)3 0.36 0.34 
[TmBut]Cd-CrCp(CO)3 0.46 0.44 
[TmBut]Cd-MoCp(CO)3 0.41 0.42 
[TmBut]Cd-WCp(CO)3 0.41 0.42 
(a)  C1 refers to the C(1)-O(1) carbonyl ligand 
(b)  C2 refers to the C(2)-O(2) carbonyl ligand 
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Infrared spectroscopy is a useful technique for characterization of metal carbonyl 
bonding, as carbonyl stretching modes have strong $CO absorptions in the range 1620-
2120 cm-1.  The frequency of the CO stretching band is greatly influenced by its binding 
mode, such that terminal carbonyl ligands in neutral metal complexes tend to absorb in 
the range $CO = 2120-1850 cm-1, while µ2-bridging carbonyls absorb in the range $CO = 
1850-1750 cm-1.27  The CpM’(CO)3H precursors display CO-stretching bands in the 
region $CO = 1819-2018 cm-1,28 while the CO-stretching bands of the [TmBu
t]M-
M’Cp(CO)3 complexes appear at lower frequencies ($CO = 1824-1944 cm-1) (Table 12), 
falling in the region of the spectrum that is typical of bridging carbonyls.  These results 
suggest that there is in fact partial bridging character to the carbonyl ligands of the 
[TmBut]M-M’Cp(CO)3 complexes. 
Table 12.  Select IR data for [TmBut]M-M’Cp(CO)3 (M = Zn, Cd; M’ = Cr, Mo, W). 
Compound $CO (cm-1) 
CpCr(CO)3H 2018(s), 1946(s), 1936(vs)a  
CpMo(CO)3Hb 2013 (s), 1915 (b,s), 1881 (s) 
CpW(CO)3Hb 2009 (s), 1868 (s,b), 1819 (s) 
[TmBut]Zn-CrCp(CO)3 1932 (s), 1824 (vs) 
[TmBut]Zn-MoCp(CO)3 1938 (s), 1835 (vs) 
[TmBut]Zn-WCp(CO)3 1938 (s), 1827 (vs) 
[TmBut]Cd-CrCp(CO)3 1936 (s), 1851 (shoulder), 1828 (vs) 
[TmBut]Cd-MoCp(CO)3 1944 (s), 1862 (s), 1828 (vs) 
[TmBut]Cd-WCp(CO)3 1930 (s), 1830 (vs) 
(a)  measurements taken in THF.  See reference 28 
(b)  measurements performed using ATR FT-IR spectroscopy 
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A series of DFT calculations were completed in an attempt to quantify the degree 
of carbonyl bridging between the neighboring metals of [TmBut]M-M’Cp(CO)3.  Figure 
9 displays the %-bonding orbital interaction between the two metals of the [TmBut]M-
M’Cp(CO)3 complexes, revealing a significant level of orbital overlap between the C(1) 
and C(2) carbonyl ligands and M.  For the [TmBut]M-M’Cp(CO)3 complexes, the 
percentage of orbital contribution from M is in the range of 19.19-20.11 % while the 
percentage of orbital contribution from M’ is 32.18-36.42 %.  This means that almost 50 
% of the orbital contribution comes from the C(1) and C(2) carbonyl ligands, further 






Figure 9.  %-bonding Fenske-Hall orbital interaction between the neighboring metals of 
[TmBut]M-M’Cp(CO)3 and the partially bridging carbonyl ligands. 
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5.3 Summary and Conclusions 
A series of [TmBut]M-M’Cp(CO)3 complexes (M = Zn, Cd; M’ = Cr, Mo, W) 
featuring a metal-metal bond between a group 12 metal and a group 6 metal were 
synthesized and structurally characterized by single crystal X-ray diffraction 
techniques.  The molecular structures of the [TmBut]M-M’Cp(CO)3 complexes revealed 
that they are all isostructural, featuring a M-M’ bond supported by two partially 
bridging carbonyl ligands.  Although a number of molecular structures have been 
reported for complexes containing a metal-metal bond between a group 6 metal and a 
mercury atom, the molecular structures of complexes featuring metal-metal bonds 
between a group 6 metal and a cadmium or zinc atom are exceedingly rare.  Synthesis 
and structural characterization of [!3-TmBut]Zn-CrCp(CO)3 and [!3-TmBu
t]Cd-WCp(CO)3 
is especially significant as their molecular structures represent the first two structures 










5.4 Experimental Section 
5.4.1 General Considerations 
All manipulations were performed using glovebox, high-vacuum and Schlenck 
techniques under a nitrogen atmosphere,29 except where otherwise stated.  Solvents 
were purified and degassed by standard procedures.  NMR solvents were purchased 
from Cambridge Isotope Labs and stored over 3Å molecular sieves.  NMR spectra 
were measured on Bruker 300 DRX, Bruker 300 DPX, Bruker 400 Avance III, Bruker 400 
Cyber-enabled Avance III, and Bruker 500 DMX spectrometers.  1H NMR chemical 
shifts are reported in ppm relative to SiMe4 (" = 0) and were referenced internally with 
respect to the protio solvent impurity (" 7.16 for C6D5H and 5.32 for CDHCl2).30  13C 
NMR spectra are reported in ppm relative to SiMe4 (" = 0) and were referenced 
internally with respect to the solvent (" 53.84 for CD2Cl2).30  Coupling constants are 
given in hertz.  Infrared spectra were recorded on a PerkinElmer Spectrum Two 
spectrometer and are reported in reciprocal centimeters (cm-1).  Mass spectra were 
obtained on a JEOL JMS-HX110HF tandem mass spectrometer using fast atom 
bombardment (FAB).  [TmBut]ZnMe19c and [TmBut]CdMe19f were prepared by 
modification of the literature procedures.  CpCr(CO)3H,31 CpMo(CO)3H,32 and 
CpW(CO)3H32 were prepared by the literature procedures.  
 
5.4.2 X-ray Structure Determinations 
X-ray diffraction data were collected on a Bruker Apex II diffractometer.  Crystal data, 
data collection and refinement parameters are summarized in Table 13.  The structures 
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were solved using direct methods and standard difference map techniques, and were 
refined by full-matrix least-squares procedures on F2 with SHELXTL (version 2008/4).33 
 
5.4.3 Computational Details 
Calculations were carried out using DFT as implemented in the Jaguar 7.7 (release 107) 
suite of ab initio quantum chemistry programs.34  Geometry optimizations were 
performed with the B3LYP density functional35 using the 6-31G** (H, B, C, N, S, O) and 
LACVP (Cr, Mo, W, Zn, Cd) basis set.36  Molecular orbital analyses were performed 
with the aid of JIMP2,37 which employs Fenske-Hall calculations and visualization 
using MOPLOT.38 
 
5.4.4 Synthesis of [TmBut]ZnCrCp(CO)3 
In an NMR tube equipped with a J. Young valve, a cloudy white suspension of 
[TmBut]ZnMe (23.5 mg, 0.042 mmol) in C6D6 (ca. 1 mL) was treated with CpCr(CO)3H 
(12.6 mg, 0.062 mmol), resulting in immediate bubbling and formation of a green 
solution.  The volatile components were removed in vacuo, and the resulting green 
powder was washed with pentane (2 × 1 mL) and Et2O (1 × 2 mL), yielding 
[TmBut]ZnCrCp(CO)3 as a pale yellow/green powder (14 mg, 44.7%).  Crystals suitable 
for X-ray diffraction were obtained via slow diffusion of pentane into a solution in 
benzene.  Analysis calcd. for [TmBut]ZnCrCp(CO)3: C, 46.8%; H, 5.3%; N, 11.3%.  
Found: C, 45.6%; H, 5.2%; N, 10.5%.  1H NMR (C6D6): 1.50 [s, 27H, 
HB{C2N2H2[C(CH3)3]CS}3], 4.76 [s, 5H, CrCp], 6.40 [d, 3JH-H = 2, 3H, 
HB{C2N2H2[C(CH3)3]CS}3], 6.63 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3].  13C{1H} 
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NMR (CD2Cl2): 29.3 [9C, HB{C2N2H2[C(CH3)3]CS}3], 59.8 [3C, HB{C2N2H2[C(CH3)3]CS}3], 
84.9 [5C of CrCp], 117.2 [3C, HB{C2N2H2[C(CH3)3]CS}3], 123.5 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 156.9 [3C, HB{C2N2H2[C(CH3)3]CS}3], not observed [3C of 
CO].  (ATR, cm-1): 2978 (w), 1932 (s), 1824 (vs), 1568 (w), 1479 (w), 1421 (m), 1398 (w), 
1361 (vs), 1306 (w), 1229 (w), 1194 (s), 1175 (s), 1070 (w), 820 (m), 763 (m), 728 (m), 684 
(s), 641 (s), 572 (w), 535 (w), 499 (m), 458 (w).  FAB-MS: m/z = 541.3 [M – CrCp(CO)3]+, 
M = [TmBut]ZnCrCp(CO)3. 
 
5.4.5 Synthesis of [TmBut]ZnMoCp(CO)3 
A cloudy white suspension of [TmBut]ZnMe (70.2 mg, 0.13 mmol) in C6H6 (ca. 5 mL) was 
treated with CpMo(CO)3H (59.2 mg, 0.24 mmol), resulting in immediate bubbling.  The 
resulting deep red solution was stirred at room temperature for 2.5 hours.  The volatile 
components were removed in vacuo, and the pink powder was washed with pentane (2 
× 4mL ) and Et2O (3 × 4 mL), yielding [TmBu
t]ZnMoCp(CO)3C as a pale pink powder 
(65.3 mg, 65.9%).  Crystals suitable for X-ray diffraction were obtained from via slow 
diffusion of pentane into a solution in benzene.  Analysis calcd. for 
[TmBut]ZnMoCp(CO)3•C6H6: C, 48.5%; H, 5.2%; N, 9.7%.  Found: C, 48.2%; H, 5.0%; N, 
9.4%.  1H NMR (CD2Cl2): 1.78 [s, 27H, HB{C2N2H2[C(CH3)3]CS}3], 5.19 [s, 5H, MoCp], 
6.84 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 7.05 [d, 3JH-H = 2, 3H, 
HB{C2N2H2[C(CH3)3]CS}3].  13C{1H} NMR (CD2Cl2): 29.3 [9C, HB{C2N2H2[C(CH3)3]CS}3], 
59.8 [3C, HB{C2N2H2[C(CH3)3]CS}3], 88.8 [5C of MoCp], 117.1 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 123.5 [3C, HB{C2N2H2[C(CH3)3]CS}3], 157.0 [3C, 




(ATR, cm-1): 3186 (w), 3153 (w), 2978 (w), 2925 (w), 2419 (w), 1938 (s), 1835 (vs), 1568 
(m), 1478 (m), 1420 (m), 1397 (m), 1360 (vs), 1307 (m), 1258 (w), 1229 (w), 1195 (s), 1174 
(s), 1136 (w), 1105 (w), 1072 (w), 1059 (w), 1036 (w), 1010 (w), 1001 (w), 926 (w), 853 (w), 
837 (w), 822 (m), 801 (m), 760 (m), 737 (m), 724 (m), 680 (vs), 598 (s), 555 (m), 515 (m), 
490 (m), 457 (w).  FAB-MS: m/z = 541.2 [M – MoCp(CO)3]+, M = [TmBu
t]ZnMoCp(CO)3. 
 
5.4.6 Synthesis of [TmBut]ZnWCp(CO)3 
A cloudy white suspension of [TmBut]ZnMe (81.7 mg, 0.146 mmol) in C6H6 (ca. 6 mL) 
was treated with CpW(CO)3H (80.7 mg, 0.24 mmol), resulting in immediate bubbling.  
The resulting tan colored solution was stirred at room temperature for 2 hours.  The 
volatile components were removed in vacuo, and the resulting tan colored powder was 
washed with pentane (2 × 3 mL) Et2O (5 × 3 mL), yielding [TmBu
t]ZnWCp(CO)3 as a 
cream colored solid (96.5 mg, 75.2%).  Crystals suitable for X-ray diffraction were 
obtained from via slow diffusion of pentane into a solution in benzene.  Analysis calcd. 
for [TmBut]ZnWCp(CO)3•0.5C6H6: C, 42.0%; H, 4.6%; N, 9.2%.  Found: C, 41.6%; H, 
4.3%; N, 9.2%.  1H NMR (CD2Cl2): 1.78 [s, 27H, HB{C2N2H2[C(CH3)3]CS}3], 5.25 [s, 5H, 
WCp], 6.83 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 7.04 [d, 3JH-H = 2, 3H, 
HB{C2N2H2[C(CH3)3]CS}3].  13C{1H} NMR (CD2Cl2): 29.3 [9C, HB{C2N2H2[C(CH3)3]CS}3], 
59.8 [3C, HB{C2N2H2[C(CH3)3]CS}3], 87.5 [5C of WCp], 117.1 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 123.4 [3C, HB{C2N2H2[C(CH3)3]CS}3], 157.2 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 3C of CO not observed.  IR Data for [TmBu
t]ZnWCp(CO)3 
(ATR, cm-1): 2971 (w), 2399 (w), 1938 (s), 1827 (vs), 1566 (w), 1480 (w), 1416 (m), 1397 
(m), 1359 (vs), 1303 (m), 1258 (w), 1230 (m), 1189 (s), 1174 (s), 1131 (m), 1063 (m), 1012 
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(w), 930 (w), 840 (w), 816 (m), 759 (m), 728 (s), 690 (s), 587 (s), 555 (m), 508 (m), 486 (s), 
463 (m).  FAB-MS: m/z = 541.4 [M – WCp(CO)3]+, M = [TmBu
t]ZnWCp(CO)3. 
 
5.4.7 Synthesis of [TmBut]CdCrCp(CO)3 
In an NMR tube equipped with a J. Young valve, a cloudy white suspension of 
[TmBut]CdMe (7.9 mg, 0.013 mmol) in C6D6 (ca. 1 mL) was treated with CpCr(CO)3H (5.3 
mg, 0.026 mmol), resulting in immediate bubbling and the formation of an 
orange/brown solution.  The volatile components were removed in vacuo, and the 
resulting powder was washed with pentane (2 × 1 mL) and Et2O (1 × 2 mL), yielding 
[TmBut]CdCrCp(CO)3 as a pale orange/tan powder (2.5 mg, 24%).  Crystals suitable for 
X-ray diffraction were obtained via slow diffusion of pentane into a solution in benzene.  
Analysis calcd. for [TmBut]CdCrCp(CO)3•0.5C6H6 : C, 46.3%; H, 5.1%; N, 10.1%.  Found: 
C, 46.1%; H, 4.9%; N, 10.0%.  1H NMR (C6D6): 1.51 [s, 27H, HB{C2N2H2[C(CH3)3]CS}3], 
4.68 [s, 5H, CrCp], 6.43 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 6.67 [d, 3JH-H = 2, 3H, 
HB{C2N2H2[C(CH3)3]CS}3].  13C{1H} NMR (CD2Cl2): 29.2 [9C, HB{C2N2H2[C(CH3)3]CS}3], 
59.7 [3C, HB{C2N2H2[C(CH3)3]CS}3], 83.7 [5C of CrCp], 117.1 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 123.4 [3C, HB{C2N2H2[C(CH3)3]CS}3], 156.7 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 3C of CO not observed.  IR Data for [TmBu
t]CdCrCp(CO)3 
(ATR, cm-1): 2978 (w), 1936 (s), 1851 (s), 1828 (vs), 1569 (w), 1480 (m), 1418 (w), 1358 (s), 
1303 (m), 1228 (w), 1193 (s), 1175 (s), 1068 (w), 1008 (w), 820 (m), 760 (m), 727 (m), 686 
(m), 667 (m), 637 (s), 588 (w), 567 (w), 531 (m), 495 (m).  FAB-MS: m/z = 591.2 [M – 





5.4.8 Synthesis of [TmBut]CdMoCp(CO)3 
A cloudy white suspension of [TmBut]CdMe (72.6 mg, 0.120 mmol) in C6H6 (ca. 4 mL) 
was treated with CpMo(CO)3H (32.5 mg, 0.132 mmol), resulting in immediate bubbling.  
The resulting pink solution was stirred at room temperature for 3.5 hour.  The volatile 
components were removed in vacuo, and the resulting deep pink powder was washed 
with pentane (ca. 3 mL) and Et2O (ca. 4 mL), yielding [TmBu
t]CdMoCp(CO)3 as a pale 
pink solid (73.8 mg, 73.6 %).  Crystals suitable for X-ray diffraction were obtained via 
slow diffusion of pentane into a solution in benzene.  Analysis calcd. for 
[TmBut]CdMoCp(CO)3•0.5 C6H6: C, 44.0%; H, 4.8%; N, 9.6%.  Found: C, 44.6%; H, 
4.51%; N, 9.13%.  1H NMR (CD2Cl2): 1.78 [s, 27H, HB{C2N2H2[C(CH3)3]CS}3], 5.16 [s, 5H, 
MoCp], 6.86 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 7.04 [d, 3JH-H = 2, 3H, 
HB{C2N2H2[C(CH3)3]CS}3].  13C{1H} NMR (CD2Cl2): 29.2 [9C, HB{C2N2H2[C(CH3)3]CS}3], 
59.7 [3C, HB{C2N2H2[C(CH3)3]CS}3], 87.5 [5C of MoCp], 117.0 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 123.3 [3C, HB{C2N2H2[C(CH3)3]CS}3], 156.9 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 3C of CO not observed.  IR Data for [TmBu
t]CdMoCp(CO)3 
(ATR, cm-1): 2976 (w), 2379 (w), 1944 (s), 1862 (s), 1828 (vs), 1567 (m), 1480 (w), 1417 (m), 
1395 (m), 1356 (vs), 1303 (m), 1264 (w), 1228 (w), 1194 (s), 1174 (s), 1127 (m), 1071 (m), 
1032 (w), 1010 (w), 927 (w), 836 (w), 822 (m), 804 (m), 773 (w), 758 (m), 733 (s), 687 (m), 





5.4.9 Synthesis of [TmBut]CdWCp(CO)3  
A cloudy white suspension of [TmBut]CdMe (81.1 mg, 0.13 mmol) in C6H6 (ca. 4 mL) was 
treated with CpW(CO)3H (53.8 mg, 0.16 mmol), resulting in immediate bubbling.  The 
resulting tan colored solution was stirred at room temperature for 3.5 hour.  The 
volatile components were removed in vacuo, and the resulting powder was washed with 
pentane (2 × 3 mL) and Et2O (ca. 2 mL), yielding [TmBu
t]CdWCp(CO3) as a tan colored 
powder (82 mg, 66.3%).  Crystals suitable for X-ray diffraction were obtained via slow 
diffusion of pentane into a solution in benzene.  Analysis calcd. for 
[TmBut]CdWCp(CO)3: C, 37.7%; H, 4.3%; N, 9.1%.  Found: C, 38.7%; H, 4.0%; N, 8.7%.  
1H NMR (CD2Cl2): 1.78 [s, 27H, HB{C2N2H2[C(CH3)3]CS}3], 5.23 [s, 5H, WCp], 6.85 [d, 3JH-
H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3], 7.04 [d, 3JH-H = 2, 3H, HB{C2N2H2[C(CH3)3]CS}3].  
13C{1H} NMR (CD2Cl2): 29.2 [9C, HB{C2N2H2[C(CH3)3]CS}3], 59.6 [3C, 
HB{C2N2H2[C(CH3)3]CS}3], 86.1 [5C of WCp], 117.0 [3C, HB{C2N2H2[C(CH3)3]CS}3], 123.3 
[3C, HB{C2N2H2[C(CH3)3]CS}3], 157.1 [3C, HB{C2N2H2[C(CH3)3]CS}3], 3C of CO not 
observed.  IR Data for [TmBut]CdWCp(CO)3 (ATR, cm-1): 3182 (w), 3149 (w), 2975 (w), 
1930 (s), 1830 (vs), 1566 (m), 1479 (m), 1417 (m), 1396 (m), 1357 (s), 1303 (m), 1263 (w), 
1227 (w), 1194 (s), 1171 (s), 1147 (m), 1129 (w), 1071 (w), 1034 (w), 1010 (w), 929 (w), 838 
(w), 809 (m), 774 (w), 758 (m), 730 (s), 681 (s), 672 (s), 590 (s), 554 (m), 491 (s), 457 (m).  









5.5 Crystallographic Data  








lattice Monoclinic Triclinic 
formula C64H84B2Cr2N12O6S6Zn2 C41H51BMoN6O3S3Zn 
formula weight 1566.15 944.18 
space group P21/n P-1 
a/Å 17.9805(18) 10.2866(10) 
b/Å 20.161(2) 12.0489(12) 
c/Å 20.692(2) 19.2260(19) 
&/˚ 90 92.6350(10) 
'/˚ 97.8927(15) 93.9040(10) 
(/˚ 90 114.8880(10) 
V/Å3 7429.9(13) 2149.3(4) 
Z 4 2 
temperature (K) 130(2) 296(2) 
radiation (), Å) 0.71073 0.71073 
* (calcd.), g cm-3 1.400 1.459 
µ (Mo K&), mm-1 1.147 1.040 
+ max, deg. 30.681 30.63 
no. of data collected 121282 35130 
no. of data used 22921 13225 
no. of parameters 878 518 
R1 [I > 2%(I)] 0.0408 0.0398 
wR2 [I > 2%(I)] 0.0955 0.0871 
R1 [all data] 0.0635 0.0607 
wR2 [all data] 0.1071 0.0965 
GOF 1.024 1.033 
Rint 0.0535 0.0504 
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lattice Monoclinic Triclinic 
formula C33.50H40.50BN6O3S3WZn C32H42BCdCrN6O3S3 
formula weight 931.43 830.10 
space group C2/c P-1 
a/Å 18.1735(18) 11.2055(10) 
b/Å 11.9831(12) 11.5168(10) 
c/Å 33.901(3) 16.7996(15) 
&/˚ 90 104.0741(12) 
'/˚ 91.6467(14) 96.5523(12) 
(/˚ 90 114.7225(11) 
V/Å3 7379.6(13) 1852.0(3) 
Z 8 2 
temperature (K) 130(2) 130(2) 
radiation (), Å) 0.71073 0.71073 
* (calcd.), g cm-3 1.677 1.489 
µ (Mo K&), mm-1 3.977 1.077 
+ max, deg. 30.653 30.58 
no. of data collected 59479 30071 
no. of data used 11392 11316 
no. of parameters 410 437 
R1 [I > 2%(I)] 0.0340 0.0356 
wR2 [I > 2%(I)] 0.0710 0.0798 
R1 [all data] 0.0418 0.0492 
wR2 [all data] 0.0733 0.0879 
GOF 1.109 1.059 













lattice Monoclinic Triclinic 
formula C29H39BCdMoN6O3S3 C38H48BCdN6O3S3 
formula weight 834.99 1040.06 
space group P2(1)/n P-1 
a/Å 12.229(6) 11.1589(10) 
b/Å 16.498(8) 11.7771(11) 
c/Å 18.198(9) 16.5865(16) 
&/˚ 90 99.0487(13) 
'/˚ 106.899(7) 90.6009(13) 
(/˚ 90 106.0490(12) 
V/Å3 3513(3) 2065.4(3) 
Z 4 2 
temperature (K) 130(2) 130(2) 
radiation (), Å) 0.71073 0.71073 
* (calcd.), g cm-3 1.579 1.672 
µ (Mo K&), mm-1 1.179 3.492 
+ max, deg. 30.55 30.67 
no. of data collected 49011 34140 
no. of data used 10751 12696 
no. of parameters 410 491 
R1 [I > 2%(I)] 0.0380 0.0215 
wR2 [I > 2%(I)] 0.0775 0.0504 
R1 [all data] 0.0588 0.0245 
wR2 [all data] 0.0844 0.0519 
GOF 1.055 1.020 
Rint 0.0636 0.0324 
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6.1 Introduction 
The synthesis of 2,2’:6’2’’-terpyridine was first reported over eighty years ago,1 and 
its ability to stabilize a vast number of main group and transition metal complexes has 
made it one of the most extensively studied ligand systems in coordination chemistry.2  
Terpyridine ligands can assume a unidentate, bidentate, or tridentate coordination 
mode and have even been known to bridge metal centers.2a,e,3  An advantage of 
2,2’:6’2’’-terpyridine is that it is commercially available and offers a wide variety of 
easily accessible substituted alkyl and aryl derivatives (Figure 1).2a  The electronic 
influence of these substituent groups on the metal center often results in interesting 
redox chemistries and photophysical properties.4  The ability to tailor the structure and 
electronics of the terpyridine ligand, as well as its conformational flexibility, has 
resulted in the application of terpyridine ligands in the widespread fields of catalysis, 
materials science, nanoscience, supramolecular chemistry, and biochemistry.2d,e 
 There are 3319 metal complexes listed in the Cambridge Structural Database 
(CSD) that feature terpyridine ligands.5  It is therefore hard to imagine that the 
coordination chemistry of metal complexes featuring 6,6”-di(aryl)-2,2’:6’2’’-terpyridine 
ligands (aryl = p-tolyl, mesityl) has not been extensively investigated.  Only two 
examples of complexes featuring 6,6”-dimesityl-2,2’:6’2’’-terpyridine ligands, [tpyMes2], 
are listed in the CSD,6 and only one example exists of a metal complex featuring a 6,6”-
di(p-tolyl)-2,2’:6’2’’-terpyridine ligand, [tpyp-Tol2].7  For this reason we were interested in 
probing the coordination chemistry of a variety of metal complexes that employ these 





Figure 1.  The [tpyR2] and [bppR2] ligands, as illustrated in their !3-N3 coordination 
modes. 
 
Another ligand system that is very similar in overall structure to terpyridines is 2,6-
bis(pyrazolyl)pyridine, [bppR] (Figure 1).  Nevertheless, the mixed heterocycle 
framework of 2,6-bis(pyrazolyl)pyridine causes the chemistry of these ligand systems to 
differ in several ways, including: (i) electron richness, (ii) kinetic lability, and (iii) 
luminescent properties.2c  Similar to the terpyridine ligands, the 2,6-
bis(pyrazolyl)pyridine ligands can be functionalized by adding different substituent 
groups.  This flexibility of structure has led this class of ligands to be extensively 
studied, having found applications in catalysis, electronic devices, and materials 
science.2e  There are 274 molecular structures of metal complexes featuring 2,6-
bis(pyrazolyl)pyridine ligands listed in the CSD;5 although numerous, this number is 
not nearly as overwhelming as the number of terpyridine metal complexes.  
Interestingly, there is a dearth of information regarding the coordination chemistry of 
the 2,6,-bis(3-tert-butyl-N-pyrazolyl)pyridine ligand, [bppBut].  It is therefore significant 
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that we report the synthesis and structural analysis of a variety of main group and 
transition metal complexes that feature the [bppBut] ligand. 
 
6.2 Results and Discussion 
6.2.1 Synthesis and structural analysis of 6,6”-di(aryl)-2,2’:6’2’’-terpyridine ligands  
The [tpyMes2] ligand was synthesized according to a modification of the literature 
procedure (Scheme 1),8 and the [tpyp-Tol2] ligand was prepared by an analogous method.  
Interestingly, the molecular structures of these two ligands have not been previously 
reported; therefore, it is significant that we characterized the [tpyAr2] (Ar = p-tolyl, 
mesityl) ligands using X-ray diffraction.  The molecular structures of these complexes 












Figure 2.  Molecular structure of 6,6”-di(p-tolyl)-2,2’:6’2’’-terpyridine, [tpyp-Tol2]. 
 






Figure 3.  Molecular structure of 6,6”-dimesityl-2,2’:6’2’’-terpyridine, [tpyMes2]. 
 







The pyridine rings of the [tpyAr2] (Ar = p-tolyl, mesityl) ligands are free to rotate 
about the Cpyr –Cpyr (pyr = pyridine) bond (Figure 4), allowing the ligands to assume 
various conformations and coordination modes.  It is this flexibility that allows the 
[tpyAr2] ligands to support a variety of main group and transition metal complexes.  
The structural flexibility of the terpyridine class of ligands is clearly illustrated in the 
molecular structures of the free [tpyAr2] (Ar = p-tolyl, mesityl) ligands (Figures 2-3).  
The terminal N(1) and N(3)-pyridine moieties rotate out of the plane of the central 
pyridine ring, featuring N-C-C-N torsions angles ranging between 168.21-175.67 ˚ 
(Tables 1-2).  Likewise, the aryl substituent groups of the [tpyAr2] (Ar = p-tolyl, mesityl) 
ligands are free to rotate about the Ctpy-CAr bond (Figure 5).  For example, the p-tolyl 
groups of the free [tpyp-Tol2] ligand twist slightly out of the plane of the terpyridine 
moiety, with N-C-Cipso-Cortho torsion angles of only 20.82˚ (Table 1).  The mesityl groups 
of the free [tpyMes2] ligand exhibit an even greater degree of rotation about the Ctpy-CAr 










Figure 5.  N-C-Cipso-Cortho torsion angles in the [tpyp-Tol2] and [tpyMes2] ligands. 
 
 
6.2.2 Synthesis and structural analysis of [tpyp-Tol2]CoX2 
Two [tpyp-Tol2]CoX2 (X = Cl, I) complexes were prepared by treating a solution of 
[tpyAr2] in CH2Cl2 with CoX2 (Scheme 2).  The reaction mixtures were filtered and 
crystals were grown via slow evaporation of CH2Cl2.  The [tpyAr2]MX2 complexes were 
characterized by X-ray diffraction, and their molecular structures are presented in 








Figure 6.  Molecular structure of [tpyp-Tol2]CoCl2. 
 
Table 3.  Select bond lengths, bond angles, and torsion angles for [tpyp-Tol2]CoCl2. 
Bond Lengths (Å) Bond Angles (˚) Torsion Angles (º) 
Co-Cl(1) 2.2979(7) Cl(1)-Co-Cl(2) 153.50(3) N(2)-C(25)-C(11)-N(1) 11.70 
Co-Cl(2) 2.3359(6) Cl(1)-Co-N(1) 90.36(5) N(2)-C(21)-C(35)-N(3) 3.79 
Co-N(1) 2.1808(19) Cl(1)-Co-N(2) 110.64(6) N(1)-C(15)-C(51)-C(52) 59.88 
Co-N(2) 2.0139(19) Cl(1)-Co-N(3) 96.25(5) N(3)-C(31)-C(41)-C(42) 35.53 
Co-N(3) 2.1908(19) Cl(2)-Co-N(1) 92.92(5)   
  Cl(2)-Co-N(2) 95.73(6)   
  Cl(2)-Co-N(3) 91.58(5)   
  N(1)-Co-N(2) 77.50(7)   
  N(1)-Co-N(3) 155.48(7)   




Figure 7.  Molecular structure of [tpyp-Tol2]CoI2. 
 
Table 4.  Select bond lengths, bond angles, and torsion angles for [tpyp-Tol2]CoI2. 
Bond Lengths (Å) Bond Angles (˚) Torsion Angles (º) 
Co-I(1) 2.6483(7) I(1)-Co-I(2) 159.90(3) N(2)-C(21)-C(15)-N(1) 7.68 
Co-I(2) 2.7629(8) I(1)-Co-N(1) 91.76(10) N(2)-C(25)-C(35)-N(3) 6.75 
Co-N(1) 2.154(4) I(1)-Co-N(2) 109.39(11) N(1)-C(11)-C(41)-C(42) 53.03 
Co-N(2) 2.009(4) I(1)-Co-N(3) 91.56(10) N(3)-C(31)-C(51)-C(52) 43.41 
Co-N(3) 2.164(4) I(2)-Co-N(1) 92.31(10)   
  I(2)-Co-N(2) 90.71(10)   
  I(2)-Co-N(3) 92.53(10)   
  N(1)-Co-N(2) 78.43(15)   
  N(1)-Co-N(3) 156.42(15)   
  N(2)-Co-N(3) 78.45(16)   
 
 275 
The molecular structure of [tpyp-Tol2]CoCl2 reveals that the two Co-Cl bond 
lengths are approximately equal.  Likewise, the two Co-I bonds in [tpyp-Tol2]CoI2 have 
similar lengths.  In addition, the three Co-N bonds in both the [tpyp-Tol2]CoCl2 and [tpyp-
Tol2]CoI2 complexes have similar lengths ("(Co-N) < 0.18 Å).  This result is consistent 
with [tpyp-Tol2] behaving as an L3-type ligand in [tpyp-Tol2]CoX2,9 coordinating to the 
cobalt metal in a !3-N3 fashion.  To describe the molecular geometries of the [tpyp-
Tol2]CoX2 complexes a geometric parameter, #5 = ($ - %)/60 (where % and $ are the two 
largest central angles in the molecule), is provided.10  For complexes exhibiting an ideal 
square-pyramidal geometry, #5 = 0, while complexes featuring a perfect trigonal 
bipyramidal geometry have a value of #5 = 1.  Based on their respective #5 values (Table 
5), the molecular geometries of the [tpyp-Tol2]CoX2 complexes can best be described as 
square-pyramidal with the N(2) atom located in the axial position.  
In both compounds, the N(1) and N(3)-pyridine rings twist slightly out of the 
plane of the central N(2)-pyridine moiety, with the N(2)-C-C-N(n) (n = 1, 3) torsion 
angles ranging between 3.79-11.70˚.  As is evident from their molecular structures 
(Figures 2, 3, 6, and 7) and the increase in N-C-Cipso-Cortho torsion angles (Tables 1-4), 
coordination of the [tpyp-Tol2] ligand to CoX2 (X = Cl, I) results in the p-tolyl groups 
rotating to a greater degree about the Ctpy-CAr bond.  For example, the free [tpyp-Tol2] 
ligand features N-C-Cipso-Cortho torsion angles of 20.82˚, while the [tpyp-Tol2]CoCl2 features 
torsion angles of 35.53˚ and 59.88˚ and the [tpyp-Tol2]CoI2 complex features even larger 












6.2.3 Synthesis and structural analysis of [tpyAr2]ZnI2 and {[tpyp-Tol2]2Zn}{ZnI4} 
Two [tpyAr2]ZnI2 (Ar = p-tolyl, mesityl) complexes were synthesized by a method 
analogous to the [tpyp-Tol2]CoX2 complexes.  [tpyp-Tol2]ZnI2 was prepared by treating a 
solution of [tpyp-Tol2] in CH2Cl2 with ZnI2, resulting in the formation of a white 
suspension.  After stirring the suspension for 24 hours, the suspension was filtered and 
crystals were grown via vapor diffusion of hexane into CH2Cl2.  The molecular 
structure of [tpyp-Tol2] ZnI2 is presented in Figure 8, and select bond lengths, bond angles, 






Figure 8.  Molecular structure of [tpyp-Tol2]ZnI2. 
 
 
Table 6.  Select bond lengths, bond angles, and torsion angles for [tpyp-Tol2]ZnI2. 
Bond Lengths (Å) Bond Angles (˚) Torsion Angles (º) 
Zn-I(1) 2.5482(11) I(1)-Zn-I(2) 113.63(4) N(2)-C(21)-C(15)-N(1) 13.56 
Zn-I(2) 2.5549(11) I(1)-Zn-N(1) 124.61(17) N(2)-C(25)-C(35)-N(3) 138.74 
Zn-N(1) 2.092(6) I(1)-Zn-N(2) 106.93(17) N(1)-C(11)-C(51)-C(52) 39.28 
Zn-N(2) 2.088(7) I(2)-Zn-N(1) 106.10(7) N(3)-C(31)-C(41)-C(42) 26.85 
  I(2)-Zn-N(2) 121.36(17)   







The [tpyp-Tol2] ligand in the [tpyp-Tol2]ZnI2 exhibits a very different conformation to 
that featured in the [tpyp-Tol2]CoX2 (X = Cl, I) complexes.  The molecular structure of 
[tpyp-Tol2]ZnI2 reveals the Zn-N(1) and Zn-N(2) bond lengths to be quite similar; 
however, the Zn•••N(3) is significantly longer (4.544 Å), suggesting that there is no Zn-
N(3) bonding interaction.  Additionally, the N(2)-C(25)-C(35)-N(3) torsion angle is 
138.74 Å, indicating that the N(3)-pyridine ring is twisted out of the plane of the N(1) 
and N(2) pyridine rings.  No Zn•••N(3) bonding interaction is possible because the 
N(3) lone pair of electrons is not directed toward the Zn center.  Based on these results, 
it is very interesting to note that Zn complexes featuring [tpyAr2] ligands typically 
exhibit !3-N3 coordination.  In fact, no examples of [tpyAr2]Zn complexes listed in the 
Cambridge Structural Database feature !2-N2 coordination.5 
Another interesting result was obtained when a solution of [tpyp-Tol2] in CD3CN 
was treated with ZnI2 and heated at 80˚ C for four days.  The reaction was monitored 
by 1H NMR spectroscopy and the spectrum obtained indicated that a new species had 
formed.  Crystals grown from the reaction mixture where characterized by using X-ray 
diffraction, and the molecular structure revealed the complex to be {[tpyp-Tol2]2Zn}{ZnI4} 
(Figure 9).  Although bis-terpyridine metal complexes, [tpyR2]2M, are well known in the 
literature,11,12 a {[tpyp-Tol2]2Zn}2+ complex has not yet been reported.  The two [tpyp-Tol2] 
ligands provide a very sterically hindered environment around the zinc center, which 
forces the [tpyp-Tol2] ligands to distort.  The N(13)- and N(23)-pyridine rings in the two 
coordinating [tpyp-Tol2] ligands are forced to twist out of the plane of the N(1)- and N(2)-
pyridine rings, as illustrated by their larger N(n2)-C-C-N(n3) torsion angles (Table 7).  
The DFT geometry optimized structure of the {[tpyp-Tol2]2 Zn} cation is consistent with 
our experimentally obtained structure, with the Zn-N(n3) bond approximately 0.3 Å 
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longer than the Zn-N(n1) bond (Table 8).  Although both the experimental [2.462(4) Å 
and 2.439(4) Å] and theoretical [2.583 Å and 2.574 Å] Zn•••N(3) distances are 
significantly larger than the sum of the covalent radii of zinc and nitrogen (1.93 Å),13 
the orientation of the N(n3)-pyridine ring is such that the lone pair of electrons is still 
directed toward the zinc center.  Therefore, it is likely that at least a weak secondary 
Zn-N(n3) bonding interaction is present in the molecule.  We depict this secondary 














Figure 9.  Molecular structure of {[tpyp-Tol2]2Zn}2+.  There is also a ZnI42- anion, which is 
not displayed.  
 
Table 7.  Select bond lengths, bond angles, and torsion angles for the {[tpyMes2]2Zn}2+ 
cation. 
Bond Lengths (Å) Bond Angles (˚) Torsion Angles (º) 
Zn-N(11) 2.181(4) N(11)-Zn-N(12) 78.04(16) N(12)-C(125)-C(131)-N(13) 20.30 
Zn-N(12) 2.040(4) N(12)-Zn-N(13) 73.06(15) N(12)-C(121)-C(115)-N(11) 11.61 
Zn-N(13) 2.462(4) N(21)-Zn-N(22) 77.86(16) N(22)-C(225)-C(215)-N(21) 6.19 
Zn-N(21) 2.211(4) N(22)-Zn-N(23) 73.77(15) N(22)-C(221)-C(235)-N(23) 26.21 
Zn-N(22) 2.022(4)     




Table 8.  Experimental and theoretical Zn-N bond lengths in the {[tpyMes2]2Zn}2+ cation. 
 Experimental Theoretical 
 n = 1 n = 2 n = 1 n = 2 
Zn-N(n1) 2.181(4) 2.211(4) 2.258 2.268 
Zn-N(n2) 2.040(4) 2.022(4) 2.061 2.060 
Zn-N(n3) 2.462(4) 2.439(4) 2.583 2.574 
 
 
 [tpyMes2]ZnI2 was prepared by treating a solution of [tpyMes2] in CHCl3 with ZnI2, 
resulting in the formation of a white suspension.  After stirring the suspension for 24 
hours, the reaction mixture was filtered and crystals were grown from the CHCl3 
filtrate.  The molecular structure of [tpyMes2]ZnI2 was obtained (Figure 10) and select 
bond lengths, bond angles, and torsion angles are presented in Table 9.  It should be 
noted, however, that the crystal quality was not optimal, and a better crystal structure 










Figure 10.  Molecular structure of [tpyMes2]ZnI2.  
 
Table 9.  Select bond lengths, bond angles, and torsion angles for [tpyMes2]ZnI2. 
Bond Lengths (Å) Bond Angles (˚) Torsion Angles (º) 
Zn-I(1) 2.526(2) I(1)-Zn-I(2) 129.21(8) N(1)-C(15)-C(21)-N(2) 11.39 
Zn-I(2) 2.55192) I(1)-Zn-N(1) 94.1(3) N(2)-C(25)-C(35)-N(3) 21.60 
Zn-N(1) 2.391(11) I(1)-Zn-N(2) 114.0(3) N(1)-C(11)-C(41)-C(42) 75.58 
Zn-N(2) 2.073(11) I(2)-Zn-N(1) 107.9(3) N(3)-C(31)-C(51)-C(52) 118.88 
Zn•••N(3) 2.578 I(2)-Zn-N(2) 115.3(3)   




The molecular structure of the [tpyMes2]ZnI2 complex exhibits Zn-N(1) and Zn-
N(2) bonds of 2.391(11) Å and 2.073(11) Å, respectively, while the Zn•••N(3) interaction 
is significantly elongated (2.578 Å).  Unlike in [tpyp-Tol2]ZnI2, however, the N(3)-
pyridine ring in [tpyMes2]ZnI2 is not significantly rotated.  The N(2)-C(25)-C(35)-N(3) 
torsion angle for the [tpyMes2]ZnI2 complex is only 21.60˚, which means that the lone pair 
of electrons on the N(3) atom are oriented toward the Zn center.  Although the Zn-N(3) 
distance is significantly larger than the sum of the covalent radii of zinc and nitrogen 
(1.93 Å),13 it is possible that there is a weak secondary Zn•••N(3) interaction present in 
the molecule. 
 As the [tpyAr2]ZnI2 (Ar = p-tolyl, mesityl) complexes are four-coordinate 
structures, their molecular geometries can be described by using the geometric 
parameter #4 = (360˚ -(% + $))/141˚, where % and $ are the two largest central angles in 
the molecule.14  Complexes exhibiting a perfect square planar geometry have a value of 
#4 = 0, while complexes featuring an ideal tetrahedral geometry have a value of #4 = 1.00.  
Complexes that feature a seesaw (#4 = 0.07-0.64) or trigonal monopyramidal geometry 
(#4 = 0.85) have intermediate geometrical parameters (0 ≤ #4 ≤ 1.00).14  Based on their 
respective #4 values, the [tpyAr2]ZnI2 (Ar = p-tolyl, mesityl) complexes are best described 
as exhibiting distorted trigonal monopyramidal geometries (Table 10). 
 






6.2.4 Synthesis and structural analysis of 2,6-di(pyrazolyl)pyridine metal complexes 
The 2,6-bis(pyrazolyl)pyridine ligand, [bppBut], was synthesized according to the 
literature procedure (Scheme 3).15  A series of [bppBut]MX2 (M = Fe, Co, Zn, Cd; X = Cl, 
I) complexes were prepared by treating a solution of [bppBut] in CH2Cl2 with MX2 
(Scheme 4), resulting in the generation of a thick suspension.  Each of the suspensions 
were stirred at 25˚ C for 24 hours, filtered, and crystals were grown via vapor diffusion 








Scheme 4.  Preparation of the [bppBut]MX2 complexes. 
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The [bppBut]MX2 (M = Fe, Co, Zn, Cd; X = Cl, I) complexes were characterized by 
X-ray diffraction, and their molecular structures are presented in Figures 12-16.  Select 
bond lengths and bond angles are presented in Tables 11-15.  Like the [tpyAr2] ligands, 
the pyrazole rings of the [bppAr] ligands are free to rotate about the Npz-Cpyr bond (pz = 
pyrazole; pyr = pyridine) (Figure 11).  For example, in the molecular structure of the 
[bppBut] ligand the two pyrazole rings rotate out of the plane of the central pyridine 
ring, featuring N-C-N-N torsions angles of 176.56˚.2c  In [bppBut] metal complexes, the 
pyrazole and pyridine rings are typically oriented in the same direction (average N-C-
N-N torsion angle = 0.26˚),5 as all three nitrogen atoms typically interact with the metal 
center.  Nevertheless, there are a few examples of [bppBut] metal complexes listed in the 
CSD that feature a twisted structure.5  [Re(CO)3(bpzpy)Cl], for example, contains a 
[bpzpy] ligand that coordinates to the Re center through the nitrogen atom of the 
pyridine ring and the nitrogen atom of one pyrazole group.16  The other pyrazole 
group is twisted out of the plane of the pyridine ring, and features a N-C-N-N torsion 
angle of 121.06˚.  As a comparison, the N-C-N-N torsion angles for the [bppBut]MX2 
complexes reported herein, are also provided in Tables 11-15 
 
 




Figure 12.  Molecular structure of [bppBut]FeCl2. 
 
Table 11.  Select bond lengths, bond angles, and torsion angles for [bppBut]FeCl2. 
Bond Lengths (Å) Bond Angles (˚) Torsion Angles (º) 
Fe-Cl(1) 2.3056(5) Cl(1)-Fe-Cl(1A) 146.37(3) N(21)-C(21)-N(12)-N(11) 5.24 
Fe-N(11) 2.2847(14) Cl(1)-Fe-N(11) 91.13(3)   
Fe-N(21) 2.0882(19) Cl(1)-Fe-N(11A) 97.61(4)   
  Cl(1)-Fe-N(21) 106.817(14)   
  N(11)-Fe-N(21) 74.75(4)   





Figure 13.  Molecular structure of [bppBut]FeI2.  
 
Table 12.  Select bond lengths, bond angles, and torsion angles for [bppBut]FeI2. 
Bond Lengths (Å) Bond Angles (˚) Torsion Angles (º) 
Fe-I(1) 2.6175(9) I(1)-Fe-I(2) 146.72(3) N(3)-C(31)-N(11)-N(12) 7.84 
Fe-I(2) 2.6422(9) I(1)-Fe-N(11) 92.81(11) N(3)-C(35)-N(21)-N(22) 1.61 
Fe-N(11) 2.254(4) I(1)-Fe-N(21) 93.06(11)   
Fe-N(21) 2.267(4) I(1)-Fe-N(31) 110.51(12)   
Fe-N(31) 2.082(4) I(2)-Fe-N(11) 92.90(11)   
  I(2)-Fe-N(21) 98.14(11)   
  I(2)-Fe-N(31) 102.65(12)   
  N(11)-Fe-N(21) 149.95(15)   
  N(11)-Fe-N(31) 75.05(16)   




Figure 14.  Molecular structure of [bppBut]CoI2. 
 
Table 13.  Select bond lengths, bond angles, and torsion angles for [bppBut]CoI2. 
Bond Lengths (Å) Bond Angles (˚) Torsion Angles (º) 
Co-I(1) 2.6141(6) I(1)-Co-I(2) 146.768(18) N(31)-C(31)-N(12)-N(11) 3.20 
Co-I(2) 2.6312(5) I(1)-Co-N(11) 92.83(7) N(31)-C(35)-N(22)-N(21) 7.51 
Co-N(11) 2.233(2) I(1)-Co-N(21) 93.08(7)   
Co-N(21) 2.233(3) I(1)-Co-N(31) 110.69(7)   
Co-N(31) 2.024(2) I(2)-Co-N(11) 91.91(7)   
  I(2)-Co-N(21) 97.69(7)   
  I(2)-Co-N(31) 102.39(7)   
  N(11)-Co-N(21) 152.47(9)   
  N(11)-Co-N(31) 76.28(9)   




Figure 15.  Molecular structure of [bppBut]ZnI2. 
 
Table 14.  Select bond lengths, bond angles, and torsion angles for [bppBut]ZnI2. 
 
 
Bond Angles (˚) Torsion Angles (º) 
Zn-I(1) 2.5606(8) I(1)-Zn-I(2) 142.18(3) N(31)-C(31)-N(12)-N(11) 9.73 
Zn-I(2) 2.5738(8) I(1)-Zn-N(11) 93.46(12) N(31)-C(35)-N(22)-N(21) 5.86 
Zn-N(11) 2.327(5) I(1)-Zn-N(21) 94.25(12)   
Zn-N(21) 2.328(5) I(1)-Zn-N(31) 105.80(13)   
Zn-N(31) 2.079(4) I(2)-Zn-N(11) 98.76(12)   
  I(2)-Zn-N(21) 93.48(12)   
  I(2)-Zn-N(31) 105.80(13)   
  N(11)-Zn-N(21) 148.75(17)   
  N(11)-Zn-N(31) 74.45(17)   




Figure 16.  Molecular structure of [bppBut]CdI2. There are three molecules of 
[bppBut]CdI2 in the asymmetric unit.  Only one of the molecules is presented here.  
 
Table 15.  Select bond lengths, bond angles, and torsion angles for [bppBut]CdI2.a 
Bond Lengths (Å) Bond Angles (˚) Torsion Angles (º) 
Cd(1)-I(11) 2.7086(7) I(11)-Cd(1)-I(12) 131.35(2) N(131)-C(135)-N(112)-N(111) 10.92 
Cd(1)-I(12) 2.7378(7) I(11)-Cd(1)-N(111) 96.45(12) N(131)-C(131)-N(122)-N(121) 3.21 
Cd(1)-N(111) 2.513(5) I(11)-Cd(1)-N(121) 101.48(12)   
Cd(1)-N(121) 2.525(5) I(11)-Cd(1)-N(131) 118.11(11)   
Cd(1)-N(131) 2.344(4) I(12)-Cd(1)-N(111) 98.71(12)   
  I(12)-Cd(1)-N(121) 98.22(12)   
  I(12)-Cd(1)-N(131) 110.47(11)   
  N(111)-Cd(1)-N(121) 136.79(16)   
  N(111)-Cd(1)-N(131) 68.59(16)   
  N(121)-Cd(1)-N(131) 68.26(16)   




Table 15 (cont.).  Select bond lengths, bond angles, and torsion angles for [bppBut]CdI2. 
Bond Lengths (Å) Bond Angles (˚) Torsion Angles (º) 
Cd(2)-I(21) 2.7155(7) I(21)-Cd(2)-I(22) 133.58(3) N(231)-C(231)-N(212)-N(211) 5.06 
Cd(2)-I(22) 2.7191(7) I(21)-Cd(2)-N(211) 97.91(12) N(231)-C(235)-N(222)-N(221) 14.79 
Cd(2)-N(211) 2.517(5) I(21)-Cd(2)-N(221) 97.46(11)   
Cd(2)-N(221) 2.518(5) I(21)-Cd(2)-N(231) 109.21(11)   
Cd(2)-N(231) 2.327(5) I(22)-Cd(2)-N(211) 99.26(13)   
  I(22)-Cd(2)-N(221) 98.29(12)   
  I(22)-Cd(2)-N(231) 117.21(11)   
  N(211)-Cd(2)-N(221) 137.38(16)   
  N(211)-Cd(2)-N(231) 68.65(17)   
  N(221)-Cd(2)-N(231) 68.77(16)   
 
 
Table 15 (cont.).  Select bond lengths, bond angles, and torsion angles for [bppBut]CdI2. 
Bond Lengths (Å) Bond Angles (˚) Torsion Angles (º) 
Cd(3)-I(31) 2.7147(6) I(31)-Cd(3)-I(32) 130.82(2) N(331)-C(331)-N(312)-N(311) 16.67 
Cd(3)-I(32) 2.7311(6) I(31)-Cd(3)-N(311) 98.85(11) N(331)-C(335)-N(322)-N(321) 18.39 
Cd(3)-N(311) 2.510(5) I(31)-Cd(3)-N(321) 102.40(13)   
Cd(3)-N(321) 2.510(5) I(31)-Cd(3)-N(331) 123.81(11)   
Cd(3)-N(331) 2.336(5) I(32)-Cd(3)-N(311) 101.07(11)   
  I(32)-Cd(3)-N(321) 93.51(12)   
  I(32)-Cd(3)-N(331) 105.34(11)   
  N(311)-Cd(3)-N(321) 135.91(17)   
  N(311)-Cd(3)-N(331) 68.09(16)   
  N(321)-Cd(3)-N(331) 67.95(18)   
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The [bppBut]MX2 (M = Fe, Co, Zn, Cd; X = Cl, I) complexes are all isostructural.  
Each of the [bppBut]MX2 complexes exhibit two M-Npz bonds of approximately equal 
lengths, while the M-Npyr bond is slightly shorter.  The [bppBu
t] ligand can be described 
as an L3-type ligand in the [bppBu
t]MX2 (M = Fe, Co, Zn, Cd; X = Cl, I) complexes,9 
coordinating in a !3-N3 fashion to the metal center.  Even the [bppBu
t]ZnI2 complex 
exhibits !3-N3 coordination, which is quite different from the structures of the 
[tpyAr2]ZnI2 (Ar = p-Tolyl, mesityl) complexes presented above.  
The pyrazole rings of the [bppBut] ligand rotate slightly out of the plane of the 
pyridine moiety in the [bppBut]MX2 complexes.  In each case, one pyrazole group 
rotates slightly more than the other, and the difference between their N-N-C-N torsion 
angles is presented in Table 16.  Interestingly, the molecular structure of [bppBut]FeCl2 
reveals the two pyrazole moieties to be related by crystallographic symmetry (Figure 
12), such that the differences in their N-N-C-N torsion angles is 0˚ C.  As the 
[bppBut]MX2 complexes are all five-coordinate species, their molecular geometries can be 
described using the #5 geometrical parameter, and all of the complexes exhibit a square 































(a) This is the average #5 parameter for the three 





Inspired by Chirik’s work on the synthesis of bis(imino)pyridine metal alkyl 
complexes,17 we attempted to pursue the synthesis of an alkyl [bppBut]MR2 (R = Me, Et) 
complex.  Initially, we tried to synthesize a [bppBut]ZnR2 (R = Me, Et) complex by 
treating [bppBut] with R2Zn; however no [bppBu
t]MR2 complex was isolated.  As Chirik 
has successfully used MeLi to methylate bis(imino)pyridine iron halide complexes, we 
attempted to use this synthetic approach with our [bppBut]MX2 complexes.17  Although 
this new method proved unsuccessful, a very interesting result was obtained when a 
solution of [bppBut]FeCl2 in C6H6 was treated with MeLi.  The reaction mixture was 
stirred at 25˚ C for 12 hours, generating a thick suspension.  The suspension was 
filtered and crystals were grown via slow evaporation of the C6H6 filtrate.  The crystals 
were characterized by using X-ray diffraction, thereby revealing the complex to be 
[bppBut]LiI (Figure 17).  Select bond lengths, bond angles, and torsion angles are 
presented in Table 18, and the molecular geometry of the four coordinate [bppBut]LiI 
complex is best described as a distorted seesaw (#4 = 0.67).14  It is particularly 
significant that we obtained a molecular structure of [bppBut]LiI as it is the first example 





Figure 17.  Molecular structure of [bppBut]LiI. 
 
Table 18.  Select bond lengths, bond angles, and torsion angles for [bppBut]LiI. 
Bond Lengths (Å) Bond Angles (˚) Torsion Angles (º) 
Li-I 2.719(5) I-Li-N(11) 109.5(2) N(31)-C(13)-N(12)-N(11) 5.81 
Co-N(11) 2.164(5) I-Li-N(21) 103.33(19) N(31)-C(35)-N(22)-N(21) 12.01 
Co-N(21) 2.203(5) I-Li-N(31) 121.0(2)   
Co-N(31) 2.034(5) N(11)-Li-N(21) 144.1(2)   
  N(11)-Li-N(31) 76.23(18)   




6.3 Summary and Conclusion 
A series of [tpyAr2]MX2 (Ar = p-tolyl, mesityl; M = Co, Zn; X = Cl, I) complexes 
were synthesized and characterized by X-ray diffraction.  In addition, the molecular 
structure of {[tpyp-Tol2]2Zn}{ZnI4} was obtained.  The [tpyp-Tol2] ligand was found to 
behave as an L2-type ligand in the [tpyAr2]ZnI2 complex, coordinating to the zinc atom in 
a !2-N2 manner.  The [tpyp-Tol2] ligands in {[tpyp-Tol2]2 Zn}{ZnI4} exhibit elongated Zn-
N(n3) bonds, suggesting that there is only a weak secondary Zn-N(n3) interaction 
present in the molecule.  Likewise, the [tpyMes2]ZnI2 molecule contains an elongated Zn-
N(3) bond, however the orientation of the N(3)-pyridine moiety suggests that a 
secondary Zn-N(3) bonding interaction is possible. 
The [bppBut] ligand was employed to synthesize a series of [bppBut]MX2 (M = Fe, 
Co, Zn, Cd; X = Cl, I) complexes.  The molecular structures of each of these complexes 
were obtained, and in each case, the [bppBut] ligand coordinates to the metal center in a 
!3-N3 fashion.  The molecular structure of the [bppBu
t]LiI complex was obtained, which 








6.4 Experimental Section 
6.4.1 General Considerations 
All manipulations were performed using a combination of glovebox, high-vacuum and 
Schlenck techniques under a nitrogen atmosphere,19 except where otherwise stated.  
Solvents were purified and degassed by standard procedures.  NMR solvents were 
purchased from Cambridge Isotope Labs and stored over 3Å molecular sieves.  NMR 
spectra were measured on Bruker 300 DRX, Bruker 300 DPX, Bruker 400 Avance III, 
Bruker 400 Cyber-enabled Avance III, and Bruker 500 DMX spectrometers.  1H-NMR 
chemical shifts are reported in ppm relative to SiMe4 (& = 0) and were referenced 
internally with respect to the protio solvent impurity (& = 7.16 for C6D6).20  Coupling 
constants are given in hertz.  The [tpyp-Tol2],8 [tpyMes2],8 and [bppBut]15 ligands were 
prepared according to the literature procedures.  LiI (Aldrich), FeI2 (Aldrich), CoCl2 
(Aldrich), CoI2 (Aldrich), ZnI2 (Aldrich), and CdI2 (Aldrich) were commercially obtained 
and used without further purification. 
 
6.4.2 X-ray Structure Determinations 
X-ray diffraction data were collected on a Bruker Apex II diffractometer.  Crystal data, 
data collection and refinement parameters are summarized in Table 19.  The structures 
were solved using direct methods and standard difference map techniques, and were 




6.4.3 Computational Details 
Calculations were carried out using DFT as implemented in the Jaguar 7.7 (release 107) 
suite of ab initio quantum chemistry programs. 22   Geometry optimizations and 
frequency calculations were performed with the B3LYP density functional23 using the 
6-31G** (H, C, N, I) and LACVP (Zn) basis set.24   
 
6.4.4 Molecular structure of [tpyp-Tol2]  
A solution of [tpyp-Tol2] (8 mg, 0.02 mmol) in CH2Cl2 was treated with Zn(OAc)2, resulting 
in a thick white suspension.  The suspension was stirred at 25˚ C for 24 hours, then 
filtered.  Crystals suitable for X-ray diffraction were obtained for the free [tpyp-Tol2] 
ligand via evaporation of the CH2Cl2 solution. 
 
6.4.5 Molecular structure of [tpyMes2]  
[tpyMes2] (9.7 mg, 0.02 mmol) was added to an NMR tube equipped with a J. Young 
valve, and 21.2 µL of a 0.976 M solution of Et2Zn in C6D6 (0.02 mmol) was added to the 
tube.  The volatile components were removed by lyophilization, and the resulting 
white powder was redissolved in C6D6.  Crystals suitable for X-ray diffraction were 
obtained for the free [tpyMes2] ligand via evaporation of the C6D6 solution. 
 
6.4.6 Synthesis of [tpyp-Tol2]CoCl2  
A solution of [tpyp-Tol2] (10 mg, 0.024 mmol) in CH2Cl2 (ca. 2 mL) was treated with CoCl2 
(5 mg, 0.04 mmol), resulting in a thick bright blue suspension.  The suspension was 
stirred at 25˚ C for 24 hours, then filtered through a filter pipette.  Green crystals of 
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[tpyp-Tol2]CoCl2 (ca. 2 mg, 15 %) suitable for X-ray diffraction were obtained via vapor 
diffusion of hexane into the CH2Cl2 solution. 
 
6.4.7 Synthesis of [tpyp-Tol2]CoI2  
A solution of [tpyp-Tol2] (8 mg, 0.02 mmol) in CH2Cl2 (ca. 2 mL) was treated with CoI2 (9 
mg, 0.03 mmol), resulting in a thick brown suspension.  The suspension was stirred at 
25˚ C for 24 hours, then filtered through a filter pipette.  Purple crystals of [tpyp-Tol2]CoI2 
(ca. 1 mg, 7 %) suitable for X-ray diffraction were obtained via vapor diffusion of hexane 
into the CH2Cl2 solution. 
 
6.4.8 Synthesis of [tpyp-Tol2]ZnI2  
A solution of [tpyp-Tol2] (12 mg, 0.03 mmol) in CH2Cl2 (ca. 2 mL) was treated with ZnI2 (12 
mg, 0.04 mmol), resulting in a thick white suspension.  The suspension was stirred at 
25˚ C for 24 hours, then filtered through a filter pipette.  Crystals of [tpyp-Tol2]ZnI2 (ca. 2 
mg, 9%) suitable for X-ray diffraction were obtained via vapor diffusion of hexane into 
the CH2Cl2 solution. 
 
6.4.9 Synthesis of {[tpyp-Tol2]2 Zn}{ZnI4}  
A solution of [tpyp-Tol2] (10 mg, 0.02 mmol) in CD3CN (ca. 1 mL) was treated with ZnI2 (9 
mg, 0.03 mmol) was prepared in an NMR tube equipped with a J. Young valve.  The 
reaction mixture was heated at 80˚ C for 4 days, resulting in the formation of colorless 




6.4.10 Synthesis of [tpyMes2]ZnI2  
A solution of [tpyMes2] (15 mg, 0.03 mmol) in CH2Cl2 (ca. 2 mL) was treated with ZnI2 (25 
mg, 0.08 mmol), resulting in a thick white suspension.  The suspension was stirred at 
25˚ C for 24 hours, then filtered through a filter pipette.  Crystals of [tpyMes2]ZnI2 (ca. 4 
mg, 16 %) suitable for X-ray diffraction were obtained via vapor diffusion of hexane into 
the CH2Cl2 solution. 
 
6.4.11 Synthesis of [bppBut]FeCl2  
A solution of [bppBut] (14 mg, 0.05 mmol) in CH2Cl2 (ca. 2 mL) was treated with FeCl2 (7 
mg, 0.06 mmol), resulting in a thick tan colored suspension.  The suspension was 
stirred at 25˚ C for 24 hours, then filtered through a filter pipette.  Large tan colored 
crystals of [bppBut]FeCl2 (ca. 3 mg, 14 %) suitable for X-ray diffraction were obtained via 
vapor diffusion of hexane into the CH2Cl2 solution.  1H NMR (C6D6): 1.44 [s, 18H of 
{(C3N2H2)C(CH3)3}2C5NH3], 6.19 [d, 3JH-H = 3, 2H of {(C3N2H2)C(CH3)3}2C5NH3], 7.12 [t, 3JH-
H = 8, 1H of {(C3N2H2)C(CH3)3}2C5NH3], 7.75 [d, 3JH-H = 8, 2H of 
{(C3N2H2)C(CH3)3}2C5NH3], 8.32 [d, 3JH-H = 3, 2H of {(C3N2H2)C(CH3)3}2C5NH3]. 
 
6.4.12 Synthesis of [bppBut]FeI2  
A solution of [bppBut] (16 mg, 0.05 mmol) in CH2Cl2 (ca. 2 mL) was treated with FeI2 (9 
mg, 0.07 mmol), resulting in a dark purple colored suspension.  The suspension was 
stirred at 25˚ C for 24 hours, then filtered through a filter pipette.  Yellow colored 
crystals of [bppBut]FeI2 (ca. 4 mg, 13 %) suitable for X-ray diffraction were obtained via 
vapor diffusion of hexane into the CH2Cl2 solution.  1H NMR (C6D6): 1.45 [s, 18H of 
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{(C3N2H2)C(CH3)3}2C5NH3], 6.21 [d, 3JH-H = 3, 2H of {(C3N2H2)C(CH3)3}2C5NH3], 7.12 [t, 3JH-
H = 8, 1H of {(C3N2H2)C(CH3)3}2C5NH3], 7.75 [d, 3JH-H = 8, 2H of 
{(C3N2H2)C(CH3)3}2C5NH3], 8.32 [d, 3JH-H = 3, 2H of {(C3N2H2)C(CH3)3}2C5NH3]. 
 
6.4.13 Synthesis of [bppBut]CoI2  
A solution of [bppBut] (18 mg, 0.06 mmol) in CH2Cl2 (ca. 2 mL) was treated with CoI2 (19 
mg, 0.06 mmol), resulting in a green suspension.  The suspension was stirred at 25˚ C 
for 48 hours, then filtered through a filter pipette.  Green crystals of [bppBut]ZnI2 (ca. 4 
mg, 11 %) suitable for X-ray diffraction were obtained via vapor diffusion of hexane into 
the CH2Cl2 solution. 
 
6.4.14 Synthesis of [bppBut]ZnI2  
A solution of [bppBut] (15 mg, 0.05 mmol) in CH2Cl2 (ca. 2 mL) was treated with ZnI2 (19 
mg, 0.06 mmol), resulting in a thick white suspension.  The suspension was stirred at 
25˚ C for 48 hours, then filtered through a filter pipette.  Crystals of [bppBut]ZnI2 (ca. 2 
mg, 7 %) suitable for X-ray diffraction were obtained via vapor diffusion of hexane into 
the CH2Cl2 solution. 
 
6.4.15 Synthesis of [bppBut]CdI2  
A solution of [bppBut] (15 mg, 0.05 mmol) in CH2Cl2 (ca. 2 mL) was treated with CdI2 (22 
mg, 0.06 mmol), resulting in a thick tan colored suspension.  The suspension was 
stirred at 25˚ C for 48 hours, then filtered through a filter pipette.  Large tan colored 
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crystals of [bppBut]CdI2 (ca. 3 mg, 9 %) suitable for X-ray diffraction were obtained via 
vapor diffusion of hexane into the CH2Cl2 solution. 
 
6.4.16 Synthesis of [bppBut]LiI  
A solution of [bppBut] (20 mg, 0.06 mmol) in C6H6 (ca. 2 mL) was treated with FeCl2 (10 
mg, 0.08 mmol), resulting in a pale yellow colored suspension.  The suspension was 
stirred at 25˚ C for 48 hours.  To the suspension was added MeLi (8 mg, mmol) and the 
reaction mixture was stirred at 25˚ C for 12 hours.  The suspension was filtered using a 
filter pipette.  Crystals of [bppBut]LiI suitable for X-ray diffraction were obtained via 
vapor diffusion of hexane into the C6H6 solution.  1H NMR (C6D6): 1.45 [s, 18H of 
{(C3N2H2)C(CH3)3}2C5NH3], 6.2 [d, 3JH-H = 3, 2H of {(C3N2H2)C(CH3)3}2C5NH3], 7.12 [t, 3JH-H 
= 8, 1H of {(C3N2H2)C(CH3)3}2C5NH3], 7.75 [d, 3JH-H = 8, 2H of {(C3N2H2)C(CH3)3}2C5NH3], 













6.5 Crystallographic Data  








lattice Orthorhombic Orthorhombic 
formula C29H23N3 C33H31N3 
formula weight 413.50 469.61 
space group Cmc21 Pbca 
a/Å 43.167(7) 12.732(11) 
b/Å 7.5075(12) 12.125(11) 
c/Å 6.5755(10) 33.74(3) 
%/˚ 90.00 90.00 
$/˚ 90.00 90.00 
'/˚ 90.00 90.00 
V/Å3 21330.9(6) 5209(8) 
Z 4 8 
temperature (K) 125(2) 125(2) 
radiation ((, Å) 0.71073 0.71073 
) (calcd.), g cm-3 1.289 1.198 
µ (Mo K%), mm-1 0.076 0.070 
* max, deg. 32.47 25.35 
no. of data collected 17270 54167 
no. of data used 3727 4776 
no. of parameters 150 331 
R1 [I > 2+(I)] 0.0520 0.0850 
wR2 [I > 2+(I)] 0.1367 0.0925 
R1 [all data] 0.0708 0.3792 
wR2 [all data] 0.1522 0.1490 
GOF 1.013 0.983 
Rint 0.0425 0.9900 
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lattice Triclinic Monoclinic 
formula C29H23Cl2CoN3 C29H23CoI2N3 
formula weight 543.33 726.23 
space group P-1 P21/c 
a/Å 10.2156(12) 9.2216(13) 
b/Å 10.9385(12) 28.687(4) 
c/Å 12.3862(14) 10.3786(15) 
%/˚ 71.470(2) 90 
$/˚ 76.116(2) 105.484(2) 
'/˚ 70.852(2) 90 
V/Å3 1225.4(2) 2645.9(7) 
Z 2 4 
temperature (K) 125(2) 125(2) 
radiation ((, Å) 0.71073 0.71073 
) (calcd.), g cm-3 1.473 1.823 
µ (Mo K%), mm-1 0.942 3.005 
* max, deg. 26.371 30.594 
no. of data collected 14942 42333 
no. of data used 5020 8098 
no. of parameters 316 316 
R1 [I > 2+(I)] 0.0339 0.0471 
wR2 [I > 2+(I)] 0.0781 0.1013 
R1 [all data] 0.0481 0.0864 
wR2 [all data] 0.0830 0.1125 
GOF 1.206 1.187 
Rint 0.0364 0.0702 
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lattice Monoclinic Orthorhombic 
formula C29H23I2N3Zn C64H55I4N9Zn2 
formula weight 732.67 1588.51 
space group P21/n Pbca 
a/Å 7.7472(10) 18.9254(14) 
b/Å 37.339(5) 21.9086(17) 
c/Å 9.1403(11) 29.536(2) 
%/˚ 90 90 
$/˚ 93.265(2) 90 
'/˚ 90 90 
V/Å3 2639.7(6) 12246.5(16) 
Z 4 8 
temperature (K) 125(2) 125(2) 
radiation ((, Å) 0.71073 0.71073 
) (calcd.), g cm-3 1.844 1.723 
µ (Mo K%), mm-1 3.292 2.847 
* max, deg. 26.370 30.565 
no. of data collected 31771 192217 
no. of data used 5411 18734 
no. of parameters 316 715 
R1 [I > 2+(I)] 0.0541 0.0548 
wR2 [I > 2+(I)] 0.0721 0.1160 
R1 [all data] 0.1406 0.1291 
wR2 [all data] 0.0923 0.1412 
GOF 1.000 1.091 
Rint 0.2084 0.1559 
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lattice Monoclinic Monoclinic 
formula C34H32Cl3I2N3Zn C19H25ILiN5 
formula weight 908.14 457.28 
space group P21/n P21/n 
a/Å 12.476(11) 13.230(3) 
b/Å 17.087(15) 12.087(2) 
c/Å 16.953(15) 14.635(4) 
%/˚ 90 90 
$/˚ 102.655(14) 116.828(3) 
'/˚ 90 90 
V/Å3 3526(5) 2088.4(8) 
Z 4 4 
temperature (K) 125(2) 150(2) 
radiation ((, Å) 0.71073 0.71073 
) (calcd.), g cm-3 1.711 1.454 
µ (Mo K%), mm-1 2.703 1.545 
* max, deg. 27.094 32.170 
no. of data collected 47971 35601 
no. of data used 9191 7258 
no. of parameters 361 235 
R1 [I > 2+(I)] 0.0910 0.0420 
wR2 [I > 2+(I)] 0.1479 0.0746 
R1 [all data] 0.2706 0.0919 
wR2 [all data] 0.1915 0.0884 
GOF 1.079 1.005 
Rint 0.3975 0.0831 
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lattice Monoclinic Monoclinic 
formula C19H25FeCl2N5 C19H25FeI2N5 
formula weight 450.19 633.09 
space group C2/c P21/c 
a/Å 18.3603(17) 9.4915(19) 
b/Å 12.6993(12) 15.198(3) 
c/Å 9.2679(9) 15.753(3) 
%/˚ 90 90.00 
$/˚ 109.3340(10) 98.021(3) 
'/˚ 90 90.00 
V/Å3 2039.1(3) 2250.3(8) 
Z 4 4 
temperature (K) 200(2) 150(2) 
radiation ((, Å) 0.71073 0.71073 
) (calcd.), g cm-3 1.466 1.869 
µ (Mo K%), mm-1 1.016 3.428 
* max, deg. 30.487 30.60 
no. of data collected 16156 35983 
no. of data used 3110 6915 
no. of parameters 127 250 
R1 [I > 2+(I)] 0.0346 0.0474 
wR2 [I > 2+(I)] 0.0795 0.0882 
R1 [all data] 0.0518 0.1070 
wR2 [all data] 0.0890 0.1068 
GOF 1.028 1.004 
Rint 0.0434 0.1102 
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lattice Monoclinic Monoclinic 
formula C19H25CoI2N5 C19H25I2N5Zn 
formula weight 636.17 642.61 
space group P21/c  
a/Å 9.5177(17) 9.5849(15) 
b/Å 15.327(3) 15.297(2) 
c/Å 15.792(3) 15.839(2) 
%/˚ 90 90 
$/˚ 97.931(3) 100.023(2) 
'/˚ 90 90 
V/Å3 2281.7(7) 2286.9(6) 
Z 4 4 
temperature (K) 200(2) 200(2) 
radiation ((, Å) 0.71073 0.71073 
) (calcd.), g cm-3 1.852 1.866 
µ (Mo K%), mm-1 3.471 3.787 
* max, deg. 30.507 30.664 
no. of data collected 35672 35746 
no. of data used 6965 7017 
no. of parameters 250 244 
R1 [I > 2+(I)] 0.0334 0.0473 
wR2 [I > 2+(I)] 0.0509 0.1034 
R1 [all data] 0.0703 0.1102 
wR2 [all data] 0.0586 0.1341 
GOF 1.001 1.011 
Rint 0.0653 0.0876 
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formula weight 2238.77 









temperature (K) 200(2) 
radiation ((, Å) 0.71073 
) (calcd.), g cm-3 1.891 
µ (Mo K%), mm-1 3.340 
* max, deg. 30.526 
no. of data collected 124473 
no. of data used 23928 
no. of parameters 784 
R1 [I > 2+(I)] 0.0545 
wR2 [I > 2+(I)] 0.1229 
R1 [all data] 0.1069 
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